
<html lang="en"     class="pb-page"  data-request-id="cfa2e1e0-086c-48e8-afba-b554a3739eeb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm101459g;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder" /></meta><meta name="dc.Creator" content="Benny  Bang-Andersen" /></meta><meta name="dc.Creator" content="Thomas  Ruhland" /></meta><meta name="dc.Creator" content="Morten  Jørgensen" /></meta><meta name="dc.Creator" content="Garrick  Smith" /></meta><meta name="dc.Creator" content="Kristen  Frederiksen" /></meta><meta name="dc.Creator" content="Klaus Gjervig  Jensen" /></meta><meta name="dc.Creator" content="Huailing  Zhong" /></meta><meta name="dc.Creator" content="Søren Møller  Nielsen" /></meta><meta name="dc.Creator" content="Sandra  Hogg" /></meta><meta name="dc.Creator" content="Arne  Mørk" /></meta><meta name="dc.Creator" content="Tine Bryan  Stensbøl" /></meta><meta name="dc.Description" content="The synthesis and structure−activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter (SERT) are described. C..." /></meta><meta name="Description" content="The synthesis and structure−activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter (SERT) are described. C..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 12, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101459g" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101459g" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101459g" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101459g" /></link>
        
    
    

<title>Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101459g" /></meta><meta property="og:title" content="Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0015.jpeg" /></meta><meta property="og:description" content="The synthesis and structure−activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter (SERT) are described. Compound 5m (Lu AA21004) was the lead compound, displaying high affinity for recombinant human 5-HT1A (Ki = 15 nM), 5-HT1B (Ki = 33 nM), 5-HT3A (Ki = 3.7 nM), 5-HT7 (Ki = 19 nM), and noradrenergic β1 (Ki = 46 nM) receptors, and SERT (Ki = 1.6 nM). Compound 5m displayed antagonistic properties at 5-HT3A and 5-HT7 receptors, partial agonist properties at 5-HT1B receptors, agonistic properties at 5-HT1A receptors, and potent inhibition of SERT. In conscious rats, 5m significantly increased extracellular 5-HT levels in the brain after acute and 3 days of treatment. Following the 3-day treatment (5 or 10 (mg/kg)/day) SERT occupancies were only 43% and 57%, respectively. These characteristics indicate that 5m is a novel multimodal serotonergic compound, and 5m is currently in clinical development for major depressive disorder." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101459g"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101459g">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101459g&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101459g&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101459g&amp;href=/doi/10.1021/jm101459g" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3206-3221</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101388d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1014617" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benny++Bang-Andersen">Benny Bang-Andersen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Ruhland">Thomas Ruhland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Morten++J%C3%B8rgensen">Morten Jørgensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Garrick++Smith">Garrick Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristen++Frederiksen">Kristen Frederiksen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Klaus+Gjervig++Jensen">Klaus Gjervig Jensen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huailing++Zhong">Huailing Zhong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%B8ren+M%C3%B8ller++Nielsen">Søren Møller Nielsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Hogg">Sandra Hogg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arne++M%C3%B8rk">Arne Mørk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tine+Bryan++Stensb%C3%B8l">Tine Bryan Stensbøl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652-1431, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +45 3643 3247. Fax: +45 3643 8237. E-mail: <a href="/cdn-cgi/l/email-protection#2c4e4d426c405942484e494f47024f4341"><span class="__cf_email__" data-cfemail="97f5f6f9d7fbe2f9f3f5f2f4fcb9f4f8fa">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101459g&amp;href=/doi/10.1021%2Fjm101459g" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3206–3221</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 12, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 November 2010</li><li><span class="item_label"><b>Published</b> online</span>12 April 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 May 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101459g" title="DOI URL">https://doi.org/10.1021/jm101459g</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3206%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBenny%2BBang-Andersen%252C%2BThomas%2BRuhland%252C%2BMorten%2BJ%25C3%25B8rgensen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D9%26contentID%3Djm101459g%26title%3DDiscovery%2Bof%2B1-%255B2-%25282%252C4-Dimethylphenylsulfanyl%2529phenyl%255Dpiperazine%2B%2528Lu%2BAA21004%2529%253A%2BA%2BNovel%2BMultimodal%2BCompound%2Bfor%2Bthe%2BTreatment%2Bof%2BMajor%2BDepressive%2BDisorder%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3221%26publicationDate%3DMay%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101459g"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6392</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">255</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101459g" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Benny&quot;,&quot;last_name&quot;:&quot;Bang-Andersen&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Ruhland&quot;},{&quot;first_name&quot;:&quot;Morten&quot;,&quot;last_name&quot;:&quot;Jørgensen&quot;},{&quot;first_name&quot;:&quot;Garrick&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Kristen&quot;,&quot;last_name&quot;:&quot;Frederiksen&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;Gjervig Jensen&quot;},{&quot;first_name&quot;:&quot;Huailing&quot;,&quot;last_name&quot;:&quot;Zhong&quot;},{&quot;first_name&quot;:&quot;Søren&quot;,&quot;last_name&quot;:&quot;Møller Nielsen&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Hogg&quot;},{&quot;first_name&quot;:&quot;Arne&quot;,&quot;last_name&quot;:&quot;Mørk&quot;},{&quot;first_name&quot;:&quot;Tine&quot;,&quot;last_name&quot;:&quot;Bryan Stensbøl&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;3206-3221&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101459g&quot;},&quot;abstract&quot;:&quot;The synthesis and structure−activity relationship of a novel series of compounds with combined effects on 5-HT3A and 5-HT1A receptors and on the serotonin (5-HT) transporter (SERT) are described. Compound 5m (Lu AA21004) was the lead compound, displaying high affinity for recombinant human 5-HT1A (Ki = 15 nM), 5-HT1B (Ki = 33 nM), 5-HT3A (Ki = 3.7 nM), 5-HT7 (Ki = 19 nM), and noradrenergic β1 (Ki = 46 nM) receptors, and SERT (Ki = 1.6 nM). Compound 5m displayed antagonistic properties at 5-HT3A and 5-HT7 receptors, partial agonist properties at 5-HT1B receptors, agonistic properties at 5-HT1A receptors, and potent inhibition of SERT. In conscious rats, 5m significantly increased extracellular 5-HT levels in the brain after acute and 3 days of treatment. Following the 3-day treatment (5 or 10 (mg/kg)/day) SERT occupancies were only 43% and 57%, respectively. These characteristics indicate that 5m is a novel multimodal serotonergic compound, and 5m is currently in clinical development for major depressive disor&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101459g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101459g" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101459g&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101459g" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101459g&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101459g" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101459g&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101459g&amp;href=/doi/10.1021/jm101459g" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101459g" /></input><a href="/doi/pdf/10.1021/jm101459g" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101459g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101459g%26sid%3Dliteratum%253Aachs%26pmid%3D21486038%26genre%3Darticle%26aulast%3DBang-Andersen%26date%3D2011%26atitle%3DDiscovery%2Bof%2B1-%255B2-%25282%252C4-Dimethylphenylsulfanyl%2529phenyl%255Dpiperazine%2B%2528Lu%2BAA21004%2529%253A%2BA%2BNovel%2BMultimodal%2BCompound%2Bfor%2Bthe%2BTreatment%2Bof%2BMajor%2BDepressive%2BDisorder%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D9%26spage%3D3206%26epage%3D3221%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jmcmar.2011.54.issue-9/production/jmcmar.2011.54.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and structure−activity relationship of a novel series of compounds with combined effects on 5-HT<sub>3A</sub> and 5-HT<sub>1A</sub> receptors and on the serotonin (5-HT) transporter (SERT) are described. Compound <b>5m</b> (Lu AA21004) was the lead compound, displaying high affinity for recombinant human 5-HT<sub>1A</sub> (<i>K</i><sub>i</sub> = 15 nM), 5-HT<sub>1B</sub> (<i>K</i><sub>i</sub> = 33 nM), 5-HT<sub>3A</sub> (<i>K</i><sub>i</sub> = 3.7 nM), 5-HT<sub>7</sub> (<i>K</i><sub>i</sub> = 19 nM), and noradrenergic β<sub>1</sub> (<i>K</i><sub>i</sub> = 46 nM) receptors, and SERT (<i>K</i><sub>i</sub> = 1.6 nM). Compound <b>5m</b> displayed antagonistic properties at 5-HT<sub>3A</sub> and 5-HT<sub>7</sub> receptors, partial agonist properties at 5-HT<sub>1B</sub> receptors, agonistic properties at 5-HT<sub>1A</sub> receptors, and potent inhibition of SERT. In conscious rats, <b>5m</b> significantly increased extracellular 5-HT levels in the brain after acute and 3 days of treatment. Following the 3-day treatment (5 or 10 (mg/kg)/day) SERT occupancies were only 43% and 57%, respectively. These characteristics indicate that <b>5m</b> is a novel multimodal serotonergic compound, and <b>5m</b> is currently in clinical development for major depressive disorder.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The approximate lifetime prevalence of major depressive disorder (MDD) and anxiety disorders in the United States is 17% and 29%, respectively, and onset is typically in childhood or adolescence.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> According to the World Health Organization’s Global Burden of Disease project, MDD will become the second leading cause of disability worldwide within the next 10 years.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Pharmacotherapy for MDD and anxiety disorders has been available since the late 1950s, when the tricyclic antidepressants (TCAs) and the monoamine oxidase inhibitors (MAOIs) became clinically available. During the 1980s, the first selective serotonin (5-HT) reuptake inhibitors (selective SRIs or SSRIs) were introduced and since then have become the most widely prescribed medication for the treatment of depression and related disorders.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> SSRIs such as fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram (<b>1</b>) show similar efficacy but clear advantages in terms of improved tolerability and a superior safety profile compared to TCAs and MAOIs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The serotonin and norepinephrine (NE) reuptake inhibitors (SNRIs) venlafaxine, duloxetine, desvenlafaxine, and milnacipran, as well as the allosteric serotonin reuptake inhibitor escitalopram, have been marketed in the 1990s and during the new millennium. In contrast to SSRIs, SNRIs display modest improved efficacy and a slightly faster onset of antidepressant action but lower tolerability.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Despite more than 5 decades of research, there are still high unmet needs in the treatment of depression. For example, the treatment with currently available antidepressants shows modest efficacy, and the majority of patients with MDD fail to achieve full remission with current therapies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition, a relatively long time to onset of symptom relief and issues with relapse characterize marketed antidepressants. Future drugs will also need to address cognitive impairment, pain, and drug-related side effects such as sexual dysfunction, nausea/emesis, weight gain, and potential cardiovascular effects.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">For many years, the medical community and pharmaceutical companies have been focusing on developing superior pharmacotherapeutic strategies for the treatment of depression and anxiety.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Clinical research has demonstrated that the antidepressant activity of SSRIs may be augmented by coadministration of pindolol, an effect that has been attributed to pindolol’s partial agonistic effect at the 5-HT<sub>1A</sub> receptor.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This observation has inspired many pharmaceutical companies to launch research programs with the aim of discovering designed multiple ligands (DMLs)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> with dual activity at the serotonin transporter (SERT) and the 5-HT<sub>1A</sub> receptor. Other profiles such as triple reuptake inhibitors [SERT, NE transporter (NET), and dopamine (DA) transporter (DAT) inhibition] and compounds inhibiting SERT plus various combinations of 5-HT receptor subtypes have also been pursued.<a onclick="showRef(event, 'ref7 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref12">(7, 12)</a></div><div class="NLM_p">At H. Lundbeck A/S, DML programs were pursued with the goal of finding a new generation of antidepressants. These were defined prior to initiation of the lead generation program (5-HT<sub>2C</sub> antagonism and SRI),<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> or they emerged from the knowledge that was generated during such programs (5-HT<sub>3</sub> receptor antagonism, 5-HT<sub>1A</sub> receptor agonism, and SRI). The objective of the current program was to find a compound that combines 5-HT<sub>3</sub> receptor antagonism, 5-HT<sub>1A</sub> receptor agonism, and SERT inhibition in a single molecule and that will exert superior antidepressant effects in humans compared to marketed drugs. Recently, the term multimodal was coined for compounds that combine at least two separate pharmacological modes of action that complement each other in terms of efficacy or tolerability.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Here we describe the biological rationale for a novel class of putative multimodal antidepressants, which is proposed to act via different modes of action, namely, blocking ligand-gated ion channels (5-HT<sub>3</sub> receptor) and monoamine transporters (SERT), as well as activating G-protein-coupled receptors (5-HT<sub>1A</sub> receptor). SERT inhibition is important for antidepressant and anxiolytic activity.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The simultaneous use of an efficacious 5-HT<sub>1A</sub> receptor agonist, together with a SERT inhibitor, is expected to rapidly desensitize the inhibitory somatodendritic 5-HT<sub>1A</sub> autoreceptors and, at the same time, to mediate part of the antidepressant effect through activation of postsynaptic 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The rationale for adding 5-HT<sub>3</sub> receptor antagonism was based on preclinical studies demonstrating that 5-HT<sub>3</sub> receptor antagonists eliminate the inhibitory tonus of 5-HT<sub>3</sub> receptors on the release of NE and acetylcholine (AcCh) in the forebrain, via 5-HT<sub>3</sub> heteroreceptors located on inhibitory γ-aminobutyric acid (GABA)-ergic interneurons.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19)</a><a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(-22)</a> These studies indicate that 5-HT<sub>3</sub> receptor antagonists may exert positive effects on mood and cognitive impairment in patients with depression. Adding to this point, 5-HT<sub>1A</sub> receptor agonists such as buspirone (<b>2</b>) are used as anxiolytics in the clinic, whereas 5-HT<sub>3</sub> receptor antagonists such as ondansetron (<b>3</b>) are used to treat the nausea associated with chemotherapy and have shown some success in alleviating the gastrointestinal distress associated with SSRIs.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Interestingly, litoxetine, initially described as an SSRI, was later shown to possess antiemetic properties in ferrets that were ascribed to its moderate 5-HT<sub>3</sub> receptor antagonistic properties.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Hence, a combined 5-HT<sub>3</sub> receptor antagonist, 5-HT<sub>1A</sub> receptor agonist, and SERT inhibitor was hypothesized to have the potential to treat significant clinical unmet needs in MDD and generalized anxiety disorder (GAD).</div><div class="NLM_p">In a focused screening program we identified the arylpiperazine <b>4b</b> and a number of structural analogues as a lead series. Arylpiperazines are well-known motifs that are typically found in compounds possessing activities toward a broad range of targets, including various 5-HT receptor subtypes. For example, some 1-(2-phenoxyaryl)piperazines, although structurally similar to our lead series, were recently found to display a slightly different pharmacological profile, such as high 5-HT<sub>1A</sub> receptor affinity but only modest SERT inhibition.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This and other examples indicate that the design of molecules, interacting in a predefined manner with three different target classes (i.e., ligand-gated ion channels, G-protein-coupled receptors, and monoamine transporters), will be challenging, and it was also anticipated that compounds fulfilling our design hypothesis might well interact with additional targets in a subsequent broader target profiling. Indeed, we found that compound <b>4b</b> displays moderate human (h) 5-HT<sub>3A</sub> receptor affinity, very weak h5-HT<sub>1A</sub> receptor affinity, and potent rat (r) SERT inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), as well as high affinity (<i>K</i><sub>i</sub> < 100 nM) for h5-HT<sub>2C</sub> and rα<sub>1</sub> receptors (data not shown). Structurally closely related members of the series displayed substantially higher affinity for h5-HT<sub>3A</sub> and/or h5-HT<sub>1A</sub> receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In contrast to compound <b>4b</b>, some of the analogues showed good human microsomal stability and/or minimal cytochrome P450 (CYP450) enzyme inhibition (data not shown). Thus, the series was a useful starting point for a number of DML programs, including the structure−activity relationship (SAR) studies reported herein that led to the discovery of <b>5m</b> (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0014.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of citalopram (<b>1</b>), buspirone (<b>2</b>), ondansetron (<b>3</b>), target compounds (<b>4-6</b>) and <b>5m</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structure−Activity Relationship of Compounds <b>4a</b>−<b>1</b> Compared with Reference Compounds Citalopram (<b>1</b>), Buspirone (<b>2</b>), and Ondansetron (<b>3</b>) at Human (h) 5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> Receptors and the Rat (r) Serotonin Transporter (rSERT)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0002.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">synthesis method</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">h5-HT<sub>3A</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">h5-HT<sub>1A</sub><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">rSERT<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4a</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4b</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">4000</td><td class="colsep0 rowsep0" align="left">7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4c</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">500</td><td class="colsep0 rowsep0" align="left">2500</td><td class="colsep0 rowsep0" align="left">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4d</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">440</td><td class="colsep0 rowsep0" align="left">1100</td><td class="colsep0 rowsep0" align="left">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4e</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">260</td><td class="colsep0 rowsep0" align="left">2800</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4f</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">390</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4g</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4h</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4i</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4j</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4k</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4l</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">C(CH<sub>3</sub>)<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">450</td><td class="colsep0 rowsep0" align="left">2500</td><td class="colsep0 rowsep0" align="left">2100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b>, citalopram</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">3.9<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b>, buspirone</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3</b>, ondansetron</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">>2000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data are the mean of a minimum of two determinations covering 6 decades for each compound. <i>K</i><sub>i</sub> values were calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>d</sub>)). NT, not tested.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">[<sup>3</sup>H]Granisetron binding to cloned 5-HT<sub>3A</sub> receptors.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">[<sup>3</sup>H]5-Carboxamidotryptamine binding to cloned 5-HT<sub>1A</sub> receptors.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">[<sup>3</sup>H]5-HT uptake measured in rat synaptosomes.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Reference <a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">59</a>.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Several different strategies were employed for the synthesis of the target compounds <b>4</b>−<b>6</b>. The compound class was initially prepared by solid-phase synthesis in order to generate compound libraries for lead discovery programs. The key step of this synthetic strategy was the generation of aromatic carbon−heteroatom bonds through iron-assisted nucleophilic aromatic substitution.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> This was a suitable method for the preparation of focused libraries in a short space of time. However, a different approach was necessary in order to synthesize such molecules in larger quantities and in order to prepare molecules with a more complex substitution pattern on the central benzene ring. For this purpose, the target compounds were synthesized either by two sequential palladium-catalyzed carbon−heteroatom bond formations<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> (methods A and B, Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) or through cyclization of anilines with bis(2-bromoethyl)amine (method C). In method A, the synthesis started from 2-bromo-substituted <i>N</i>-phenylpiperazines <b>7</b> that were readily available in multigram quantities through a selective monoamination of dihalogenated benzenes.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The thioether linkage was subsequently formed using the method reported by Schopfer and Schlapbach.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In the analogous method B, the order of steps was reversed. For both strategies, the required starting materials, halogenated benzenes, were either commercially available or could be readily obtained from the corresponding anilines. Finally, the resulting <i>tert</i>-butyloxycarbonyl (Boc)-protected intermediates were deprotected to give the target molecules <b>4</b>−<b>6</b> as their hydrochloride salts. Overall, method B turned out to be more practical than methods A and C, since the Boc-protected target molecules were easily separated by chromatography from unreacted diaryl sulfides and hydrodebrominated byproducts.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds by Method A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0013.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds by Method B</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure−Activity Relationship Studies</h3><div class="NLM_p">The affinities of target compounds <b>4</b>−<b>6</b> for the cloned h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors were determined by use of in vitro binding competition assays with membranes prepared from cells expressing the relevant receptors, and data are reported as <i>K</i><sub>i</sub> values (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for p<i>K</i><sub>i</sub> ± SEM values). The inhibition of uptake of [<sup>3</sup>H]5-HT, [<sup>3</sup>H]NE, and [<sup>3</sup>H]DA into rat brain synaptosomes through the monoamine transporters was also measured, and data are reported as mean IC<sub>50</sub> values (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for pIC<sub>50</sub> ± SD/SEM values) of at least two independent determinations. These data are shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, along with the structure of the compounds. While affinity measures were used at the cloned h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors, for historical reasons a functional readout was used as the SAR driving assay for assessing potency at the SERT. Internal data and literature data, however, have demonstrated a close correlation between affinity at hSERT and potency in [<sup>3</sup>H]5-HT uptake assays, suggesting that values are comparable.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The compounds were prioritized for further SAR studies based on the ratios between the in vitro affinities/potencies at h5-HT<sub>3A</sub>, and h5-HT<sub>1A</sub> receptors and the rSERT. It has been demonstrated in both preclinical and clinical studies that a relatively high hSERT occupancy of around 80−90% is required for SSRIs and SNRIs to exert an antidepressant activity.<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> In contrast, the relationship between the in vivo occupancy in experimental animals and humans and the efficacy at 5-HT<sub>3</sub> and 5-HT<sub>1A</sub> receptors is less well described. However, receptor occupancies of >50% have been reported for the antiemetic activity of 5-HT<sub>3</sub> receptor antagonists including ondansetron (<b>3</b>),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> whereas much lower receptor occupancies have been estimated to be efficacious for buspirone (<b>2</b>) at 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> Hence, compounds were selected that displayed relative affinities/potencies (<i>K</i><sub>i</sub>/IC<sub>50</sub>) at h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors and rSERT corresponding to rSERT/h5-HT<sub>3A</sub>/h5-HT<sub>1A</sub> ≈ 1:(1−5):(5−15). From a hypothesis that the in vitro profile alone would reflect the relative in vivo occupancies, these ratios would correspond to in vivo occupancy levels of 45−80% at 5-HT<sub>3</sub> receptors and 20−45% at 5-HT<sub>1A</sub> receptors for a compound with an in vivo occupancy of 80% at SERT (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Furthermore, the compounds were only considered if the 5-HT<sub>1A</sub> receptor affinity was <100 nM in order to limit the amount of compounds for broader in vitro and in vivo profiling.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calculated relationships between the occupancy levels at 5-HT<sub>1A</sub> or 5-HT<sub>3</sub> receptors relative to serotonin (5-HT) transporter (SERT) occupancy. The line with circles (−●−) shows the relationship between the occupancies if the ratio between the SERT and 5-HT<sub>1A</sub> or 5-HT<sub>3</sub> is 1. The line with triangles (−▲−) shows the relationship when the ratio is 5, and the line with squares (−◼−) shows the relationship when the ratio is 15; i.e., a compound with occupancy of 80% at SERT would give occupancy of 45% at 5-HT<sub>1A</sub> receptors if the affinity at 5-HT<sub>1A</sub> receptors is 5-fold lower than at SERT, whereas only 20% occupancy would be obtained if the 5-HT<sub>1A</sub> receptors affinity is 15-fold lower than at SERT. The two hatched areas depict estimated clinically relevant occupancy levels at 5-HT<sub>1A</sub> and 5-HT<sub>3</sub> receptors based on these considerations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We first focused on the R<sub>1</sub> substituent in the phenylsulfanyl ring and the R<sub>5</sub> substituent in the central benzene ring of lead compound <b>4b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). A number of analogues of <b>4b</b> were available at the onset of the project. In contrast to the methoxy in <b>4b</b>, these analogues were furnished with either electron-withdrawing substituents (R<sub>1</sub> = F or CF<sub>3</sub>) or substituents with limited electronic effects (R<sub>1</sub> = Cl, CH<sub>3</sub>, and <i>tert</i>-butyl). The series of compounds was extended by synthesizing analogues carrying a hydrogen atom at R<sub>5</sub> instead of the methyl substituent of <b>4b</b>. These latter compounds demonstrated higher affinities at the 5-HT<sub>3A</sub> and 5-HT<sub>1A</sub> receptors in comparison with compounds furnished with a methyl substituent at this position, i.e., <b>4a</b>−<b>e</b> compared with <b>4f</b>−<b>j</b>. All compounds with relatively small substituents at R<sub>1</sub> and either a hydrogen atom or a methyl substituent at R<sub>5</sub> (<b>4b</b>,<b>c</b>,<b>e</b>,<b>g</b>,<b>h</b>,<b>j</b>,<b>k</b>) inhibited rSERT in the same range, whereas compounds with a fluoro atom (<b>4d</b> and <b>4i</b>) or a hydrogen atom (<b>4a</b> and <b>4f</b>) exhibited weaker rSERT inhibition. The compound <b>4l</b> with the large <i>tert</i>-butyl substituent was a significant weaker inhibitor of rSERT, demonstrating that small R<sub>1</sub> substituents are preferred for potent rSERT inhibition. It was also shown that rSERT inhibition seemed to be less affected by the electronic effects of the R<sub>1</sub> substituent as long as the substituent was above a certain size. The compounds with an electron-donating methoxy substituent (<b>4b</b> and <b>4g</b>), a more or less neutral methyl or chloro substituent (<b>4e</b>, <b>4j</b>, <b>4c</b>, and <b>4h</b>), or an electron-withdrawing trifluoromethyl substituent (<b>4k</b>) were more or less equipotent rSERT inhibitors. From this initial series, compounds <b>4h</b> and <b>4j</b> were selected for further in vitro evaluation (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), whereas compounds <b>4a</b>−<b>e</b>,<b>g</b>,<b>k</b>,<b>l</b> were discarded because of their relative low h5-HT<sub>1A</sub> receptor affinities and compounds <b>4f</b> and <b>4i</b> were discarded because of their low rSERT inhibition and suboptimal ratio between rSERT inhibition and h5-HT<sub>1A</sub> receptor affinity.</div><div class="NLM_p">We extended the series of compounds through the synthesis of analogues carrying a hydrogen atom at R<sub>5</sub> and methoxy, chloro, and/or methyl groups at other positions of the phenylsulfanyl ring. Thus, the effects of moving the substituent from R<sub>1</sub> to either R<sub>2</sub> or R<sub>3</sub> and of having two substituents (two identical or two different substituents) in the phenylsulfanyl ring were investigated (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In general, all of these compounds (<b>5a</b>−<b>p</b>) turned out to have relative high affinities for h5-HT<sub>3A</sub> receptors (<i>K</i><sub>i</sub> from 7.3 to 110 nM). These compounds also showed moderate to high affinities at the h5-HT<sub>1A</sub> receptor (<i>K</i><sub>i</sub> from 14 to 330 nM) and moderate to high activity at rSERT (IC<sub>50</sub> from 4.3 to 330 nM). Compounds with a methoxy or a methyl substituent at R<sub>2</sub> or R<sub>3</sub> (<b>5a</b>−<b>d</b>) were weaker rSERT inhibitors than the corresponding R<sub>1</sub> analogues (<b>4g</b> and <b>4j)</b>. Compound <b>5d</b>, with a monomethyl substituent at R<sub>3</sub>, showed high affinity for h5-HT<sub>1A</sub> receptors, and the corresponding R<sub>1</sub> and R<sub>2</sub> analogues <b>4j</b> and <b>5b</b> showed weaker affinities for h5-HT<sub>1A</sub> receptors compared with <b>5d</b> by factors of 3 and 7, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure−Activity Relationship of Compounds <b>5a</b>−<b>p</b> at Human (h) 5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> Receptors and the Rat (r) Serotonin Transporter (rSERT)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0003.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">synthesis method</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">h5-HT<sub>3A</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">h5-HT<sub>1A</sub><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">rSERT<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">330</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">330</td><td class="colsep0 rowsep0" align="left">7.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">23/3.7<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">39/15<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">5.3/5.4<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5n</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">94</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5o</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">9.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data are the mean of a minimum of two determinations covering 6 decades for each compound. <i>K</i><sub>i</sub> values were calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>d</sub>)).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">[<sup>3</sup>H]Granisetron binding to cloned h5-HT<sub>3A</sub> receptors.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">[<sup>3</sup>H]5-Carboxamidotryptamine binding to cloned 5-HT<sub>1A</sub> receptors.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">[<sup>3</sup>H]5-HT uptake from rat synaptosomes.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">External data obtained from Cerep, catalogue number 808-3h.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">External data obtained from MDS Pharmaservices, catalogue number 271110.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">[<sup>3</sup>H]5-HT uptake from CHO cells expressing hSERT. For compound <b>5m</b>, in-house and external data are shown for h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors, and for SERT both rat and human data are shown.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure−Activity Relationship of Key Compounds Selected from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> at Rat Serotonin Transporter (rSERT), Rat Dopamine Transporter (rDAT), and Rat Norepinephrine Transporter (rNET), as well as the Calculated Ratios rDAT/rSERT and rNET/rSERT</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">ratio</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">rSERT<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rDAT<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rNET<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rDAT/rSERT</th><th class="colsep0 rowsep0" align="center">rNET/rSERT</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4h</b></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">37/45<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">160/190<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.8/3.5<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">12/15<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">460</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">120<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">880<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">21<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">120<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">170<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">90<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">250<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">120<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">890</td><td class="colsep0 rowsep0" align="left">140</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5p</b></td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">320<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">340<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data are the mean of a minimum of two values. IC<sub>50</sub> values were determined using drug concentrations covering at least 3 decades.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">[<sup>3</sup>H]5-HT, [<sup>3</sup>H]DA, and [<sup>3</sup>H]NE uptake from rat synaptosomes.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Cerep catalogue numbers 711 and 712 for rNET and rDAT, respectively.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">For compound <b>4h</b>, ratios from in-house and external data are shown.</p></div></div></div><div class="NLM_p">Six compounds were synthesized with two identical adjacent substituents, i.e., compounds with the same substituent at R<sub>1</sub> and R<sub>2</sub> (<b>5e</b>,<b>f</b>,<b>g</b>) or at R<sub>2</sub> and R<sub>3</sub> (<b>5h</b>,<b>i</b>,<b>j</b>). These compounds were all relatively potent rSERT inhibitors with favorable ratios between the three targets. However, only compounds <b>5g</b>, <b>5i</b>, and <b>5j</b> were selected for further in vitro investigations (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Three compounds with identical substituents at R<sub>1</sub> and R<sub>3</sub> were also synthesized (<b>5k</b>,<b>l</b>,<b>m</b>), and all these compounds had the desired h5-HT<sub>3A</sub>/rSERT ratio. Whereas compound <b>5k</b> showed weak h5-HT<sub>1A</sub> receptor affinity, compounds <b>5l</b> and <b>5m</b> were selected for further in vitro profiling (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Finally, three analogues with different substituents at R<sub>1</sub> and R<sub>3</sub> were synthesized (<b>5n</b>,<b>o</b>,<b>p</b>). Only compound <b>5p</b> was selected for further in vitro profiling (Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), since compounds <b>5n</b> and <b>5o</b> showed low 5-HT<sub>1A</sub> receptor affinities, i.e., compound <b>5n</b> in relation to inhibition of SERT and <b>5o</b> with <i>K</i><sub>i</sub> > 100 nM.</div><div class="NLM_p">Compounds <b>4h</b>, <b>4j</b>, <b>5g</b>, <b>5i</b>, <b>5j</b>, <b>5l</b>, <b>5m</b>, and <b>5p</b> were tested for rNET and rDAT inhibition. The ratios between rDAT and rSERT and between rNET and rSERT inhibition are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The rNET/rSERT ratios ranged from 7 to 150, whereas the rDAT/rSERT ratios ranged from 1 to 170. Compound <b>5m</b> exhibited the highest ratio (170) between rDAT and rSERT inhibition. Compound <b>5g</b> showed the highest ratio (150) between rNET and rSERT inhibition, and a group of compounds including <b>5m</b> showed rSERT selectivity with ratios ranging from 20 to 35. Furthermore, drug metabolism and pharmacokinetic (DMPK) properties of the compounds in the series were optimized by monitoring their in vitro metabolic stability in rat and human liver microsomes and by assessing the inhibitory potential of the compounds toward recombinant (cDNA-expressed) human CYP450 enzymes. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the compounds generally showed good stability in human liver microsomes; i.e., the intrinsic clearances (CL<sub>int</sub>) of all but one (<b>5i</b>) were below that for the human liver blood flow (LBF). Conversely, in rat liver microsomes the CL<sub>int</sub> were all above the rat LBF of 20 mL/min, indicating high clearance in vivo. This was confirmed in vivo for all compounds tested in the project, e.g., for compounds <b>4h</b> and <b>5m</b> the hepatic clearances and oral bioavailabilities in rats were found to be 5.8 and 7.1 (L/h)/kg and 26% and 16%, respectively. Furthermore, inhibition of CYP1A2, CYP2C9, and CYP3A4 was found to be in the high micromolar range for all compounds, while inhibition toward CYP2D6 ranged from 0.4 μM for compound <b>4h</b> to 9.8 μM for compound <b>5m</b>. On the basis of the favorable in vitro and DMPK profile, compound <b>5m</b> was selected for further SAR exploration, as well as for broader in vitro and in vivo profiling.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Metabolic Stability in Rat and Human Liver Microsomes and Inhibition of Recombinant (cDNA-expressed) Human CYP Enzymes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">Cl<sub>int</sub> (L/min)</th><th class="rowsep1 colsep0" align="center" char=".">Cl<sub>int</sub> (mL/min)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">CYP1A2</th><th class="colsep0 rowsep0" align="center" char=".">CYP2C9</th><th class="colsep0 rowsep0" align="center" char=".">CYP2D6</th><th class="colsep0 rowsep0" align="center" char=".">CYP3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4j</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">260</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5g</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">290</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5i</b></td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">260</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5j</b></td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5l</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5m</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5p</b></td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">LBF<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">LBF, liver blood flow.</p></div></div></div><div class="NLM_p">The SAR of <b>5m</b> was further explored by a “methyl walk” around the entire molecular framework (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In addition, the piperazine ring was replaced with a homopiperazine (<b>6f</b>) and the sulfur atom with an oxygen atom (<b>6g</b>). In comparison to <b>5m</b>, all of these compounds showed weaker rSERT inhibition, and only compound <b>6g</b> had acceptable h5-HT<sub>1A</sub> receptor affinity. They also had relatively large variations in their affinity for h5-HT<sub>3A</sub> receptors, with <i>K</i><sub>i</sub> ranging from 45 to 670 nM. Compound <b>6c</b> (R<sub>6</sub> = CH<sub>3</sub>) and homopiperazine <b>6f</b> showed some selectivity for h5-HT<sub>3A</sub> receptors, whereas the oxygen analogue <b>6g</b>, in agreement with literature data, had some selectivity for h5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structure−Activity Relationship of Compounds <b>6a</b>−<b>g</b> Compared with <b>5m</b> at Human (h) 5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> Receptors and the Rat Serotonin Transporter (rSERT)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0004.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">synthesis method</th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>6</sub></th><th class="colsep0 rowsep0" align="center">R<sub>7</sub></th><th class="colsep0 rowsep0" align="center">R<sub>8</sub></th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">h5-HT<sub>3A</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">h5-HT<sub>1A</sub><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">rSERT<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">420</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">2700</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">1400</td><td class="colsep0 rowsep0" align="left">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">670</td><td class="colsep0 rowsep0" align="left">540</td><td class="colsep0 rowsep0" align="left">540</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">680</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">310</td><td class="colsep0 rowsep0" align="left">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5m</b></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">23/3.7<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">40/15<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">5.3/5.4<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Data are the mean of a minimum of two determinations covering 6 decades for each compound. <i>K</i><sub>i</sub> values were calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>d</sub>].</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">[<sup>3</sup>H]Granisetron binding to cloned 5-HT<sub>3A</sub> receptors.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">[<sup>3</sup>H]5-Carboxamidotryptamine binding to cloned 5-HT<sub>1A</sub> receptors.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">[<sup>3</sup>H]5-HT uptake from rat synaptosomes.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">External data obtained from Cerep, catalogue number 808-3h.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">External data obtained from MDS Pharmaservices, catalogue number 271110.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">[<sup>3</sup>H]5-HT uptake from CHO cells expressing hSERT. For compound <b>5m</b>, in-house and external data are shown for h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors, and for SERT both rat and human data are shown.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Further Pharmacological and Pharmacokinetic Characterization of <b>5m</b></h3><div class="NLM_p">Compound <b>5m</b> displayed high binding affinity for cloned homomeric h5-HT<sub>3A</sub> receptors [<i>K</i><sub>i</sub> = 23 nM (in-house) and <i>K</i><sub>i</sub> = 3.7 nM (Cerep)]. In agreement with this, <b>5m</b> was shown to be a potent functional antagonist (IC<sub>50</sub> = 12 nM, tested against 10 μM 5-HT) when tested in an electrophysiological setup using <i>Xenopus</i> oocytes expressing cloned homomeric h5-HT<sub>3A</sub> receptors (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Conversely, at higher concentrations, <b>5m</b> showed agonistic properties (EC<sub>50</sub> = 2100 nM), reaching a maximal response of 64% relative to 5-HT (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The agonistic response could be blocked by the 5-HT<sub>3</sub> receptor antagonist ondansetron (data not shown). At r5-HT<sub>3A</sub> receptors, no agonistic response was found over a large concentration range (0.1−100000 nM), but in agreement with the findings at h5-HT<sub>3A</sub> receptors, <b>5m</b> was found to be a potent antagonist at r5-HT<sub>3A</sub> receptors (IC<sub>50</sub>= 0.18 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Compound <b>5m</b> displayed high binding affinity for cloned h5-HT<sub>1A</sub> receptors in two different assays (<i>K</i><sub>i</sub> = 39 nM (in-house) and <i>K</i><sub>i</sub> = 15 nM (MDS Pharmaservice), whereas relative low affinity binding was found at r5-HT<sub>1A</sub> receptors (<i>K</i><sub>i</sub> = 230 nM). In a [<sup>35</sup>S]guanosine 5′-<i>O</i>-(3-thio)triphosphate ([<sup>35</sup>S]GTPγS) binding assay with h5-HT<sub>1A</sub> receptors, <b>5m</b> was found to be an agonist (EC<sub>50</sub> = 200 nM, efficacy = 96%, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In vitro characterization showed that <b>5m</b> was a potent rSERT inhibitor (IC<sub>50</sub> = 5.3 nM) when assessed in rat brain synaptosomes, and a similar potency was found on hSERT when expressed in Chinese hamster ovary (CHO) cells (IC<sub>50</sub> = 5.4 nM). Comparably, binding affinity at hSERT was found to be 1.6 nM. Weak potencies (IC<sub>50</sub> > 100 nM) of <b>5m</b> were found at rNET and rDAT (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). At 1 μM, <b>5m</b> was tested against a panel of more than 75 ion channels, G-protein-coupled receptors, enzymes, and transporters (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Modest binding affinities were found at histamine hH<sub>2</sub>, melanocortin hMC<sub>4</sub>, noradrenergic hβ<sub>2</sub>, serotonergic h5-HT<sub>2C</sub>, h5-HT<sub>5A</sub>, and h5-HT<sub>6</sub> receptors, whereas more potent binding (<i>K</i><sub>i</sub> < 180 nM) was found at noradrenergic hβ<sub>1</sub> receptors (<i>K</i><sub>i</sub> = 46 nM) and serotonergic h5-HT<sub>1B</sub> (<i>K</i><sub>i</sub> = 33 nM) and h5-HT<sub>7</sub> (<i>K</i><sub>i</sub> = 19 nM) receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). At h5-HT<sub>1B</sub>receptors, <b>5m</b> proved to be a partial agonist (EC<sub>50</sub> = 120 nM, efficacy = 55%) when tested in a [<sup>35</sup>S]GTPγS binding assay, whereas <b>5m</b> was shown to be an antagonist (<i>K</i><sub>i</sub> = 450 nM) at h5-HT<sub>7</sub> receptors when tested in a cAMP dependent fluorescence based assay using cloned h5-HT<sub>7</sub> receptors expressed in HEK-CNG cells. The unique in vitro pharmacological properties of <b>5m</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) translate into an in vivo profile that differs from those of currently used antidepressants. Compound <b>5m</b> (2.5, 5, or 10 mg/kg sc) increased the extracellular levels of 5-HT in the ventral hippocampus in conscious rats (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). In a similar experiment administration of the SSRI escitalopram enhanced hippocampal 5-HT levels by 700% at the dose yielding maximal response (data not shown). Three days of treatment with <b>5m</b> (5 or 10 (mg/kg)/day) also resulted in significantly higher basal levels of 5-HT in the medial prefrontal cortex (mPFC) compared to animals treated with vehicle. The occupancy of SERT by <b>5m</b> after 3 days of treatment with 5 or 10 (mg/kg)/day was 43% and 57%, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Furthermore, <b>5m</b> showed a robust antidepressant- and anxiolytic-like profile in multiple preclinical assays, such as the mouse forced-swim and tail-suspension tests and the rat social interaction and conditioned-fear paradigms.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>5m</b> and ondansetron (<b>3</b>) were tested for antagonistic effects on human (h) and rat (r) 5-HT<sub>3A</sub> receptors expressed in oocytes. Compound <b>5m</b> inhibited the h5-HT<sub>3A</sub> and r5-HT<sub>3A</sub> receptors with IC<sub>50</sub> equal to 12 and 0.18 nM, respectively. Ondansetron (<b>3</b>) showed similar inhibition of both h5-HT<sub>3A</sub> and r5-HT<sub>3A</sub> receptors with IC<sub>50</sub> ≈ 0.1 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>5m</b> displayed an agonistic response on human (h) 5-HT<sub>3A</sub> receptors (arrowhead) but not on rat (r) 5-HT<sub>3A</sub> receptors (arrow). At h5-HT<sub>3A</sub> receptors, <b>5m</b> had an EC<sub>50</sub> of 2100 nM, reaching a maximal response of 64% compared with the maximal response with 5-HT. Note that after only one application of <b>5m</b> for 30 s, the subsequent application of either <b>5m</b> or 5-HT (10 μM) did not induce any response at all, indicating that <b>5m</b> induces functional antagonism. That means that it is only possible to test one concentration of <b>5m</b> on each oocyte, so the agonism dose-reponse curves for <b>5m</b> has been obtained from a test of each single concentration of <b>5m</b> using three to six separate oocytes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose relationship depicting potency and intrinsic activity (IA) of <b>5m</b>, buspirone, and 5-OH DPAT in a [<sup>35</sup>S]guanosine 5′-<i>O</i>-(3-thio)triphosphate ([<sup>35</sup>S]GTPγS) binding assay in CHO membranes expressing h5-HT<sub>1A</sub> receptors. IA<sub>max</sub> was defined by 5-HT binding. Raw data were obtained by MDS Pharmaservices and were then analyzed by sigmoidal dose response curve-fittings using GraphPad Prism 4 to generate EC<sub>50</sub> and intrinsic activity (IA) results. Data shown in the graph were averaged from <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of administration of <b>5m</b> (2.5, 5, and 10 mg/kg) or vehicle subcutaneous on extracellular 5-HT levels in the rat ventral hippocampus. Data are expressed as the mean ± SEM. There was a dose and time-dependent increase in extracellular 5-HT following drug administration [<i>F</i>(27,159) = 7.081; <i>P</i> < 0.001]. Extracellular concentrations of 5-HT were significantly increased relative to baseline from <i>t</i> = 60 until <i>t</i> = 120 min after administration of 2.5 mg/kg <b>5m</b> and from <i>t</i> = 40 until <i>t</i> = 180 min after 5 or 10 mg/kg <b>5m</b> (<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of 3-day treatment with vehicle or <b>5m</b> (5 or 10 mg/kg sc) on extracellular 5-HT levels in the rat medial prefrontal cortex (mPFC) and SERT occupancy. Data are expressed as the mean ± SEM. Three days of treatment with <b>5m</b> (5 or 10 (mg/kg)/day) resulted in significantly higher basal levels of 5-HT in the mPFC compared to animals treated with vehicle (<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Broad Screening of <b>5m</b> at Cerep, MDS Pharmaservices, or H. Lundbeck A/S<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">Targets</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">adenosine: hA<sub>1</sub>, hA<sub>2A</sub>, hA<sub>3</sub></td><td class="colsep0 rowsep0" align="left">angiotensin II: hAT<sub>1</sub>, hAT<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">benzodiazepine: BZD (central); BZD (peripheral)</td><td class="colsep0 rowsep0" align="left">bombesin: BB (nonselective)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bradykinin: hB<sub>2</sub></td><td class="colsep0 rowsep0" align="left">calcitonin: hCGRP</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cannabinoid: hCB<sub>1</sub></td><td class="colsep0 rowsep0" align="left">cholecystokinin: hCCK<sub>1</sub>, hCCK<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dopamine: hD<sub>1</sub>, hD<sub>2</sub>, hD<sub>3</sub>, hD<sub>4.4</sub>, hD<sub>5</sub></td><td class="colsep0 rowsep0" align="left">endothelin: hET<sub>A,</sub> hET<sub>B,</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">γ-aminobutyric acid (nonselective)</td><td class="colsep0 rowsep0" align="left">galanin: hGAL1, hGAL2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">growth factors: platelet-derived growth factor, h interleukin-8B, tumor necrosis factor-α, chemokine receptor 1</td><td class="colsep0 rowsep0" align="left">glutamate (nonselective): phenylcyclidine binding site</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">histamine: hH<sub>1</sub>, hH<sub>2</sub> (<i>K</i><sub>i</sub> = 180 nM)</td><td class="colsep0 rowsep0" align="left">melanocortin: hMC<sub>4</sub> (% inh = 51)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">melatonin: hML<sub>1</sub></td><td class="colsep0 rowsep0" align="left">muscarinic: hM<sub>1</sub>, hM<sub>2</sub>, hM<sub>3</sub>, hM<sub>4</sub>, hM<sub>5</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neurokinin: hNK<sub>1</sub>, hNK<sub>2</sub>, hNK<sub>3</sub></td><td class="colsep0 rowsep0" align="left">noradrenergic (nonselective): α<sub>1</sub> (nonselective), α<sub>2</sub> (nonselective), β<sub>1</sub> (<i>K</i><sub>i</sub> = 46 nM), β<sub>2</sub> (<i>K</i><sub>i</sub> = 560 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neuropeptide Y: hY<sub>1</sub>, hY<sub>2</sub></td><td class="colsep0 rowsep0" align="left">neurotensin: hNT<sub>1</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">opiate: hδ, κ, hμ</td><td class="colsep0 rowsep0" align="left">orphanin: hORL<sub>1</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pituitary adenylate cyclase activating polypeptide: PAC1</td><td class="colsep0 rowsep0" align="left">prostaglandin: human thromboxane A/PGH<sub>2</sub>, hPGI<sub>2</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">purinic: P2X, P2Y</td><td class="colsep0 rowsep0" align="left">serotonergic: h5-HT<sub>1A</sub> (% inh = 98),<a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> h5-HT<sub>1B</sub> (% inh = 100),<a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> h5-HT<sub>2A</sub>, h5-HT<sub>2C</sub> (<i>K</i><sub>i</sub> = 180 nM), h5-HT<sub>3A</sub> (% inh 100),<a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> h5-HT<sub>5A</sub> (<i>K</i><sub>i</sub> = 220 nM), h5-HT<sub>6</sub> (<i>K</i><sub>i</sub> = 330 nM), h5-HT<sub>7</sub> (<i>K</i><sub>i</sub> = 19 nM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">σ (nonselective)</td><td class="colsep0 rowsep0" align="left">somatostatin (nonselective): sst</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vasoactive intestinal peptide: hVIP<sub>1</sub> (VPAC<sub>1</sub>)</td><td class="colsep0 rowsep0" align="left">vasopression: hV<sub>1a</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ion channels: Ca<sup>2+</sup> (L, verapamil site), K<sup>+</sup>v channel, SK<sup>+</sup><sub>Ca</sub> channel, Na<sup>+</sup> channel (site 2), Cl<sup>−</sup> channel</td><td class="colsep0 rowsep0" align="left">transporters: hNE transporter (% inh = 88),<a class="ref internalNav" href="#t6fn1" aria-label="b">b</a> hDA transporter</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">For targets where % inhibition (inh) of binding at 1000 nM was greater than 50%, <i>K</i><sub>i</sub> values or % inhibition are specified. Data were generated in a high-throughput profile at Cerep 2002. Follow-up was made at Cerep, MDS Pharmaservices or at H. Lundbeck A/S. Data are the mean of a minimum of two determinations covering 6 decades for each compound. <i>K</i><sub>i</sub> values were calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [L]/<i>K</i><sub>d</sub>)).</p></div><div class="footnote" id="t6fn1"><sup>b</sup><p class="last">IC<sub>50</sub>/<i>K</i><sub>i</sub> values are reported elsewhere in manuscript.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Primary Human (h) in Vitro Binding Profile of <b>5m</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0005.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h5-HT<sub>3A</sub></td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h5-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hSERT</td><td class="colsep0 rowsep0" align="left">1.6</td></tr></tbody></table></div></div><div class="NLM_p last">The prediction of the hepatic clearance of <b>5m</b> in humans was done by in vitro/in vivo extrapolation from the predicted hepatic clearance in rats and humans and the observed systemic in vivo clearance in rats. According to the well-stirred model, the hepatic clearance in each species (CL<sub>pred</sub>) was predicted from hepatic microsomal intrinsic clearance (CL<sub>int</sub>) according to<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/jm-2010-01459g_m001.gif" alt="" /></img></span>where LBF is liver blood flow and <i>f</i><sub>u</sub> is the unbound fraction in plasma. Human clearance was then predicted from the observed in vivo rat clearance and the clearances that are predicted based on in vitro clearances from each species (CL<sub>pred,human</sub> and CL<sub>pred,rat</sub>) according to<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/jm-2010-01459g_m002.gif" alt="" /></img></span>The plasma protein binding of <b>5m</b> was determined to 98.3% and 99.2% for human and rat, respectively, resulting in a predicted low human hepatic clearance of 35 L/h, which turned out to be off by only a few liters when measured in human healthy volunteers (data not shown). Thus, compound <b>5m</b> was indeed predicted to display promising pharmacokinetic characteristics and low CYP450 enzyme inhibitory potential in humans.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A novel series of compounds with combined effects on h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors and on the rSERT was discovered. Compound <b>5m</b> was identified as the lead compound from this series, displaying the desired relative affinities/potencies (<i>K</i><sub>i</sub>/IC<sub>50</sub>) between 5-HT<sub>3A</sub>, 5-HT<sub>1A</sub>, and SERT, as well as appropriate pharmacokinetic properties for further development. Compound <b>5m</b> met the criteria set for efficacy at these targets, displaying antagonistic properties at h5-HT<sub>3A</sub> receptors, agonistic properties at h5-HT<sub>1A</sub> receptors, and inhibition of hSERT. Whereas <b>5m</b> showed comparable potencies at both rat and human SERT, species differences were found at 5-HT<sub>1A</sub> and 5-HT<sub>3A</sub> receptors. Hence, rat models should be used with caution when predicting the clinical potential of <b>5m</b>. Additional profiling revealed that compound <b>5m</b> exerted high affinity (<i>K</i><sub>i</sub> < 100 nM) at noradrenergic hβ<sub>1</sub> (<i>K</i><sub>i</sub> = 46 nM), serotonergic h5-HT<sub>1B</sub> (<i>K</i><sub>i</sub> = 33 nM), and h5-HT<sub>7</sub> (<i>K</i><sub>i</sub> = 19 nM) receptors. In vitro functional characterization at these receptors showed that <b>5m</b> was a partial agonist at h5-HT<sub>1B</sub> receptors and an antagonist at h5-HT<sub>7</sub> receptors. Taken together, compound <b>5m</b> exerts a multimodal serotonergic action, by inhibiting SERT and interacting with h5-HT<sub>1A</sub>, h5-HT<sub>1B</sub>, h5-HT<sub>3</sub>, and h5-HT<sub>7</sub> receptors. Indeed, the action of an efficacious 5-HT<sub>1A</sub> receptor agonist is expected to rapidly desensitize the somatodendritic 5-HT<sub>1A</sub> autoreceptor<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and simultaneously activate postsynaptic 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref42 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref42 ref17 ref18">(42, 17, 18)</a> Moreover, the 5-HT<sub>3</sub> receptor antagonistic effect of <b>5m</b> may counteract the inhibitory tonus of the 5-HT<sub>3</sub> receptor on the noradrenergic and cholinergic systems, leading to a facilitating effect on these systems,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> both of which are known to be important in the pathology of mood disorders.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Additionally, we have shown that the 5-HT<sub>3</sub> receptor antagonist ondansetron potentiates citalopram-induced increases in 5-HT levels in the rat brain,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> demonstrating that 5-HT<sub>3</sub> receptor blockade also facilitates 5-HT release. While the affinity of <b>5m</b> for the noradrenergic hβ<sub>1</sub> receptor did not translate to an obvious pharmacology in vivo, the h5-HT<sub>1B</sub> and h5-HT<sub>7</sub> receptor affinity may contribute to the in vivo pharmacological profile. The 5-HT<sub>1B</sub> receptors are present on 5-HT nerve terminals, and a number of studies have shown that stimulating 5-HT<sub>1B</sub> receptors leads to a decrease in 5-HT output. Conversely, the combination of SERT blockade and 5-HT<sub>1B</sub> receptor antagonism has been shown to augment 5-HT levels in microdialysis studies.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> We have demonstrated that <b>5m</b> exerts a partial agonistic profile at the h5-HT<sub>1B</sub> receptors, which could translate to an inhibitory control of 5-HT<sub>1B</sub> receptors in vivo, thus further substantiating the potential of <b>5m</b> in a clinical setting. Similarly, 5-HT<sub>7</sub> receptor blockade has been shown to be efficacious in animal models of depression, e.g., the mouse forced-swim test and tail-suspension test.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The combination of an SSRI with 5-HT<sub>7</sub> receptor blockade synergistically augments the levels of 5-HT in the prefrontal cortex,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> suggesting that 5-HT<sub>7</sub> receptor antagonism alone or in combination with SERT blockade has antidepressant potential.</div><div class="NLM_p last">In this study we demonstrate that <b>5m</b> affects 5-HT levels in both the ventral hippocampus and mPFC, two important brain regions involved in regulation of mood.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> After acute administration in rat microdialysis experiments, compound <b>5m</b> induced a robust increase in extracellular 5-HT levels in the ventral hippocampus. This increase is higher than those obtained after acute administration of SSRIs<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and SNRIs<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> at doses that maximally block SERT,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> suggesting that the combined pharmacological effects of <b>5m</b> in rats on SERT and 5-HT<sub>1B</sub>, 5-HT<sub>3</sub>, and 5-HT<sub>7</sub> receptors lead to an augmentation of the extracellular 5-HT levels when compared to that of SSRIs or SNRIs. As mentioned above, activation by 5-HT<sub>1A</sub> receptor agonists leads to rapid desensitization of somatodendritic 5-HT<sub>1A</sub> receptors,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> suggesting an additional beneficial effect in humans, which might be difficult to model in rats because the r5-HT<sub>1A</sub> receptor affinity is low. Thus, the effects of <b>5m</b> on the 5-HT receptors may cancel out inhibitory feedback effects exerted on acute SERT inhibition.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> In the rat microdialysis experiments, 3 days of treatment with <b>5m</b> resulted in significant increases in extracellular 5-HT levels at low SERT occupancy, again suggesting a multimodal mode of action of <b>5m</b>. This is in contrast to treatment with SSRIs, where chronic treatment is generally required to overcome the inhibitory feedback mechanisms and to produce a positive 5-HT response in preclinical models.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In conclusion, these characteristics indicate that <b>5m</b> is a novel multimodal serotonergic compound that has the potential to benefit symptomatologies associated with mood disorders. Compound <b>5m</b> (Lu AA21004) is currently in clinical development for MDD.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Reagents and solvents were obtained from commercial sources and used as received. Thin layer chromatography was carried out on Merck silica gel 60 F254. Flash chromatography was performed using Merck silica gel 60 (40−63 μm). <sup>1</sup>H and <sup>13</sup>C nuclear magnetic resonance (NMR) spectra were recorded at ambient temperature on a Bruker Avance AV-500 at 500.13 and 125.77 MHz, respectively. Chemical shifts (δ) are reported in parts per million relative to tetramethylsilane (TMS) or residual solvent, and coupling constants (<i>J</i>) are given in hertz. High-resolution mass spectrometry (HRMS) was recorded on a Bruker Daltonics MicrOTOF operating with external calibration with lithium formate (for ESI) and PEG200/PEG400/PEG600 (1:1:1) [for atmospheric pressure photo ionization (APPI)]. Liquid chromatography/MS (LC/MS), solvent system A was water/trifluoroacetic acid (TFA) (100:0.05) and B was acetonitrile/water/TFA (95:5:0.035). Instruments were API 150EX and LC system Shimadzu LC10ADvp/SLC-10Avp with Sedere Sedex75 ELS and column operating at 60 °C. LC/MS method 1 involved the following: column 30 mm × 4.6 mm Waters Symmetry C18 with 3.5 μm particles operating at room temperature; linear gradient elution with 10% B to 100% B in 2.4 min at a flow rate of 3.3 mL/min. LC/MS method 2 involved the following: as above but instead with a 30 mm × 4.6 mm Waters Atlantis column with 3 μm particles operating at 40 °C; linear gradient elution with 2% B to 100% B in 2.4 min at a flow rate of 3.3 mL/min. LC/MS method 3 involved the following: solvent system A consisting of water/ammonia (99.9:0.1) and B consisting of acetonitrile/water/ammonia (94.9:5:0.1); instruments were Sciex API300 and Waters Acquity UPLC with diode array detector (DAD) and evaporative light scattering (ELS) (Waters); column 50 mm × 2.1 mm Waters BEH with 1.7 μm particles operatomg at 60 °C. Linear gradient elution with 10% B to 100% B in 1 min at a flow rate of 1.2 mL/min. All pharmacologically characterized compounds were >95% pure as determined by LC/MS, with the exception of <b>6c</b> and <b>6d</b>, which had ultraviolet (UV) purities of 94% and 93%, respectively. These compounds were also characterized by <sup>1</sup>H NMR and <sup>13</sup>C NMR as well as either elemental analysis or HRMS. Synthesis intermediates were characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS data for new compounds, except for synthesis intermediates <b>13b</b>, <b>13c</b>, and <b>13d</b> for which no <sup>13</sup>C NMR data are reported due to rotamers.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Procedure 1 for the Formation of Diaryl Sulfides<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h3><div class="NLM_p last">Potassium <i>tert</i>-butoxide (1.1 equiv) and a solution of an aryl bromide/iodide (1.0 equiv, if this was a solid) were added to Pd<sub>2</sub>dba<sub>3</sub> (2.5 mol %) and DPEphos (10 mol %). Subsequent toluene (the amount required to make a ∼10% w/w solution of the aryl bromide/iodide), the aryl bromide/iodide (1.0 equiv, if this was a liquid), and the thiophenol (1.0 equiv) were added. The flask was immersed in an oil bath preheated to 100 °C. The mixture was stirred at this temperature until the reaction was complete (typically <2 h for aryl iodides and overnight for aryl bromides). The crude mixture was loaded onto a silica gel column and eluted with heptane/ethyl acetate to give the products in >95% purity as determined by <sup>1</sup>H NMR.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure 2 for the Formation of Boc-Protected Arylpiperazines from Aryl Bromides<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></h3><div class="NLM_p last">Aryl bromide (1.0 equiv, if this was a solid), Boc-piperazine (1.2 equiv), and sodium <i>tert</i>-butoxide (1.4 equiv) were added to Pd<sub>2</sub>dba<sub>3</sub> (2.5 mol %) and racemic BINAP (7.5 mol %). Subsequently toluene (the amount required to make a ∼10% w/w solution of the aryl bromide) and the aryl bromide (1.0 equiv, if this was a liquid) were added. The flask was immersed in an oil bath preheated to 100 °C. The mixture was stirred at this temperature overnight. The crude mixture was loaded onto a silica gel column and eluted with heptane/ethyl acetate to give the products in >95% purity as determined by <sup>1</sup>H NMR.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure 3 for the Cleavage of Boc Groups</h3><div class="NLM_p">The substrate was dissolved in methanol (the amount required to make a solution of approximately 20% w/w of the substrate). An HCl solution (2 M) in Et<sub>2</sub>O (approximately 3 equiv) was added to the mixture, and the resulting mixture was stirred at room temperature overnight. If required, the mixture was cooled in an ice/water bath and diluted with Et<sub>2</sub>O to precipitate the product as the hydrochloride salt. No attempts were made to isolate additional product from the filtrate.</div><div class="NLM_p last">The synthesis procedure and compound characterization data for the final compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> are summarized below. The synthesis and characterization data for the remaining final compounds and all intermediates are in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Compounds Prepared According to Method A (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>)</h3><div class="NLM_p">These compounds were prepared by initial formation of 2-bromophenylpiperazines accordoing to general method 2 followed by formation of the thioether linkage according to general procedure 1. Deprotection and salt formation were done according to general method 3.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 1-[2-(4-Chlorophenylsulfanyl)phenyl]piperazine Hydrochloride (<b>4h</b>)</h4><div class="NLM_p last"><b>4h</b> was prepared according to general procedure 3 starting from intermediate <b>11h</b> in a yield of 31%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 2H), 7.48 (d, <i>J</i> = 6.4, 2H), 7.42−7.34 (m, 2H), 7.27 (t, <i>J</i> = 7.2, 1H), 7.20 (d, <i>J</i> = 7.7, 1H), 7.06 (d, <i>J</i> = 7.0, 1H), 6.92 (d, <i>J</i> = 7.7, 1H), 3.22−3.08 (m, 8H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.73, 134.19 (2C), 133.10, 132.69, 131.70, 130.14, 130.01 (2C), 128.27, 125.58, 121.10, 48.54 (2C), 43.62 (2C). HRMS calcd for C<sub>16</sub>H<sub>17</sub>ClN<sub>2</sub>S + H, 305.0874; found, 305.0876. LC/MS (method 1): <i>t</i><sub>R</sub> = 0.98 min, UV purity 97%, ELS purity 100%. Anal. (C<sub>16</sub>H<sub>17</sub>ClN<sub>2</sub>S·HCl) C, H, N.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 1-(2-<i>p</i>-Tolylsulfanylphenyl)piperazine Hydrochloride (<b>4j</b>)</h4><div class="NLM_p last"><b>4j</b> was prepared according to general procedure 3 from impure 4-[2-(4-methylphenylsulfanyl)phenyl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>11j</b>) in a yield of 60%. <b>11j</b> was prepared starting from <b>7a</b> and 4-methylthiophenol according general procedure 1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.21 (s, 2H), 7.35 (d, <i>J</i> = 8.0, 2H), 7.28 (d, <i>J</i> = 8.0, 2H), 7.22−7.13 (m, 2H), 7.05−6.96 (m, 1H), 6.69 (d, <i>J</i> = 7.6, 1H), 3.18 (broad s, 8H), 2.34 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 148.51, 138.82, 134.33 (2C), 134.13, 130.91 (2C), 128.69, 127.86, 126.94, 125.44, 120.69, 48.53 (2C), 43.67 (2C), 21.14. HRMS calcd for C<sub>17</sub>H<sub>20</sub>N<sub>2</sub>S + H, 285.1420; found, 285.1422. LC/MS (method 1): <i>t</i><sub>R</sub> = 0.96 min, UV purity 98%, ELS purity 100%. Anal. (C<sub>17</sub>H<sub>20</sub>N<sub>2</sub>S·HBr) C, H, N for a batch of the hydrobromide salt.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 1-[2-(3,4-Dimethylphenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5g</b>)</h4><div class="NLM_p last"><b>5g</b> was prepared according to general procedure 3 from impure 4-[2-(3,4-dimethylphenylsulfanyl)phenyl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12g</b>) in a yield of 70% over two steps. <b>12g</b> was prepared starting from <b>7a</b> and 3,4-dimethylthiophenol according general procedure 1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.38 (s, 2H), 7.30−7.10 (m, 5H), 7.05−6.94 (m, 1H), 6.66 (d, <i>J</i> = 7.8, 1H), 3.18 (broad s, 8H), 2.25 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 153.57, 143.74, 143.01, 140.66, 139.74, 137.36, 136.54, 133.80, 132.80, 131.96, 130.65, 125.84, 53.75 (2C), 48.87 (2C), 24.85, 24.75. HRMS calcd for C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>S + H, 299.1576; found, 299.1586. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.03 min, UV purity 97%, ELS purity 100%.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-[2-(2,3-Dichlorophenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5i</b>)</h4><div class="NLM_p last"><b>5i</b> was prepared according to general procedure 3 starting from impure 4-[2-(2,3-dichlorophenylsulfanyl)phenyl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12i</b>) in a yield of 6%. <b>12i</b> was prepared from <b>7a</b> and 2,3-dichlorothiophenol according general procedure 1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (s, 2H), 7.59 (dd, <i>J</i> = 8.0, 1.1, 1H), 7.40 (dd, <i>J</i> = 10.9, 4.3, 1H), 7.34−7.24 (m, 2H), 7.19−7.07 (m, 2H), 7.03−6.97 (m, 1H), 3.22−3.13 (m, 4H), 3.04 (s, 4H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.34, 135.99, 131.80, 130.41, 129.20, 129.01, 128.38, 128.12, 127.25, 124.81, 120.70, 112.10, 47.62 (2C), 42.72 (2C). HRMS calcd for C<sub>16</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>2</sub>S + H, 339.0484; found, 339.0486. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.03 min, UV purity 99%, ELS purity 100%.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-[2-(2,4-Dichlorophenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5l</b>)</h4><div class="NLM_p last"><b>5l</b> was prepared according to general procedure 3 starting from impure 4-[2-(2,4-dichlorophenylsulfanyl)phenyl]piperazine-1-carboxylic acid <i>tert</i>-butyl ester (<b>12l</b>) in a yield of 6%. <b>12l</b> was prepared from <b>7a</b> and 2,4-dichlorothiophenol according general procedure 1. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.66 (s, 2H), 8.33 (s, 1H), 8.00−7.85 (m, 2H), 7.79 (d, <i>J</i> = 7.9, 1H), 7.74−7.63 (m, 2H), 7.53 (d, <i>J</i> = 7.8, 1H), 3.72 (s, 4H), 3.62 (s, 4H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.69, 135.51, 133.93, 133.22, 132.68, 131.55, 129.90, 129.39, 128.95, 128.69, 125.79, 121.56, 48.52 (2C), 43.66 (2C). HRMS calcd for C<sub>16</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>2</sub>S + H, 339.0484; found, 339.0492. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.07 min, UV purity 96%, ELS purity 100%.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5m</b>)</h4><div class="NLM_p last"><b>5m</b> was prepared according to general procedure 3 starting from intermediate <b>12m</b> in a yield of 78%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 2H), 7.33 (d, <i>J</i> = 7.7, 1H), 7.24 (s, 1H), 7.17−7.07 (m, 3H), 6.96 (dd, <i>J</i> = 7.6, 6.0, 1H), 6.41 (d, <i>J</i> = 7.8, 1H), 3.21 (broad s, 8H), 2.31 (s, 3H), 2.24 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 148.22, 142.04, 139.68, 136.11, 133.74, 132.14, 128.46, 127.19, 126.40, 126.13, 125.46, 120.64, 48.47 (2C), 43.67 (2C), 21.10, 20.47. HRMS calcd for C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>S + H, 299.1576; found, 299.1584. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.02 min, UV purity 97%, ELS purity 100%. Anal. (C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>S·HCl) C, H, N.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Compounds Prepared According to Method B (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>)</h3><div class="NLM_p">These compounds were prepared by initial formation of brominated diarylsulfides according to general procedure 1 followed by aryl amination under the conditions described for general procedure 2. Deprotection and salt formation were done according to general method 3.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-[2-(2,3-Dimethylphenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5j</b>)</h4><div class="NLM_p last"><b>5j</b> was prepared according to general procedure 3 starting from intermediate <b>12j</b> in a yield of 48%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 2H), 7.29−7.25 (m, 2H), 7.15 (t, <i>J</i> = 6.4, 3H), 6.97 (dt, <i>J</i> = 8.3, 4.3, 1H), 6.48 (d, <i>J</i> = 7.8, 1H), 3.25−3.17 (m, 8H), 2.31 (s, 3H), 2.25 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 148.42, 140.37, 138.43, 133.54, 133.31, 131.23, 131.10, 127.03, 126.97, 126.63, 125.46, 120.72, 48.48 (2C), 43.61 (2C), 20.92, 17.16. HRMS calcd for C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>S + H, 299.1576; found, 299.1582. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.05 min, UV purity 98%, ELS purity 100%.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-[2-(2-Chloro-4-methylphenylsulfanyl)phenyl]piperazine Hydrochloride (<b>5p</b>)</h4><div class="NLM_p last"><b>5p</b> was prepared according to general procedure 3 starting from intermediate <b>12p</b> in a yield of 44%. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.47 (s, 2H), 7.48 (s, 1H), 7.35−7.25 (m, 4H), 7.04 (t, <i>J</i> = 7.5, 1H), 6.68 (d, <i>J</i> = 7.8, 1H), 3.24−3.07 (m, 8H), 2.34 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 149.33, 140.95, 136.48, 135.19, 131.47, 131.04, 129.49, 128.72, 128.27, 127.85, 125.60, 121.07, 48.44 (2C), 43.58 (2C), 20.74. HRMS calcd for C<sub>17</sub>H<sub>19</sub>ClN<sub>2</sub>S + H, 319.1030; found, 319.1032. LC/MS (method 1): <i>t</i><sub>R</sub> = 1.04 min, UV purity 98%, ELS purity 100%.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Compound Prepared According to Method C</h3><div class="NLM_p">Final compound <b>6g</b> was prepared by aromatic nucleophilic substitution of 2-fluoronitrobenzene with 2,4-dimethylphenol leading to 2,4-dimethyl-1-(2-nitrophenoxy)benzene (<b>14</b>) that was reduced to 2-(2,4-dimethylphenoxy)phenylamine (<b>15</b>), which was reacted further as described below.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-[2-(2,4-Dimethylphenoxy)phenyl]piperazine Hydrochloride (<b>6g</b>)</h4><div class="NLM_p last">Compound <b>15</b> (2.13 g) and bis(2-bromoethyl)amine hydrobromide<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (3.89 g) were suspended in chlorobenzene (50 mL). The mixture was boiled under reflux for 4 h. The solvent was evaporated off, and the residual oil was partitioned between water (100 mL) and ethyl acetate (50 mL). The aqueous layer was basified and extracted with ethyl acetate (2 × 50 mL). The combined organic layers were washed with brine (100 mL), dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford an oil. This material was purified by column flash chromatography (eluent EtOAc/MeOH 9:1 → EtOAc/MeOH/Et<sub>3</sub>N 9:1:1) to afford the crude title compound. This material was partitioned between water/brine and methylene chloride. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the free base. This material was dissolved in ethyl acetate and treated with 2 M HCl in Et<sub>2</sub>O to precipitate the title compound (0.83 g, 26%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.54 (s, 2H), 7.13−7.08 (m, 2H), 7.06 (t, <i>J</i> = 7.4, 1H), 7.00−6.92 (m, 2H), 6.69−6.60 (m, 2H), 3.31 (s, 4H), 3.08 (s, 4H), 2.24 (s, 3H), 2.16 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 150.17, 147.60, 139.38, 130.82, 130.23, 126.23, 126.01, 122.14, 122.01, 118.10, 116.47, 116.07, 45.41 (2C), 41.24 (2C), 18.66, 14.25. HRMS calcd for C<sub>18</sub>H<sub>22</sub>N<sub>2</sub>O + H, 283.1805; found, 283.1818. LC/MS (method 1): <i>t</i><sub>R</sub> = 0.98 min, UV purity 100%, ELS purity 98%.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> In Vitro Pharmacology</h3><div class="NLM_p last">The assays used for the SAR studies are described below. Details and all other pharmacology are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. In general for binding affinity assays, data points were expressed as percent of the specific binding, and the IC<sub>50</sub> values were determined by nonlinear regression analysis using a sigmoidal variable slope curve fitting. The dissociation constant (<i>K</i><sub>i</sub>) was calculated from the Cheng−Prusoff equation (<i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + ([L]/<i>K</i><sub>d</sub>)), where the concentration of free radioligand L is approximated to the concentration of added radioligand in the assay, and <i>K</i><sub>d</sub> equals the affinity of the radioligand to the receptor. In general IC<sub>50</sub> values are based on 6−8 different concentrations covering 4−6 decades.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> h5-HT<sub>3A</sub> Binding Affinity Assay</h3><div class="NLM_p last">[<sup>3</sup>H]Granisetron (1 nM) (Perkin-Elmer) binding to h5-HT<sub>3A</sub> receptors was evaluated in membranes from a HEK-293 cell line stably expressing the hHT<sub>3A</sub> receptor. Nonspecific binding was measured in the presence of 10 μM bemesetron. After incubation, the membrane preparations were rapidly filtered under a vacuum using glass-fiber filters. Compounds were tested at least three times over a 6 log concentration range. IC<sub>50</sub> values were determined by nonlinear regression analysis using Hill equation curve fitting, and <i>K</i><sub>i</sub> values were calculated based on the Cheng−Prusoff equation.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> h5-HT<sub>1A</sub> Binding Affinity Assay</h3><div class="NLM_p last">[<sup>3</sup>H]5-Carboxamidotryptamine (0.15 nM) (Perkin-Elmer) binding to cloned human 5-HT<sub>1A</sub> receptors in CHO cells or HeLa was assayed in a membrane-based scintillation proximity assay. The level of nonspecific binding was obtained in the presence of 10 μM 5-HT or metergoline. Compounds were tested at least three times over a 6 log concentration range. IC<sub>50</sub> values were determined by nonlinear regression analysis using Hill equation curve fitting, and <i>K</i><sub>i</sub> values were calculated based on the Cheng−Prusoff equation.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Inhibition of [<sup>3</sup>H]NE, [<sup>3</sup>H]DA, and [<sup>3</sup>H]5-HT Uptake by Rat Synaptosomes</h3><div class="NLM_p last">NET, DAT, and SERT transporter inhibition (IC<sub>50</sub>) in rat synaptosomes was measured using [<sup>3</sup>H]NE, [<sup>3</sup>H]DA, and [<sup>3</sup>H]5-HT, respectively. After incubation, the membrane preparations were rapidly filtered under a vacuum using glass-fiber filters. The filters were washed with ice-cold buffer using a harvester. Bound radioactivity was measured by scintillation counting using a scintillation cocktail. Compounds were tested at least twice over a 6 log concentration range. IC<sub>50</sub> values were determined by nonlinear regression analysis using Hill equation curve fitting.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Cytochrome P450 Enzyme Inhibition</h3><div class="NLM_p last">CYP enzyme inhibition was performed using recombinant enzymes (Supersome, Gentest), expressing individual CYP enzymes (CYP1A2, CYP2C9, CYP2D6 and CYP3A4). The inhibition of CYP enzymes by the test compounds was assessed by incubating each enzyme with its substrate (7-ethoxy-3-cyanocoumarin was used for CYP1A2 (10 μM); dibenzylfuorescein (2 μM) was used for CYP2C9; resorufin benzyl ether (100 μM) was used for CYP3A4; and 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin (3 μM) was used for CYP2D6) alone or in the presence of the test compounds at eight different concentrations (40−0.02 μM). All incubations (28 min for CYP1A2, 30 min for CYP3A4, and 45 min for CYP2C9 and CYP2D6) were performed in phosphate buffer with an NADPH regenerating system containing NADP<sup>+</sup>, glucose 6-phosphate dehydrogenase, glucose 6-phosphate, sodium citrate and MgCl<sub>2</sub>. At the end of the incubation period, the amount of metabolite formed was measured using a fluorescence spectrophotometer. The excitation and emission wavelengths in nanometers are 405 (ex) and 465 (em) for CYP1A2 and CYP2D6, 485 (ex) and 535 (em) for CYP2C9, and 530 (ex) and 590 (em) for CYP3A4. Inhibitions were expressed relative to controls (without inhibitors), and IC<sub>50</sub> values were calculated using Microsoft Excel software.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Microsomal Stability Determination</h3><div class="NLM_p last">The microsomal intrinsic clearance was determined by assessing the elimination of test compound over the incubation time. The test compounds were incubated at 1 μM with human and rat microsomes (BD Biosciences) for 60 min, using NADPH as cofactor. An NADPH regenerating system containing NADP<sup>+</sup>, glucose 6-phosphate dehydrogenase, glucose 6-phosphate, sodium citrate, and MgCl<sub>2</sub> (cofactor mix) was used as a source of NADPH. Human and rat microsomes were thawed at room temperature, and cofactor mix was added. The mixture was stirred on a vortex and put in a water bath at 37 °C for 10 min. The reaction was initiated by adding test compound (final concentration 1 μM, 0.5 mg of protein/mL). Separate incubations were made for each test compound and time point. The samples were incubated for 0, 5, 15, 30, and 60 min, and the reactions were stopped by adding 100 μL of acetonitrile and transferred to a 96-well stop plate with seals. The stop plates were centrifuged for 10 min at 3300 rpm and 4 °C before being analyzed by liquid chromatography coupled to a tandem mass spectrometer (LC−MS/MS, Waters QuattroMicro, Manchester, U.K.).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Plasma Binding by Equilibrium Dialysis Measurements</h3><div class="NLM_p last">The method was a modification of that reported by Kalvass et al.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Briefly, a 96-well equilibrium dialysis apparatus was used to determine the free fraction in the plasma (HT Dialysis LLC, Gales Ferry, CT, U.S.). Membranes (3 kDa cutoff) were conditioned in deionized water for 40 min, followed by conditioning in 80:20 deionized water/ethanol for 20 min, and then rinsed in deionized water before use. Plasma was diluted 1:1 with PBS. Diluted plasma was spiked with the 1 μM test compound and loaded into the 96-well equilibrium dialysis plate. Dialysis versus PBS (100 uL) was carried out for 5 h in a temperature controlled incubator at 37 °C, before being analyzed by liquid chromatography coupled to a tandem mass spectrometer (LC−MS/MS, Waters QuattroMicro, Manchester, U.K.).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In Vivo Pharmacokinetics in Rats</h3><div class="NLM_p last">In vivo pharmacokinetics was studied in rats following single intravenous (1 mg/kg) or oral (2 mg/kg) administration of compounds. Serial blood samples were collected at various time points up to 6 h after dosing. In vivo pharmacokinetic parameters were obtained following compartmental modeling. Bioanalysis of samples were analyzed by liquid chromatography coupled to a tandem mass spectrometer (LC−MS/MS, Waters QuattroMicro, Manchester, U.K.).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Microdialysis in Rats</h3><div class="NLM_p last">Rats (300−350 g; Harlan, Horst, The Netherlands) were used for the experiments. For acute administration <b>5m</b> was dissolved in 10% hydroxypropyl-β-cyclodextrin and administered subcutaneously (sc) in a volume of 1 mL/kg. For 3-day treatment with <b>5m</b> minipumps were used to deliver the solutions. Under isoflurane anesthesia osmotic minipumps (2ML2, Alzet, U.S.) were implanted in a subcutaneous pocket created on the right side parallel to the spine of the animal. By stereotaxic surgery I-shaped microdialysis probes (Hospal AN 69 membrane, 4 mm exposed surface; BrainLink) were inserted into the ventral hippocampus or medial prefrontal cortex under isoflurane anesthesia. Microdialysis experiments were performed 24−48 h after surgery by perfusing the probes with artificial CSF (147 mM NaCl, 3.0 mM KCl, 1.2 mM CaCl<sub>2</sub>, and 1.2 mM MgCl<sub>2</sub>) at a flow rate of 1.5 μL/min. Microdialysis samples were collected at 20 or 30 min intervals into minivials. After the experiment the rats were sacrificed and the position of each probe was histologically verified by making coronal sections of the brain.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Serotonin Analysis</h3><div class="NLM_p last">Aliquots were injected onto a HPLC column. Chromatographic separation was performed using an isocratic mobile phase. Mobile phase was run through the system at a flow rate of 0.4 mL/min, and 5-HT was detected electrochemically at +500 mV. For acute experiments four consecutive pretreatment samples were taken as baseline and their mean concentration was set to 100%. Drug effects were expressed as percentages of basal level (mean ± SEM) within the same animal. Moreover, differences between basal outputs of 5-HT (fmol/30 min sample) after treatment with <b>5m</b> or vehicle for 3 days were compared.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> SERT Occupancy in Rats</h3><div class="NLM_p last">After the microdialysis experiments rats were sacrificed and the brains were removed and stored at −80 °C until cutting. Sections of 20 μm containing the striatum were cut and air-dried before the binding experiment. For SERT occupancy 0.5 nM [<sup>3</sup>H]DASB was used as radioligand. The control for nonspecific binding was 1 μM escitalopram. The binding buffer consisted of 50 mM Tris, 150 mM NaCl, and 5 mM KCl, pH 7.4, and the incubation time was 90 min. Slides were washed in the respective buffers at 4 °C three times for 5 min, then briefly dipped in distilled water and air-dried. The slides were analyzed in a Biospace β-imager 2000 for at least 6 h.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm101459g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for synthesis of intermediates and target compounds; combustion analysis and HRMS data; descriptions for in vitro and in vivo assays; p<i>K</i><sub>i</sub> ± SEM values for h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors; and pIC<sub>50</sub> ± SD/SEM values for rSERT, rNET, and rDAT. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101459g/suppl_file/jm101459g_si_001.pdf">jm101459g_si_001.pdf (443.2 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm101459g" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benny Bang-Andersen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9dbd8d7f9d5ccd7dddbdcdad297dad6d4"><span class="__cf_email__" data-cfemail="d5b7b4bb95b9a0bbb1b7b0b6befbb6bab8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Ruhland</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Morten Jørgensen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Garrick Smith</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristen Frederiksen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus Gjervig Jensen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huailing Zhong</span> - <span class="hlFld-Affiliation affiliation">Lundbeck Research USA, 215 College Road, Paramus, New Jersey 07652-1431, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Søren Møller Nielsen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Hogg</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arne Mørk</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tine Bryan Stensbøl</span> - <span class="hlFld-Affiliation affiliation">Neuroscience Drug Discovery Denmark, H. Lundbeck A/S, 9 Ottiliavej, DK-2500 Copenhagen-Valby, Denmark</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. Kim Andersen and Ejner K. Moltzen for valuable input regarding design of compounds and Dr. Klaus P. Bøgesø for helpful input in the discovery phase and insightful discussions to improve the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> Abbreviations Used</h2><tr><td class="NLM_term">AcCh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">APPI</td><td class="NLM_def"><p class="first last">atmospheric pressure photoionization</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CYP450</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DAD</td><td class="NLM_def"><p class="first last">diode array detector</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DML</td><td class="NLM_def"><p class="first last">designed multiple ligand</p></td></tr><tr><td class="NLM_term">ELS</td><td class="NLM_def"><p class="first last">evaporative light scattering</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">GAD</td><td class="NLM_def"><p class="first last">generalized anxiety disorder</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-(3-thio)triphosphate</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">MAOI</td><td class="NLM_def"><p class="first last">monoamine oxidase inhibitor</p></td></tr><tr><td class="NLM_term">MDD</td><td class="NLM_def"><p class="first last">major depressive disorder</p></td></tr><tr><td class="NLM_term">mPFC</td><td class="NLM_def"><p class="first last">medial prefrontal cortex</p></td></tr><tr><td class="NLM_term">NE</td><td class="NLM_def"><p class="first last">norepinephrine</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">norepinephrine transporter</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure−activity relationship</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">SNRI</td><td class="NLM_def"><p class="first last">serotonin and norepinephrine reuptake inhibitor</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin reuptake inhibitor</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">tricyclic antidepressant</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87681" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87681" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, E. E.</span><span> </span><span class="NLM_article-title">Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1001%2Farchpsyc.62.6.593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15939837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ptlSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=593-602&author=R.+C.+Kesslerauthor=P.+Berglundauthor=O.+Demlerauthor=R.+Jinauthor=K.+R.+Merikangasauthor=E.+E.+Walters&title=Lifetime+prevalence+and+age-of-onset+distributions+of+DSM-IV+disorders+in+the+National+Comorbidity+Survey+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication</span></div><div class="casAuthors">Kessler Ronald C; Berglund Patricia; Demler Olga; Jin Robert; Merikangas Kathleen R; Walters Ellen E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">593-602</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">CONTEXT:  Little is known about lifetime prevalence or age of onset of DSM-IV disorders.  OBJECTIVE:  To estimate lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the recently completed National Comorbidity Survey Replication.  DESIGN AND SETTING:  Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using the fully structured World Health Organization World Mental Health Survey version of the Composite International Diagnostic Interview.  PARTICIPANTS:  Nine thousand two hundred eighty-two English-speaking respondents aged 18 years and older.  MAIN OUTCOME MEASURES:  Lifetime DSM-IV anxiety, mood, impulse-control, and substance use disorders.  RESULTS:  Lifetime prevalence estimates are as follows: anxiety disorders, 28.8%; mood disorders, 20.8%; impulse-control disorders, 24.8%; substance use disorders, 14.6%; any disorder, 46.4%.  Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders.  Half of all lifetime cases start by age 14 years and three fourths by age 24 years.  Later onsets are mostly of comorbid conditions, with estimated lifetime risk of any disorder at age 75 years (50.8%) only slightly higher than observed lifetime prevalence (46.4%).  Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.  CONCLUSIONS:  About half of Americans will meet the criteria for a DSM-IV disorder sometime in their life, with first onset usually in childhood or adolescence.  Interventions aimed at prevention or early treatment need to focus on youth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG4lFrjFq_mTdblLE_E9PWfW6udTcc2eZ9qjCQQQtcgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ptlSqtQ%253D%253D&md5=79d6630df98f374c22ebe3965880ec4d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.62.6.593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.62.6.593%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DBerglund%26aufirst%3DP.%26aulast%3DDemler%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DWalters%26aufirst%3DE.%2BE.%26atitle%3DLifetime%2520prevalence%2520and%2520age-of-onset%2520distributions%2520of%2520DSM-IV%2520disorders%2520in%2520the%2520National%2520Comorbidity%2520Survey%2520Replication%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2005%26volume%3D62%26spage%3D593%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Murray, C. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. D.</span><span> </span><span class="NLM_article-title">Evidence-based health policy: lessons from the Global Burden of Disease Study</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=740-743&author=C.+J.+L.+Murrayauthor=A.+D.+Lopez&title=Evidence-based+health+policy%3A+lessons+from+the+Global+Burden+of+Disease+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26atitle%3DEvidence-based%2520health%2520policy%253A%2520lessons%2520from%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D740%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Bauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montejo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantchev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demyttenaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Cebrian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perahia, D. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tylee, A.</span><span> </span><span class="NLM_article-title">Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study</span> <span class="citation_source-journal">Eur. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.eurpsy.2007.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=18164600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1c7nsVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=66-73&author=M.+Bauerauthor=B.+U.+Monzauthor=A.+L.+Montejoauthor=D.+Quailauthor=N.+Dantchevauthor=K.+Demyttenaereauthor=A.+Garcia-Cebrianauthor=L.+Grassiauthor=D.+G.+S.+Perahiaauthor=C.+Reedauthor=A.+Tylee&title=Prescribing+patterns+of+antidepressants+in+Europe%3A+results+from+the+Factors+Influencing+Depression+Endpoints+Research+%28FINDER%29+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study</span></div><div class="casAuthors">Bauer Michael; Monz Brigitta U; Montejo Angel L; Quail Deborah; Dantchev Nicolas; Demyttenaere Koen; Garcia-Cebrian Ana; Grassi Luigi; Perahia David G S; Reed Catherine; Tylee Andre</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-73</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">Antidepressant prescribing patterns and factors influencing the choice of antidepressant for the treatment of depression were examined in the Factors Influencing Depression Endpoints Research (FINDER) study, a prospective, observational study in 12 European countries of 3468 adults about to start antidepressant medication for their first episode of depression or a new episode of recurrent depression.  Selective serotonin reuptake inhibitors (SSRIs) were the most commonly prescribed antidepressant (63.3% patients), followed by serotonin-norepinephrine reuptake inhibitors (SNRIs, 13.6%), but there was considerable variation across countries.  Notably, tricyclic and tetracyclic antidepressants (TCAs) were prescribed for 26.5% patients in Germany.  The choice of the antidepressant prescribed was strongly influenced by the previous use of antidepressants, which was significantly associated with the prescription of a SSRI (OR 0.64; 95% CI 0.54, 0.76), a SNRI (OR 1.49; 95% CI 1.18, 1.88) or a combination of antidepressants (OR 2.78; 95% CI 1.96, 3.96).  Physician factors (age, gender, speciality) and patient factors (severity of depression, age, education, smoking, number of current physical conditions and functional syndromes) were associated with initial antidepressant choice in some models.  In conclusion, the prescribing of antidepressants varies by country, and the type of antidepressant chosen is influenced by physician- as well as patient-related factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfvr0P35AyhU2yPDyEFiigfW6udTcc2eZ9qjCQQQtcgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7nsVOhsQ%253D%253D&md5=75d04868ebb5158193257bcb3e4ea592</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2007.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2007.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DMontejo%26aufirst%3DA.%2BL.%26aulast%3DQuail%26aufirst%3DD.%26aulast%3DDantchev%26aufirst%3DN.%26aulast%3DDemyttenaere%26aufirst%3DK.%26aulast%3DGarcia-Cebrian%26aufirst%3DA.%26aulast%3DGrassi%26aufirst%3DL.%26aulast%3DPerahia%26aufirst%3DD.%2BG.%2BS.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DTylee%26aufirst%3DA.%26atitle%3DPrescribing%2520patterns%2520of%2520antidepressants%2520in%2520Europe%253A%2520results%2520from%2520the%2520Factors%2520Influencing%2520Depression%2520Endpoints%2520Research%2520%2528FINDER%2529%2520study%26jtitle%3DEur.%2520Psychiatry%26date%3D2008%26volume%3D23%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawaja, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajarao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Differentiating antidepressants of the future: efficacy and safety</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.pharmthera.2006.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17010443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=134-153&author=S.+Rosenzweig-Lipsonauthor=C.+E.+Beyerauthor=Z.+A.+Hughesauthor=X.+Khawajaauthor=S.+J.+Rajaraoauthor=J.+E.+Malbergauthor=Z.+Rahmanauthor=R.+H.+Ringauthor=L.+E.+Schechter&title=Differentiating+antidepressants+of+the+future%3A+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating antidepressants of the future: Efficacy and safety</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Beyer, Chad E.; Hughes, Zoe A.; Khawaja, Xavier; Rajarao, Somana J.; Malberg, Jessica E.; Rahman, Zia; Ring, Robert H.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-153</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There have been significant advances in the treatment of depression since the serendipitous discovery that modulating monoaminergic neurotransmission may be a pathol. underpinning of the disease.  Despite these advances, particularly over the last 15 years with the introduction of selective serotonin and/or norepinephrine reuptake inhibitors (SNRI), there still remain multiple unmet clin. needs that would represent substantial improvements to current treatment regimens.  In terms of efficacy there have been improvements in the percentage of patients achieving remission but this can still be dramatically improved and, in fact, issues still remain with relapse.  Furthermore, advances are still required in terms of improving the onset of efficacy as well as addressing the large proportion of patients who remain treatment resistant.  While this is not well understood, collective research in the area suggests the disease is heterogeneous in terms of the multiple parameters related to etiol., pathol. and response to pharmacol. agents.  In addn. to efficacy further therapeutic advances will also need to address such issues as cognitive impairment, pain, sexual dysfunction, nausea and emesis, wt. gain and potential cardiovascular effects.  With these unmet needs in mind, the next generation of antidepressants will need to differentiate themselves from the current array of therapeutics for depression.  There are multiple strategies for addressing unmet needs that are currently being investigated.  These range from combination monoaminergic approaches to subtype selective agents to novel targets that include mechanisms to modulate neuropeptides and excitatory amino acids (EAA).  This review will discuss the many facets of differentiation and potential strategies for the development of novel antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKfWRF69kPI7Vg90H21EOLACvtfcHk0lg7NAa_FJ2_1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCktQ%253D%253D&md5=a5cd4a022dd082dcaffc4dfe360660ca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKhawaja%26aufirst%3DX.%26aulast%3DRajarao%26aufirst%3DS.%2BJ.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DDifferentiating%2520antidepressants%2520of%2520the%2520future%253A%2520efficacy%2520and%2520safety%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D134%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Papakostas, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, R. C.</span><span> </span><span class="NLM_article-title">Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.biopsych.2007.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17588546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ymu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=1217-1227&author=G.+I.+Papakostasauthor=M.+E.+Thaseauthor=M.+Favaauthor=J.+C.+Nelsonauthor=R.+C.+Shelton&title=Are+antidepressant+drugs+that+combine+serotonergic+and+noradrenergic+mechanisms+of+action+more+effective+than+the+selective+serotonin+reuptake+inhibitors+in+treating+major+depressive+disorder%3F+A+meta-analysis+of+studies+of+newer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents</span></div><div class="casAuthors">Papakostas, George I.; Thase, Michael E.; Fava, Maurizio; Nelson, J. Craig; Shelton, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1217-1227</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Recent studies suggest that the treatment of major depressive disorder (MDD) with newer antidepressant drugs that simultaneously enhance norepinephrine and serotonin neurotransmission might result in higher response and remission rates than the selective serotonin reuptake inhibitors (SSRIs).  The goal of our work was to compare response rates among patients with MDD treated with either of these two broad categories of antidepressant drugs.  Methods: Medline/Pubmed, EMBase, clin. trial registries, program syllabi from major psychiatric meetings held since 1995, and documents from relevant pharmaceutical companies were searched for double-blind, randomized trials comparing a newer serotonergic-noradrenergic antidepressant drug (venlafaxine, duloxetine, milnacipran, mirtazapine, mianserin, or moclobemide) with an SSRI for MDD.  Results: Ninety-three trials (n = 17,036) were combined using a random-effects model.  Treatment with serotonergic + noradrenergic antidepressant drugs was more likely to result in clin. response than the SSRIs (risk ratio [RR] = 1.059; response rates 63.6% vs. 59.3%; p = .003).  There was no evidence for heterogeneity among studies combined (p = 1.0).  Excluding each individual agent did not significantly alter the pooled RR.  With the exception of duloxetine (.985), RRs for response for each individual serotonergic + noradrenergic antidepressant drug were within the 95% confidence interval of the pooled RR (1.019-1.101).  Conclusions: Serotonergic-noradrenergic antidepressant drugs seem to have a modest efficacy advantage compared with SSRIs in MDD.  With the No. Needed to Treat (NNT) statistic as one indicator of clin. significance, nearly 24 patients would need to be treated with dual-action antidepressant drugs instead of SSRIs in order to obtain one addnl. responder.  This difference falls well below the mark of NNT = 10 suggested by the United Kingdom's National Institute of Clin. Excellence but nonetheless might be of public health relevance given the large no. of depressed patients treated with SSRI /serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant drugs.  Further research is needed to examine whether larger differences between classes of antidepressant drugs might exist in specific MDD sub-populations or for specific MDD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTcv5V6MlT7Vg90H21EOLACvtfcHk0lg4GMzVJGVdDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ymu7jI&md5=4c4bd9fe021e6fab91cb3a18b779c4e5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2007.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2007.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DFava%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DJ.%2BC.%26aulast%3DShelton%26aufirst%3DR.%2BC.%26atitle%3DAre%2520antidepressant%2520drugs%2520that%2520combine%2520serotonergic%2520and%2520noradrenergic%2520mechanisms%2520of%2520action%2520more%2520effective%2520than%2520the%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520in%2520treating%2520major%2520depressive%2520disorder%253F%2520A%2520meta-analysis%2520of%2520studies%2520of%2520newer%2520agents%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D62%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Trivedi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norquist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shores-Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramani, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span> </span><span class="NLM_article-title">Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fappi.ajp.163.1.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16390886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FgsVaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2006&pages=28-40&author=M.+H.+Trivediauthor=A.+J.+Rushauthor=S.+R.+Wisniewskiauthor=A.+A.+Nierenbergauthor=D.+Wardenauthor=L.+Ritzauthor=G.+Norquistauthor=R.+H.+Howlandauthor=B.+Lebowitzauthor=P.+J.+McGrathauthor=K.+Shores-Wilsonauthor=M.+M.+Biggsauthor=G.+K.+Balasubramaniauthor=M.+Fava&title=Evaluation+of+outcomes+with+citalopram+for+depression+using+measurement-based+care+in+STAR*D%3A+implications+for+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice</span></div><div class="casAuthors">Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Warden Diane; Ritz Louise; Norquist Grayson; Howland Robert H; Lebowitz Barry; McGrath Patrick J; Shores-Wilson Kathy; Biggs Melanie M; Balasubramani G K; Fava Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-40</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established.  The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.  METHOD:  This clinical study included outpatients with major depressive disorder who were treated in 23 psychiatric and 18 primary care "real world" settings.  The patients received flexible doses of citalopram prescribed by clinicians for up to 14 weeks.  The clinicians were assisted by a clinical research coordinator in the application of measurement-based care, which included the routine measurement of symptoms and side effects at each treatment visit and the use of a treatment manual that described when and how to modify medication doses based on these measures.  Remission was defined as an exit score of <or=7 on the 17-item Hamilton Depression Rating Scale (HAM-D) (primary outcome) or a score of <or=5 on the 16-item Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) (secondary outcome).  Response was defined as a reduction of >or=50% in baseline QIDS-SR score.  RESULTS:  Nearly 80% of the 2,876 outpatients in the analyzed sample had chronic or recurrent major depression; most also had a number of comorbid general medical and psychiatric conditions.  The mean exit citalopram dose was 41.8 mg/day.  Remission rates were 28% (HAM-D) and 33% (QIDS-SR).  The response rate was 47% (QIDS-SR).  Patients in primary and psychiatric care settings did not differ in remission or response rates.  A substantial portion of participants who achieved either response or remission at study exit did so at or after 8 weeks of treatment.  Participants who were Caucasian, female, employed, or had higher levels of education or income had higher HAM-D remission rates; longer index episodes, more concurrent psychiatric disorders (especially anxiety disorders or drug abuse), more general medical disorders, and lower baseline function and quality of life were associated with lower HAM-D remission rates.  CONCLUSIONS:  The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials.  The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0p9Gt0lootWx8TEN9K18QfW6udTcc2eZmtmzenXmxDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FgsVaksA%253D%253D&md5=818ae4f8032b21462aa63c14942a0942</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.163.1.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.163.1.28%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DM.%2BH.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DWisniewski%26aufirst%3DS.%2BR.%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DWarden%26aufirst%3DD.%26aulast%3DRitz%26aufirst%3DL.%26aulast%3DNorquist%26aufirst%3DG.%26aulast%3DHowland%26aufirst%3DR.%2BH.%26aulast%3DLebowitz%26aufirst%3DB.%26aulast%3DMcGrath%26aufirst%3DP.%2BJ.%26aulast%3DShores-Wilson%26aufirst%3DK.%26aulast%3DBiggs%26aufirst%3DM.%2BM.%26aulast%3DBalasubramani%26aufirst%3DG.%2BK.%26aulast%3DFava%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520outcomes%2520with%2520citalopram%2520for%2520depression%2520using%2520measurement-based%2520care%2520in%2520STAR%252AD%253A%2520implications%2520for%2520clinical%2520practice%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2006%26volume%3D163%26spage%3D28%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span> </span><span class="NLM_article-title">Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century—a medicinal chemistry survey</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.2174%2F156802606778249810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17017959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1801-1823&author=E.+K.+Moltzenauthor=B.+Bang-Andersen&title=Serotonin+reuptake+inhibitors%3A+the+corner+stone+in+treatment+of+depression+for+half+a+century%E2%80%94a+medicinal+chemistry+survey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century - a medicinal chemistry survey</span></div><div class="casAuthors">Moltzen, Ejner K.; Bang-Andersen, Benny</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1801-1823</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibition of serotonin (5-HT) reuptake has been a central theme in the therapy of depression for half a century.  Through the years these therapies have improved, particularly with regard to side effects, and today's selective serotonin reuptake inhibitors (SSRIs) constitute a reasonably effective offer for the patients.  However, there is still room for major improvement and considering that almost 20% of the population in the western world will experience a depressive period in their lifetime, there is a large need for improved therapies.  A large spectrum of targets and strategies are currently being pursued, but so far none of these new approaches have been successful, mainly due to lack of a deeper understanding of the disease biol.  Since inhibition of 5-HT reuptake ensures a certain degree of antidepressant efficacy, there has been a large interest in various combinations with serotonin reuptake inhibitors (SRIs) in order to improve on the shortcomings of treatment with SSRIs.  Some of these approaches have resulted in marketed antidepressants, e.g., combinations of SRI with norepinephrine (NE) reuptake inhibition, whereas other approaches are still at an exptl. stage.  This review attempts to present the current status of these add-on/combination approaches with particular focus on the medicinal chem. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjBrSvGISmFbVg90H21EOLACvtfcHk0lilN6Hvn4kWKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjL&md5=2699173808138c2c85f8712992ab9afe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F156802606778249810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249810%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DSerotonin%2520reuptake%2520inhibitors%253A%2520the%2520corner%2520stone%2520in%2520treatment%2520of%2520depression%2520for%2520half%2520a%2520century%25E2%2580%2594a%2520medicinal%2520chemistry%2520survey%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1801%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mathew, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Novel drugs and therapeutic targets for severe mood disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2080</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2080-2092&author=S.+J.+Mathewauthor=H.+K.+Manjiauthor=D.+S.+Charney&title=Novel+drugs+and+therapeutic+targets+for+severe+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26aulast%3DManji%26aufirst%3DH.%2BK.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520drugs%2520and%2520therapeutic%2520targets%2520for%2520severe%2520mood%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2080%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span> </span><span class="NLM_article-title">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1001%2Farchpsyc.1994.03950030084009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=248-251&author=F.+Artigasauthor=V.+Perezauthor=E.+Alvarez&title=Pindolol+induces+a+rapid+improvement+of+depressed+patients+treated+with+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span></div><div class="casAuthors">Artigas F; Perez V; Alvarez E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-51</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8elF--uOnsj69zv1FsJFMfW6udTcc2eYvbyNV0e1DObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D&md5=19dc44e630d37442b5707cc26daa4a90</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030084009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030084009%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DAlvarez%26aufirst%3DE.%26atitle%3DPindolol%2520induces%2520a%2520rapid%2520improvement%2520of%2520depressed%2520patients%2520treated%2520with%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span> </span><span class="NLM_article-title">Pindolol augmentation of antidepressant response</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.2174%2F138945006775515446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16475955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Ghsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=139-147&author=F.+Artigasauthor=A.+Adellauthor=P.+Celada&title=Pindolol+augmentation+of+antidepressant+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol augmentation of antidepressant response</span></div><div class="casAuthors">Artigas, Francesc; Adell, Albert; Celada, Pau</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Pindolol, a partial β-adrenoceptor/5-HT1A receptor antagonist was first used to accelerate the onset of action of antidepressant drugs in 1994.  Since then, it has been used in more than a dozen controlled trials to examine whether it can reduce the lag to clin. improvement, and/or improve the clin. response in treatment-resistant patients.  A recent metaanal. concluded that pindolol accelerates the antidepressant response but does not increase the effectiveness of SSRIs in unresponsive patients.  Several studies have examd. the pharmacol. of pindolol to clarify the neurobiol. basis of its clin. action.  Pindolol was initially used due to its ability to block 5-HT1A receptor-mediated responses and to enhance the neurochem. effects of SSRIs.  In transfected cells, however, pindolol is a weak (20-25%) partial agonist at 5-HT1A receptors and, as such, its actions greatly depend on the system used.  In line with this, other reports have also shown that pindolol can reduce serotonergic cell firing when given alone.  Positron emission tomog. (PET) scan studies have shown that pindolol displays a preferential occupancy of pre- vs. postsynaptic 5-HT1A receptors, although the overall occupancy is lower than desirable, which suggests that higher doses (e.g., 15 mg/day) may be more effective than the currently used 7.5 mg daily dosage.  However, given the complex pharmacol. of pindolol, it is hoped that new developments in this field can proceed through the use of (a) selective and silent 5-HT1A receptor antagonists in combination with SSRIs, or (b) dual action agents (SSRI + 5-HT1A receptor blockers).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnn4ribHJkybVg90H21EOLACvtfcHk0lilN6Hvn4kWKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Ghsrw%253D&md5=abcdcbeb45be139d18db5b08342e0848</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138945006775515446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006775515446%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DAdell%26aufirst%3DA.%26aulast%3DCelada%26aufirst%3DP.%26atitle%3DPindolol%2520augmentation%2520of%2520antidepressant%2520response%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lhWOeUnmhwUBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=53-77&author=M.+J.+Millan&title=Dual-+and+triple-acting+agents+for+treating+core+and+co-morbid+symptoms+of+major+depression%3A+novel+concepts%2C+new+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDual-%2520and%2520triple-acting%2520agents%2520for%2520treating%2520core%2520and%2520co-morbid%2520symptoms%2520of%2520major%2520depression%253A%2520novel%2520concepts%252C%2520new%2520drugs%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D53%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cremers, T. I. F. H.; Wikström, H. V.; Den Boer, J. A.; Bosker, F. J.; Westerink, B. H.; Bøgesø, K. P.; Hogg, S.</span><span> </span><span class="NLM_article-title">The Combination of a Serotonin Reuptake Inhibitor and a 5-HT<sub>2C</sub> Antagonist, Inverse Agonist or Partial Agonist</span>. WO 200141701 (A2),<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=T.+I.+F.+H.+Cremers&author=H.+V.+Wikstr%C3%B6m&author=J.+A.+Den+Boer&author=F.+J.+Bosker&author=B.+H.+Westerink&author=K.+P.+B%C3%B8ges%C3%B8&author=S.+Hogg&title=The+Combination+of+a+Serotonin+Reuptake+Inhibitor+and+a+5-HT2C+Antagonist%2C+Inverse+Agonist+or+Partial+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCremers%26aufirst%3DT.%2BI.%2BF.%2BH.%26atitle%3DThe%2520Combination%2520of%2520a%2520Serotonin%2520Reuptake%2520Inhibitor%2520and%2520a%25205-HT2C%2520Antagonist%252C%2520Inverse%2520Agonist%2520or%2520Partial%2520Agonist%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosker, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bøgesø, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerink, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Boer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Inactivation of 5-HT<sub>2C</sub> receptors potentiates consequences of serotonin reuptake blockade</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1782</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1782-1789&author=T.+I.+Cremersauthor=M.+Giorgettiauthor=F.+J.+Boskerauthor=S.+Hoggauthor=J.+Arntauthor=A.+M%C3%B8rkauthor=G.+Honigauthor=K.+P.+B%C3%B8ges%C3%B8author=B.+H.+Westerinkauthor=H.+den+Boerauthor=H.+V.+Wikstr%C3%B6mauthor=L.+H.+Tecott&title=Inactivation+of+5-HT2C+receptors+potentiates+consequences+of+serotonin+reuptake+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DBosker%26aufirst%3DF.%2BJ.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DHonig%26aufirst%3DG.%26aulast%3DB%25C3%25B8ges%25C3%25B8%26aufirst%3DK.%2BP.%26aulast%3DWesterink%26aufirst%3DB.%2BH.%26aulast%3Dden%2BBoer%26aufirst%3DH.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%2BV.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DInactivation%2520of%25205-HT2C%2520receptors%2520potentiates%2520consequences%2520of%2520serotonin%2520reuptake%2520blockade%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1782%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nutt, D. J.</span><span> </span><span class="NLM_article-title">Beyond psychoanaleptics—can we improve antidepressant drug nomenclature?</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1177%2F0269881109105498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=19433474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1MzjslKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=343-345&author=D.+J.+Nutt&title=Beyond+psychoanaleptics%E2%80%94can+we+improve+antidepressant+drug+nomenclature%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?</span></div><div class="casAuthors">Nutt D J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychopharmacology (Oxford, England)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-5</span>
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwhiAlcDLSF_IW7hznt0zpfW6udTcc2eahrkC2UPwNAbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzjslKjtQ%253D%253D&md5=b252fd880909f98dec8bf3153df6c40e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F0269881109105498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881109105498%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DBeyond%2520psychoanaleptics%25E2%2580%2594can%2520we%2520improve%2520antidepressant%2520drug%2520nomenclature%253F%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2009%26volume%3D23%26spage%3D343%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span> </span><span class="NLM_article-title">The future of psychopharmacology of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.4088%2FJCP.10m06223blu" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=20797377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOrtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2010&pages=971-975&author=T.+Changauthor=M.+Fava&title=The+future+of+psychopharmacology+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The future of psychopharmacology of depression</span></div><div class="casAuthors">Chang, Trina; Fava, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-975</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  There are clear limitations to the currently approved pharmacotherapies of depression, including the fact that they are all essentially monoamine-based, have modest efficacy and a relatively slow onset of efficacy, and suffer from significant tolerability issues, particularly in the long term, including sexual dysfunction, wt. gain, and cognitive impairments.  This article reviews some of the most promising novel mechanisms that are not represented in compds. currently approved for depression in either the United States or Europe and that may represent the future of the psychopharmacol. treatment of depression, potentially addressing some of the efficacy and tolerability issues of antidepressants on the market.  These potential antidepressant treatments include the multimodal serotonergic agents, the triple uptake inhibitors, the neurokinin-based novel therapies, the glutamatergic treatments, the nicotinic receptor-based treatments, the neurogenesis-based treatments, and antiglucocorticoid therapies.  Some of these mechanisms appear to be more advanced in terms of drug development than others, but they all contribute to the global effort to develop more effective and better tolerated treatments for major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFe_QjvHixsrVg90H21EOLACvtfcHk0ljLUYkzu3YL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOrtL7O&md5=4487816d52472e18fdc52e923fda88b7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4088%2FJCP.10m06223blu&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.10m06223blu%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.%26aulast%3DFava%26aufirst%3DM.%26atitle%3DThe%2520future%2520of%2520psychopharmacology%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2010%26volume%3D71%26spage%3D971%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, N. M.</span><span> </span><span class="NLM_article-title">Is there a role for 5-HT<sub>1A</sub> agonists in the treatment of depression?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0006-3223%2802%2901643-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12559651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=193-203&author=P.+Blierauthor=N.+M.+Ward&title=Is+there+a+role+for+5-HT1A+agonists+in+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for 5-HT1A agonists in the treatment of depression?</span></div><div class="casAuthors">Blier, Pierre; Ward, Nick M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The role of serotonin (5-hydroxytryptamine; 5-HT) in the treatment of depressive and anxiety disorders is underscored by the therapeutic action of selective 5-HT reuptake inhibitors acting to enhance the degree of activation of various 5-HT receptor subtypes.  The 5-HT1A receptors are particularly relevant to the antidepressant and anxiolytic responses in human beings.  They are located presynaptically in the raphe nuclei, where they act as cell body autoreceptors to inhibit the firing rate of 5-HT neurons, and are located postsynaptically in limbic and cortical regions, where they also attenuate firing activity.  The azapirones are full agonists at 5-HT1A autoreceptors and are generally, but not exclusively, partial agonists at postsynaptic 5-HT1A receptors.  Some of these drugs, including gepirone and other 5-HT1A agonists such as buspirone, have been reported to exert anxiolytic and antidepressive activity in double-blind, placebo-controlled, and comparative trials.  Their delayed therapeutic activity is believed to result from increased activation of postsynaptic 5-HT1A receptors occurring only after 5-HT neurons regain their normal firing activity.  The recovery of this parameter, which is attributable to 5-HT1A autoreceptor desensitization, also restores 5-HT release.  At this point, the summed effects of a normalized level of synaptic 5-HT and the exogenous 5-HT1A agonist can be exerted on postsynaptic 5-HT1A receptors.  The widespread recognition of the clin. efficacy of such agents has largely been hampered by their undesirable pharmacokinetic properties.  Most 5-HT1A agonists are indeed readily absorbed but are also rapidly eliminated, thereby often producing either suboptimal therapeutic responses at low doses, or cumbersome adverse effects at higher doses.  Extended-release formulations allow once-daily dosing regimens, thus avoiding sharp peak plasma concns.  This improves compliance and permits the use of higher dosages, which may be assocd. with enhanced efficacy and better tolerability relative to the immediate-release formulations.  In sum, 5-HT1A receptor agonism represents a valuable and efficacious therapeutic approach to major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqave4phsEojLVg90H21EOLACvtfcHk0ljLUYkzu3YL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D&md5=94f64a33cbc40a67fc0a4ae347dc36bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2802%2901643-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252802%252901643-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DN.%2BM.%26atitle%3DIs%2520there%2520a%2520role%2520for%25205-HT1A%2520agonists%2520in%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D53%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Selective activation of postsynaptic 5-HT<sub>1A</sub> receptors induces rapid antidepressant response</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0893-133X%2896%2900242-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9109104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2sXivVegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=333-338&author=P.+Blierauthor=R.+Bergeronauthor=C.+de+Montigny&title=Selective+activation+of+postsynaptic+5-HT1A+receptors+induces+rapid+antidepressant+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-338</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It has been reported that the 5-HT1A autoreceptor antagonist pindolol can accelerate the antidepressant response to the selective serotonin (5-HT) reuptake inhibitor (SSRI) paroxetine, presumably by preventing the initial decrease in firing activity of 5-HT neurons produced by the SSRI.  The present study was aimed at further exploring this treatment strategy in three groups of 10 patients with unipolar major depression allocated sequentially to three treatment arms for 28 days.  The administration of the selective 5-HT1A agonist buspirone (20 mg/day for 1 wk and 30 mg/day thereafter) with pindolol (2.5 mg TID) was used to activate selectively postsynaptic 5-HT1A receptors.  This combination produced a greater than 50% redn. of depressive symptoms in the first week in 8 of 10 patients and the response was sustained for the remainder of the trial.  In contrast, the combination of tricyclic antidepressant drugs devoid of effect on the 5-HT reuptake process (desipramine or trimipramine, 75 mg/day for 1 wk and 150 mg/day thereafter) with pindolol resulted in only one of ten patients achieving a 50% improvement after 28/ days.  The combination of the SSRI fluvoxamine (50 mg/day for 1 wk and 100 mg/day thereafter) with pindolol produced a marked antidepressant effect but did not act as rapidly as the buspirone plus pindolol combination with none, four, and eight patients achieving a 50% amelioration after 7, 14, and 21 days of treatment, resp.  These results provide further evidence that pindolol may accelerate the antidepressant effect of drugs that alter the function of the 5-HT neurons and that the selective activation of postsynaptic 5-HT1A receptors may induce a rapid and robust antidepressant response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhCQficgy9bVg90H21EOLACvtfcHk0ljLUYkzu3YL8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVegur0%253D&md5=813015b45930966c582cd141b0adf113</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2896%2900242-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252896%252900242-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DSelective%2520activation%2520of%2520postsynaptic%25205-HT1A%2520receptors%2520induces%2520rapid%2520antidepressant%2520response%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D333%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Giovannini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandina, P.</span><span> </span><span class="NLM_article-title">Serotonergic modulation of acetylcholine release from cortex of freely moving rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9618425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1998&pages=1219-1225&author=M.+G.+Giovanniniauthor=I.+Ceccarelliauthor=B.+Molinariauthor=M.+Cecchiauthor=J.+Goldfarbauthor=P.+Blandina&title=Serotonergic+modulation+of+acetylcholine+release+from+cortex+of+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonergic modulation of acetylcholine release from cortex of freely moving rats</span></div><div class="casAuthors">Giovannini, Maria Grazia; Ceccarelli, Ilaria; Molinari, Beatrice; Cecchi, Marco; Goldfarb, Joseph; Blandina, Patrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1219-1225</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The modulation of acetylcholine (ACh) release by 5-HT3 receptor activation was studied using in vivo microdialysis.  Spontaneous and K+-stimulated ACh release were measured in frontoparietal cortex and hippocampus of freely moving rats.  Two consecutive exposures to high K+ produced ACh release of similar magnitude.  In the cortex, serotonin (5-HT) failed to alter spontaneous ACh release, but caused a concn.-dependent decrease of K+-evoked ACh release.  Phenylbiguanide (PBG) and m-chlorophenylbiguanide, two selective 5-HT3 agonists, mimicked the 5-HT responses, but 8-hydroxy-2-(di-n-propylamino)tetralin, a selective 5-HT1A agonist, was without effect.  However, PBG failed to modify K+-evoked ACh release from the hippocampus.  Systemic and local administration of a highly selective 5-HT3 antagonist, tropisetron ((3-α-tropanyl)1H-indole-carboxylic acid ester) blocked the effect of both 5-HT and PBG.  The inhibition of ACh release by PBG was sensitive to tetrodotoxin.  These observations provide direct evidence that, in rat cortex, 5-HT modulates in-vivo release of ACh through activation of 5-HT3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuhnBwWkibK7Vg90H21EOLACvtfcHk0li3Hjnk73mhJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFCmurg%253D&md5=e6b5668f5cc5567eec154c805374ee6b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26aulast%3DCeccarelli%26aufirst%3DI.%26aulast%3DMolinari%26aufirst%3DB.%26aulast%3DCecchi%26aufirst%3DM.%26aulast%3DGoldfarb%26aufirst%3DJ.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DSerotonergic%2520modulation%2520of%2520acetylcholine%2520release%2520from%2520cortex%2520of%2520freely%2520moving%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D285%26spage%3D1219%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span> </span><span class="NLM_article-title">Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=7891314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2MXktl2ksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1995&pages=1044-1051&author=M.+Matsumotoauthor=M.+Yoshiokaauthor=H.+Togashiauthor=M.+Tochiharaauthor=T.+Ikedaauthor=H.+Saito&title=Modulation+of+norepinephrine+release+by+serotonergic+receptors+in+the+rat+hippocampus+as+measured+by+in+vivo+microdialysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis</span></div><div class="casAuthors">Matsumoto, Machiko; Yoshioka, Mitsuhiro; Togashi, Hiroko; Tochihara, Masahiro; Ikeda, Toshiya; Saito, Hideya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-51</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The functional modulation of norepinephrine (NE) release by serotonergic receptors in the hippocampus of freely moving rats was studied by use of in vivo microdialysis.  To stimulate NE release from the nerve terminals, a high concn. of potassium (K+, 120 mM) was added through the perfusion system.  The K+-evoked NE release was inhibited in a concn.-dependent manner when serotonin (5-HT, 0.01-10 μM) was coperfused with K+.  A selective 5-HT3 receptor agonist, 2-methyl-5-HT, mimicked the 5-HT response at a concn. of 0.01 to 10 μM.  The 5-HT-induced (1 μM) inhibition of NE release was blocked by pretreatment with ondansetron (1 and 10 μM), a 5-HT3 receptor antagonist.  K+-evoked NE release was also reduced by coperfusion with the 5-HT reuptake inhibitor, fluoxetine (10 μM), which caused increases in the dialyzate 5-HT concn.  The fluoxetine-induced (10 μM) decreases in the K+-evoked NE release were prevented by serotonergic denervation caused by pretreatment with 5,7-dihydroxytryptamine (200 μg/rat i.c.v.).  These results indicate that the inhibition on NE release by fluoxetine was due to increased synaptic concns. of endogenous 5-HT.  The fluoxetine-induced inhibitory effect was furthermore abolished by pretreatment with ondansetron (1 and 10 μM).  These findings indicate the possibility that both exogenous and endogenous 5-HT inhibit NE release occurs from the rat hippocampus by 5-HT3 receptors.  Thus, the present study suggests that the functional modulation of NE release by 5-HT3 receptors exists in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4AzM_4yN27Vg90H21EOLACvtfcHk0li3Hjnk73mhJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktl2ksrY%253D&md5=2a973f041a5910d56e41c8d826bed935</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DTogashi%26aufirst%3DH.%26aulast%3DTochihara%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26atitle%3DModulation%2520of%2520norepinephrine%2520release%2520by%2520serotonergic%2520receptors%2520in%2520the%2520rat%2520hippocampus%2520as%2520measured%2520by%2520in%2520vivo%2520microdialysis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D272%26spage%3D1044%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Morales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span> </span><span class="NLM_article-title">The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">731</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2F0006-8993%2896%2900557-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8883870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK28XkvFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=731&publication_year=1996&pages=199-202&author=M.+Moralesauthor=E.+Battenbergauthor=L.+de+Leceaauthor=F.+E.+Bloom&title=The+type+3+serotonin+receptor+is+expressed+in+a+subpopulation+of+GABAergic+neurons+in+the+rat+neocortex+and+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus</span></div><div class="casAuthors">Morales, Marisela; Battenberg, Elena; de Lecea, Luis; Bloom, Floyd E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">731</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">199-202</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors used in situ hybridization and immunocytochem. to investigate the presence of GABA in neurons that express the type 3 serotonin receptor (5-HT3R).  Quant. anal. indicated that more than 90 of 5-HT3R expressing cells are GABAergic in the neocortex and hippocampus.  The co-existence of 5-HT3R and GABA in cortical and hippocampal neurons indicates that serotonin, via 5-HT3R, can affect GABA release and suggests the participation of 5-HT3R in the inhibitory regulation of forebrain neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEQctOYV6ArVg90H21EOLACvtfcHk0lil_8rm6Suu_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFSku7g%253D&md5=36e269c55f5f1fdfa32aa5e97a8d73e5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900557-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900557-4%26sid%3Dliteratum%253Aachs%26aulast%3DMorales%26aufirst%3DM.%26aulast%3DBattenberg%26aufirst%3DE.%26aulast%3Dde%2BLecea%26aufirst%3DL.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26atitle%3DThe%2520type%25203%2520serotonin%2520receptor%2520is%2520expressed%2520in%2520a%2520subpopulation%2520of%2520GABAergic%2520neurons%2520in%2520the%2520rat%2520neocortex%2520and%2520hippocampus%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D731%26spage%3D199%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Yan, Z.</span><span> </span><span class="NLM_article-title">Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1385%2FMN%3A26%3A2-3%3A203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2rtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=203-216&author=Z.+Yan&title=Regulation+of+GABAergic+inhibition+by+serotonin+signaling+in+prefrontal+cortex%3A+molecular+mechanisms+and+functional+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications</span></div><div class="casAuthors">Yan, Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">203-216</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonergic neurotransmission in prefrontal cortex (PFC) plays a key role in regulating emotion and cognition under normal and pathol. conditions.  Increasing evidence suggests that serotonin receptors are involved in the complex regulation of GABAergic inhibitory transmission in PFC.  Activation of postsynaptic 5-HT2 receptors in PFC pyramidal neurons inhibits GABAA-receptor currents via phosphorylation of GABAA receptor γ2 subunits by RACK1-anchored PKC.  In contrast, activation of postsynaptic 5-HT4 receptors produces an activity-dependent bi-directional regulation of GABA-evoked currents in PFC pyramidal neurons, which is mediated through phosphorylation of GABAA-receptor β subunits by anchored PKA.  On the presynaptic side, GABAergic inhibition is regulated by 5-HT through the activation of 5-HT2, 5-HT1, and 5-HT3 receptors on GABAergic interneurons.  These data provide a mol. and cellular mechanism for serotonin to dynamically regulate synaptic transmission and neuronal excitability in the PFC network, which may underlie the actions of many antidepressant and antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fSU-xegY2LVg90H21EOLACvtfcHk0lil_8rm6Suu_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2rtb8%253D&md5=61f4a131e1aa0ba08755b1b6953ce9b8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1385%2FMN%3A26%3A2-3%3A203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A26%253A2-3%253A203%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520GABAergic%2520inhibition%2520by%2520serotonin%2520signaling%2520in%2520prefrontal%2520cortex%253A%2520molecular%2520mechanisms%2520and%2520functional%2520implications%26jtitle%3DMol.%2520Neurobiol.%26date%3D2002%26volume%3D26%26spage%3D203%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Angel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prouteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garreau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, S. Z.</span><span> </span><span class="NLM_article-title">Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT<sub>3</sub> receptor antagonist and antiemetic properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2F0014-2999%2893%2990767-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8385615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1993&pages=139-145&author=I.+Angelauthor=H.+Schoemakerauthor=M.+Prouteauauthor=M.+Garreauauthor=S.+Z.+Langer&title=Litoxetine%3A+a+selective+5-HT+uptake+inhibitor+with+concomitant+5-HT3+receptor+antagonist+and+antiemetic+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties</span></div><div class="casAuthors">Angel, I.; Schoemaker, H.; Prouteau, M.; Garreau, M.; Langer, S. Z.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">139-45</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The antidepressant litoxetine (SL 81.0385) has also antiemetic properties in the ferret.  Litoxetine at 1 and 10 mg/kg i.v. dose-dependently reduced the no. of retches and vomiting as well as the no. of emetic episodes induced by cisplatin (10 mg/kg i.v.) and delayed the onset of emesis in ferrets.  Fluoxetine at 1 or 10 mg/kg i.v. failed to inhibit the cisplatin-induced emetic responses and increased the no. of retches and vomiting and accelerated the onset of emesis.  The antiemetic effects of litoxetine may be mediated through an interaction with serotoninergic 5HT3 receptors.  This was studied using [3H]quipazine or [3H]BRL-43694 to label the 5HT3 receptors.  Litoxetine had moderate affinity for the cerebral 5HT3 receptors (Ki = 85 nM), while fluoxetine, similar to other 5HT uptake inhibitors, had only negligible affinity for this receptor (Ki = 6.5 μM).  Litoxetine may inhibit the cisplatin-induced emetic responses due to its moderate 5HT3 antagonist properties.  The clin. use of serotonergic antidepressants is assocd. with gastrointestinal discomfort, particularly nausea and vomiting, as a major side-effect.  If nausea and vomiting assocd. with the use of 5 HT uptake inhibitors are due to the stimulation of 5HT3 receptors, the concomitant 5HT3 antagonism of litoxetine may limit the gastrointestinal side-effects of this novel antidepressant and thus offer an important clin. advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFy5NcXRJkm7Vg90H21EOLACvtfcHk0lgonJEjofchgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGisrg%253D&md5=4978c9f16d13e9b57d69864b9bb04c49</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990767-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990767-C%26sid%3Dliteratum%253Aachs%26aulast%3DAngel%26aufirst%3DI.%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DProuteau%26aufirst%3DM.%26aulast%3DGarreau%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DS.%2BZ.%26atitle%3DLitoxetine%253A%2520a%2520selective%25205-HT%2520uptake%2520inhibitor%2520with%2520concomitant%25205-HT3%2520receptor%2520antagonist%2520and%2520antiemetic%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D232%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Bergeron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span> </span><span class="NLM_article-title">Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fajp.151.7.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8010370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADyaK2c3nvFOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1994&pages=1084-1086&author=R.+Bergeronauthor=P.+Blier&title=Cisapride+for+the+treatment+of+nausea+produced+by+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Bergeron R; Blier P</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1084-6</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">A low dose of cisapride (5 mg b.i.d.) produced rapid relief from nausea elicited by the initiation of treatment with a selective serotonin reuptake inhibitor in eight patients.  This effect of cisapride is presumably related to its serotonin3 antagonistic property.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU3wXaEjfbYiM8MEzWGjS9fW6udTcc2eYuaNzKfRgj5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3nvFOgtg%253D%253D&md5=0fbecfcd15da5f3dd59abdfe73003090</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1176%2Fajp.151.7.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.151.7.1084%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3DBlier%26aufirst%3DP.%26atitle%3DCisapride%2520for%2520the%2520treatment%2520of%2520nausea%2520produced%2520by%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1994%26volume%3D151%26spage%3D1084%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gray, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dounay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boroski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probert, A.</span><span> </span><span class="NLM_article-title">Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6604</span><span class="NLM_x">–</span> <span class="NLM_lpage">6607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6604-6607&author=D.+L.+Grayauthor=W.+Xuauthor=B.+M.+Campbellauthor=A.+B.+Dounayauthor=N.+Bartaauthor=S.+Boroskiauthor=L.+Dennyauthor=L.+Evansauthor=N.+Stratmanauthor=A.+Probert&title=Discovery+and+pharmacological+characterization+of+aryl+piperazine+and+piperidine+ethers+as+dual+acting+norepinephrine+reuptake+inhibitors+and+5-HT1A+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DBarta%26aufirst%3DN.%26aulast%3DBoroski%26aufirst%3DS.%26aulast%3DDenny%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DStratman%26aufirst%3DN.%26aulast%3DProbert%26aufirst%3DA.%26atitle%3DDiscovery%2520and%2520pharmacological%2520characterization%2520of%2520aryl%2520piperazine%2520and%2520piperidine%2520ethers%2520as%2520dual%2520acting%2520norepinephrine%2520reuptake%2520inhibitors%2520and%25205-HT1A%2520partial%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6604%26epage%3D6607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ruhland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K.</span><span> </span><span class="NLM_article-title">Iron-assisted nucleophilic aromatic substitution on solid phase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5257</span><span class="NLM_x">–</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025721q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=5257-5268&author=T.+Ruhlandauthor=K.+S.+Bangauthor=K.+Andersen&title=Iron-assisted+nucleophilic+aromatic+substitution+on+solid+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo025721q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025721q%26sid%3Dliteratum%253Aachs%26aulast%3DRuhland%26aufirst%3DT.%26aulast%3DBang%26aufirst%3DK.%2BS.%26aulast%3DAndersen%26aufirst%3DK.%26atitle%3DIron-assisted%2520nucleophilic%2520aromatic%2520substitution%2520on%2520solid%2520phase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D5257%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ruhland, T.; Smith, G. P.; Bang-Andersen, B.; Pueschl, A.; Moltzen, E. K.; Andersen, K.</span><span> </span><span class="NLM_article-title">Phenyl-piperazine Derivatives as Serotonin Reuptake Inhibitors</span>. WO 2003029232 (A1),<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Ruhland&author=G.+P.+Smith&author=B.+Bang-Andersen&author=A.+Pueschl&author=E.+K.+Moltzen&author=K.+Andersen&title=Phenyl-piperazine+Derivatives+as+Serotonin+Reuptake+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuhland%26aufirst%3DT.%26atitle%3DPhenyl-piperazine%2520Derivatives%2520as%2520Serotonin%2520Reuptake%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Louie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides: mechanistic studies lead to coupling in the absence of tin reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides%3A+mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides%253A%2520mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Guram, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennels, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A simple catalytic method for the conversion of aryl bromides to arylamines</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1002%2Fanie.199513481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=1348-1350&author=A.+S.+Guramauthor=R.+A.+Rennelsauthor=S.+L.+Buchwald&title=A+simple+catalytic+method+for+the+conversion+of+aryl+bromides+to+arylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A simple catalytic method for the conversion of aryl bromides to arylamines</span></div><div class="casAuthors">Guram, Anil S.; Rennels, Roger A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1348-50</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Aryl bromides reacted with amines in the presence of NaOCMe3 and a catalytic amt. of PdCl2[P(o-tolyl)3]2 or Pd(dba)2/2P(o-tolyl)3 to give arylamines in good yields.  Also, cyclization of 2-XC6H4CH2(CH2)nNHCH2Ph (X = Br, iodo; n = 1, 2, 3) in the presence of NaOCMe3 and a catalytic amt. of Pd(PPh3)4 gave good yields of the N heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXDC5Vhs2d57Vg90H21EOLACvtfcHk0lj0uD4-GUaGHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D&md5=d435e21c3f535757455d53e12417596b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.199513481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199513481%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DRennels%26aufirst%3DR.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520simple%2520catalytic%2520method%2520for%2520the%2520conversion%2520of%2520aryl%2520bromides%2520to%2520arylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D1348%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Larsen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, M.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed monoamination of dihalogenated benzenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2950</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=2938-2950&author=S.+B.+Larsenauthor=B.+Bang-Andersenauthor=T.+N.+Johansenauthor=M.+J%C3%B8rgensen&title=Palladium-catalyzed+monoamination+of+dihalogenated+benzenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DS.%2BB.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DM.%26atitle%3DPalladium-catalyzed%2520monoamination%2520of%2520dihalogenated%2520benzenes%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D2938%26epage%3D2950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span> </span><span class="NLM_article-title">A general palladium-catalysed synthesis of aromatic and heteroaromatic thioethers</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3069</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=3069-3073&author=U.+Schopferauthor=A.+Schlapbach&title=A+general+palladium-catalysed+synthesis+of+aromatic+and+heteroaromatic+thioethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DA%2520general%2520palladium-catalysed%2520synthesis%2520of%2520aromatic%2520and%2520heteroaromatic%2520thioethers%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D3069%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lenox, R. H.; Frazer, A.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Antidepressants and Mood Stabilizers</span>. In  <span class="citation_source-book">Neuropsychopharmacology: The Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology </span>; <span class="NLM_contrib-group">Davis, K. L.; Charney, D.; Coyle, J. T.; Nemeroff, C.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1139</span>− <span class="NLM_lpage">1163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=1139-1163&author=R.+H.+Lenox&author=A.+Frazerauthor=K.+L.+Davis&author=D.+Charney&author=J.+T.+Coyle&author=C.+Nemeroff&title=Neuropsychopharmacology%3A+The+Fifth+Generation+of+Progress%3A+An+Official+Publication+of+the+American+College+of+Neuropsychopharmacology+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLenox%26aufirst%3DR.%2BH.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Antidepressants%2520and%2520Mood%2520Stabilizers%26btitle%3DNeuropsychopharmacology%253A%2520The%2520Fifth%2520Generation%2520of%2520Progress%253A%2520An%2520Official%2520Publication%2520of%2520the%2520American%2520College%2520of%2520Neuropsychopharmacology%2520%26aulast%3DDavis%26aufirst%3DK.%2BL.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2002%26spage%3D1139%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagrati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span> </span><span class="NLM_article-title">Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [<sup>11</sup>C]DASB positron emission tomography study</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fappi.ajp.161.5.826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15121647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itFygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=826-835&author=J.+H.+Meyerauthor=A.+A.+Wilsonauthor=S.+Sagratiauthor=D.+Husseyauthor=A.+Carellaauthor=W.+Z.+Potterauthor=N.+Ginovartauthor=E.+P.+Spencerauthor=A.+Cheokauthor=S.+Houle&title=Serotonin+transporter+occupancy+of+five+selective+serotonin+reuptake+inhibitors+at+different+doses%3A+an+%5B11C%5DDASB+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study</span></div><div class="casAuthors">Meyer Jeffrey H; Wilson Alan A; Sagrati Sandra; Hussey Doug; Carella Anna; Potter William Z; Ginovart Nathalie; Spencer Edgar P; Cheok Andy; Houle Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">826-35</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Minimum therapeutic doses of paroxetine and citalopram produce 80% occupancy for the serotonin (5-HT) transporter (5-HTT).  The authors used [(11)C]DASB positron emission tomography to measure occupancies of three other selective serotonin reuptake inhibitors (SSRIs) at minimum therapeutic doses.  The relationship between dose and occupancy was also investigated.  METHOD:  Striatal 5-HTT binding potential was measured in 77 subjects before and after 4 weeks of medication administration.  Binding potential is proportional to the density of receptors not blocked by medication.  Subjects received citalopram, fluoxetine, sertraline, paroxetine, or extended-release venlafaxine.  Healthy subjects received subtherapeutic doses; subjects with mood and anxiety disorders received therapeutic doses.  Percent reduction in 5-HTT binding potential for each medication and dose was calculated.  To obtain test-retest data, binding potential was measured before and after 4 weeks in six additional healthy subjects.  RESULTS:  Substantial occupancy occurred at subtherapeutic doses for all SSRIs.  Compared to test-retest data, each drug at the minimum therapeutic dose had a significant effect on striatal 5-HTT binding potential.  Mean occupancy at this dose was 76%-85%.  At higher plasma SSRI concentrations, 5-HTT occupancy tended to increase above 80%.  For each drug, as the dose (or plasma level) increased, occupancy increased nonlinearly, with a plateau for higher doses.  CONCLUSIONS:  At tolerable doses, SSRIs have increasing occupancy with increasing plasma concentration or dose.  Occupancy of 80% across five SSRIs occurs at minimum therapeutic doses.  This suggests that 80% 5-HTT blockade is important for therapeutic effect.  Occupancy should be measured during development of antidepressant compounds targeting the 5-HTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo4wIPTXNjlWhHGZei4OW9fW6udTcc2eZ2VnzO2dLVFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itFygsg%253D%253D&md5=55e6a09757b936684a41c80798c57f1b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.5.826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.5.826%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DSagrati%26aufirst%3DS.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DE.%2BP.%26aulast%3DCheok%26aufirst%3DA.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DSerotonin%2520transporter%2520occupancy%2520of%2520five%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520at%2520different%2520doses%253A%2520an%2520%255B11C%255DDASB%2520positron%2520emission%2520tomography%2520study%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D826%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, P. H.</span><span> </span><span class="NLM_article-title">Selectivity of [<sup>3</sup>H]MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1038%2Fsj.bjp.0705693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=14993096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=1015-1023&author=A.+K.+Larsenauthor=L.+T.+Brennumauthor=J.+Egebjergauthor=C.+S%C3%A1nchezauthor=C.+Halldinauthor=P.+H.+Andersen&title=Selectivity+of+%5B3H%5DMADAM+binding+to+5-hydroxytryptamine+transporters+in+vitro+and+in+vivo+in+mice%3B+correlation+with+behavioural+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of 3H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioral effects</span></div><div class="casAuthors">Larsen, A. K.; Brennum, L. T.; Egebjerg, J.; Sanchez, C.; Halldin, C.; Andersen, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1015-1023</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding of the novel radioligand 3H-2-(2-dimethylaminomethyl-phenylsulfanyl)-5-methylphenylamine (3H-MADAM) to the serotonin transporter (SERT) was used to characterize a range of selective serotonin reuptake inhibitors (SSRIs) in vitro and in vivo.  3H-MADAM bound with high affinity in a saturable manner to both human SERT expressed in CHO cells (Kd=0.20 nM (pKd=9.74±0.12), Bmax=35±4 fmol mg-1 protein) and mouse cerebral cortex membranes (Kd=0.21 nM (pKd=9.66±0.10), Bmax=50±24 fmol mg-1 protein).  Binding of 3H-MADAM was highly selective for SERT in vitro as demonstrated by the in vitro profile of MADAM tested at 75 different receptors, ion channels and transporters.  This was further substantiated by the pharmacol. profile of the binding.  Hence, the binding of 3H-MADAM was potently inhibited by SSRIs but not by selective inhibitors of noradrenaline transport and dopamine transport.  Likewise, a 5-HT2A/2C receptor antagonist did not inhibit 3H-MADAM binding.  3H-MADAM binding in vivo was inhibited only by compds. which also inhibited the binding of 3H-MADAM in vitro (the SSRIs, mixed SERT/noradrenaline transport inhibitors and clomipramine), confirming the selectivity of 3H-MADAM for SERT also in vivo.  Moreover, compds. effective in inhibiting 3H-MADAM binding were the only ones found to be active in the mouse 5-HTP potentiation test confirming the model as a behavioral correlate to in vivo 5-HT uptake.  Finally, it was found that a SERT occupancy of 85-95% was necessary to produce 50% of the max. behavioral response (ED50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohfnNM-lprSrVg90H21EOLACvtfcHk0lhGvgeMkNzmAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKitLg%253D&md5=ceb57d2eca6de216464989a4dc3952ff</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705693%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DP.%2BH.%26atitle%3DSelectivity%2520of%2520%255B3H%255DMADAM%2520binding%2520to%25205-hydroxytryptamine%2520transporters%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520mice%253B%2520correlation%2520with%2520behavioural%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D1015%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Owens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krulewicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">3201</span><span class="NLM_x">–</span> <span class="NLM_lpage">3212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=3201-3212&author=M.+J.+Owensauthor=S.+Krulewiczauthor=J.+S.+Simonauthor=D.+V.+Sheehanauthor=M.+E.+Thaseauthor=D.+J.+Carpenterauthor=S.+J.+Plottauthor=C.+B.+Nemeroff&title=Estimates+of+serotonin+and+norepinephrine+transporter+inhibition+in+depressed+patients+treated+with+paroxetine+or+venlafaxine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26aulast%3DKrulewicz%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DJ.%2BS.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DD.%2BJ.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DEstimates%2520of%2520serotonin%2520and%2520norepinephrine%2520transporter%2520inhibition%2520in%2520depressed%2520patients%2520treated%2520with%2520paroxetine%2520or%2520venlafaxine%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D3201%26epage%3D3212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozeki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iga, T.</span><span> </span><span class="NLM_article-title">Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT<sub>3</sub> receptor antagonists in cancer patients</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs00280-004-0798-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15168080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=185-190&author=Y.+Yamadaauthor=M.+Sugiuraauthor=K.+Higoauthor=T.+Ozekiauthor=R.+Takayanagiauthor=K.+Okuyamaauthor=K.+Yamamotoauthor=H.+Satohauthor=Y.+Sawadaauthor=T.+Iga&title=Receptor+occupancy+theory-based+analysis+of+antiemetic+effects+and+standard+doses+of+5-HT3+receptor+antagonists+in+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients</span></div><div class="casAuthors">Yamada, Yasuhiko; Sugiura, Munetoshi; Higo, Kozue; Ozeki, Takeshi; Takayanagi, Risa; Okuyama, Kiyoshi; Yamamoto, Koujirou; Satoh, Hitoshi; Sawada, Yasufumi; Iga, Tatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Purpose: The aim of this study was to det. the usefulness of receptor occupancy theory-based anal. using pharmacokinetic and pharmacodynamic parameters for predicting the av. receptor occupancy (ΦB) in humans of each of five 5-HT3 antagonists administered at std. doses.  Methods: The relation between the ΦB value and the complete vomiting inhibition rate after a single i.v. administration of cisplatin (not less than 50 mg/m2) was analyzed.  Results: The predicted ΦB values after i.v. administration and oral administration of 5-HT3 antagonists were more than 65% and 50%, resp., suggesting that relatively high receptor occupancy is required to elicit sufficient antiemetic effects of 5-HT3 antagonists.  Moreover, significant (P<0.05) linear relationships were found between ΦB values and complete vomiting inhibition rates of 5-HT3 antagonists in preventive cisplatin therapy, with correlation coeffs. higher than 0.9, suggesting that the 5-HT3 receptor occupancy is an appropriate index of clin. efficacy of 5-HT3 antagonists, with higher receptor occupancy indicating more extensive antiemetic action.  Conclusion: The receptor occupancy theory-based anal. of the antiemetic effect of a 5-HT3 receptor antagonist used in this study should be very useful for not only estg. a rational dosage regimen but also detg. the std. dose of a new drug using exptl. data obtained in a preclin. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQu7F1dLEx5LVg90H21EOLACvtfcHk0lhQKBz36A2hxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gks7c%253D&md5=35aa120ab0b5a0af45f63b1bc113046a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0798-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0798-x%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DSugiura%26aufirst%3DM.%26aulast%3DHigo%26aufirst%3DK.%26aulast%3DOzeki%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DR.%26aulast%3DOkuyama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DIga%26aufirst%3DT.%26atitle%3DReceptor%2520occupancy%2520theory-based%2520analysis%2520of%2520antiemetic%2520effects%2520and%2520standard%2520doses%2520of%25205-HT3%2520receptor%2520antagonists%2520in%2520cancer%2520patients%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D54%26spage%3D185%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">PET-characterization of [carbonyl-<sup>11</sup>C]WAY-100635 binding to 5-HT<sub>1A</sub> receptors in the primate brain</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1997&pages=196-202&author=L.+Fardeauthor=N.+Ginovartauthor=H.+Itoauthor=C.+Lundkvistauthor=V.+W.+Pikeauthor=J.+A.+McCarronauthor=C.+Halldin&title=PET-characterization+of+%5Bcarbonyl-11C%5DWAY-100635+binding+to+5-HT1A+receptors+in+the+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DPET-characterization%2520of%2520%255Bcarbonyl-11C%255DWAY-100635%2520binding%2520to%25205-HT1A%2520receptors%2520in%2520the%2520primate%2520brain%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D133%26spage%3D196%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bantick, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Occupancy of agonist drugs at the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=847-859&author=R.+A.+Bantickauthor=E.+A.+Rabinerauthor=E.+Hiraniauthor=M.+H.+de+Vriesauthor=S.+P.+Humeauthor=P.+M.+Grasby&title=Occupancy+of+agonist+drugs+at+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBantick%26aufirst%3DR.%2BA.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DHirani%26aufirst%3DE.%26aulast%3Dde%2BVries%26aufirst%3DM.%2BH.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DOccupancy%2520of%2520agonist%2520drugs%2520at%2520the%25205-HT1A%2520receptor%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D847%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span> </span><span class="NLM_article-title">6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine<sub>1A</sub> receptor occupancy in rats</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1387-1392&author=H.+Wongauthor=R.+C.+Dockensauthor=L.+Pajorauthor=S.+Yeolaauthor=J.+E.+Graceauthor=A.+D.+Starkauthor=R.+A.+Taubauthor=F.+D.+Yoccaauthor=R.+C.+Zaczekauthor=Y.-W.+Li&title=6-Hydroxybuspirone+is+a+major+active+metabolite+of+buspirone%3A+assessment+of+pharmacokinetics+and+5-hydroxytryptamine1A+receptor+occupancy+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DPajor%26aufirst%3DL.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DStark%26aufirst%3DA.%2BD.%26aulast%3DTaub%26aufirst%3DR.%2BA.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DZaczek%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DY.-W.%26atitle%3D6-Hydroxybuspirone%2520is%2520a%2520major%2520active%2520metabolite%2520of%2520buspirone%253A%2520assessment%2520of%2520pharmacokinetics%2520and%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1387%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40a"><span><span class="NLM_contrib-group">Moore, N. A.; Bang-Andersen, B.; Brennum, L. T.; Frederiksen, K.; Hogg, S.; Mørk, A.; Sanchez, C.; Smith, D. G.; Stensbøl, T. B.; Zhong, H.</span><span> </span><span class="NLM_article-title">Lu AA21004: A Novel Potential Treatment for Mood Disorders</span>. Presented at the 21st European College of Neuropsychopharmacology (ECNP), Barcelona, Spain, August 30−September 3,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster P.2.b.015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+A.+Moore&author=B.+Bang-Andersen&author=L.+T.+Brennum&author=K.+Frederiksen&author=S.+Hogg&author=A.+M%C3%B8rk&author=C.+Sanchez&author=D.+G.+Smith&author=T.+B.+Stensb%C3%B8l&author=H.+Zhong&title=Lu+AA21004%3A+A+Novel+Potential+Treatment+for+Mood+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DN.%2BA.%26atitle%3DLu%2520AA21004%253A%2520A%2520Novel%2520Potential%2520Treatment%2520for%2520Mood%2520Disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit40b"><span><span class="NLM_contrib-group">Moore, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Moore%2C+N.+A.%3B+Bang-Andersen%2C+B.%3B+Brennum%2C+L.+T.%3B+Frederiksen%2C+K.%3B+Hogg%2C+S.%3B+M%C3%B8rk%2C+A.%3B+Sanchez%2C+C.%3B+Smith%2C+D.+G.%3B+Stensb%C3%B8l%2C+T.+B.%3B+Zhong%2C+H.Neuropsychopharmacology+2008%2C+18+%28suppl.+4%29+S321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DFrederiksen%26aufirst%3DK.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DZhong%26aufirst%3DH.%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D18%26issue%3Dsuppl.%25204%26spage%3DS321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Assié, M.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenech, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravailhe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucillon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Rapid desensitization of somatodendritic 5-HT<sub>1A</sub> receptors by chronic administration of the high-efficacy 5-HT<sub>1A</sub> agonist, F13714: a microdialysis study in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1038%2Fsj.bjp.0706859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16921393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlSltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=170-178&author=M.-B.+Assi%C3%A9author=H.+Lomenechauthor=V.+Ravailheauthor=V.+Faucillonauthor=A.+Newman-Tancredi&title=Rapid+desensitization+of+somatodendritic+5-HT1A+receptors+by+chronic+administration+of+the+high-efficacy+5-HT1A+agonist%2C+F13714%3A+a+microdialysis+study+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat</span></div><div class="casAuthors">Assie, M.-B.; Lomenech, H.; Ravailhe, V.; Faucillon, V.; Newman-Tancredi, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Desensitization of somatodendritic 5-HT1A receptors is involved in the mechanism of action of several antidepressants, but the rapidity of this effect and the amt. of agonist stimulation needed are unclear.  We evaluated the capacity of the high-efficacy 5-HT1A agonist, F13714 (3-chloro-4-fluorophenyl-4-fluoro-4-{(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino-methyl}-piperidin-1-yl-methanone) and of the partial agonist, flesinoxan, to desensitize somatodendritic 5-HT1A receptors involved in the control of 5-HT release.  Intracerebral microdialysis in the hippocampus of freely moving rats was used to examine the acute and chronic effects of the two compds. (administered by osmotic pumps for 3, 7 or 14 days) on extracellular 5-HT levels, measured by HPLC with electrochem. detection.  When given acutely, F13714, flesinoxan and the low-efficacy 5-HT1A agonist, buspirone, dose-dependently decreased extracellular 5-HT concns. (ED50 values: 0.04, 0.77 and 5.6 mg kg-1, resp.).  The selective 5-HT1A antagonist WAY100635 inhibited the effects of the three compds.  F13714 (2.5 mg kg-1 per day for 3, 7 or 14 days and 0.63 mg kg-1 for 7 days) significantly attenuated the inhibition of 5-HT release induced by buspirone (10 mg kg-1).  In contrast, flesinoxan (10 mg kg-1 per day) failed to alter the response to buspirone at any of the treatment durations.  Rat somatodendritic 5-HT1A receptors controlling hippocampal 5-HT release were rapidly desensitized by chronic activation with a high-efficacy 5-HT1A agonist, but not by chronic activation with a partial agonist.  Thus, rapid 5-HT1A autoreceptor desensitization by high-efficacy agonists may accelerate the onset of the therapeutic effects of antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfk47hYMSIRbVg90H21EOLACvtfcHk0liKbLHescoMxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlSltr8%253D&md5=6342aa9d9937277a5d4e211f092a5198</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706859%26sid%3Dliteratum%253Aachs%26aulast%3DAssi%25C3%25A9%26aufirst%3DM.-B.%26aulast%3DLomenech%26aufirst%3DH.%26aulast%3DRavailhe%26aufirst%3DV.%26aulast%3DFaucillon%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DRapid%2520desensitization%2520of%2520somatodendritic%25205-HT1A%2520receptors%2520by%2520chronic%2520administration%2520of%2520the%2520high-efficacy%25205-HT1A%2520agonist%252C%2520F13714%253A%2520a%2520microdialysis%2520study%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D170%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Haddjeri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">10150</span><span class="NLM_x">–</span> <span class="NLM_lpage">10156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1523%2FJNEUROSCI.18-23-10150.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9822768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=10150-10156&author=N.+Haddjeriauthor=P.+Blierauthor=C.+de+Montigny&title=Long-term+antidepressant+treatments+result+in+a+tonic+activation+of+forebrain+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors</span></div><div class="casAuthors">Haddjeri, Nasser; Blier, Pierre; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10150-10156</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We report here the first direct functional evidence of an increase in the tonic activation of postsynaptic 5-HT1A receptors by antidepressant treatments.  Because 5-HT1A receptor activation hyperpolarizes and inhibits CA3 pyramidal neurons in the dorsal hippocampus, we detd., using in vivo extracellular recording, whether the selective 5-HT1A receptor antagonist WAY 100635 could disinhibit these neurons.  Unexpectedly, no disinhibition could be detected in controls.  However, after long-term treatment with the tricyclic antidepressant imipramine, the selective 5-HT reuptake inhibitor paroxetine, the reversible monoamine oxidase-A inhibitor befloxatone, the α2-adrenergic antagonist mirtazapine, or the 5-HT1A receptor agonist gepirone or multiple electroconvulsive shock (ECS) administration, WAY 100635 markedly increased (60-200%) the firing activity of CA3 pyramidal neurons.  Such a disinhibition was absent in rats treated with the nonantidepressant drug chlorpromazine, in rats receiving only one ECS, or in rats receiving multiple ECSs in combination with an intrahippocampal pertussis toxin treatment to inactivate Gi/o-coupled 5-HT1A receptors.  These data indicate that such antidepressant treatments, acting on entirely different primary targets, might alleviate depression by enhancing the tonic activation of forebrain postsynaptic 5-HT1A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ1AcmgEneU7Vg90H21EOLACvtfcHk0liKbLHescoMxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyqsLc%253D&md5=ff7aea089c6fba4caecebf4bcb61d762</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-23-10150.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-23-10150.1998%26sid%3Dliteratum%253Aachs%26aulast%3DHaddjeri%26aufirst%3DN.%26aulast%3DBlier%26aufirst%3DP.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DLong-term%2520antidepressant%2520treatments%2520result%2520in%2520a%2520tonic%2520activation%2520of%2520forebrain%25205-HT1A%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D10150%26epage%3D10156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Brunello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendlewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zohar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racagni, G.</span><span> </span><span class="NLM_article-title">Noradrenaline in mood and anxiety disorders: basic and clinical studies</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1097%2F00004850-200307000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12817153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ovFelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=191-202&author=N.+Brunelloauthor=P.+Blierauthor=L.+L.+Juddauthor=J.+Mendlewiczauthor=C.+J.+Nelsonauthor=D.+Soueryauthor=J.+Zoharauthor=G.+Racagni&title=Noradrenaline+in+mood+and+anxiety+disorders%3A+basic+and+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Noradrenaline in mood and anxiety disorders: basic and clinical studies</span></div><div class="casAuthors">Brunello Nicoletta; Blier Pier; Judd Lewis L; Mendlewicz Julien; Nelson Craig J; Souery Daniel; Zohar Joseph; Racagni Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-202</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The neurotransmitter noradrenaline is known to be involved in a range of physiological and psychological processes, and dysfunctions of this neurotransmitter system have been implicated in a range of psychiatric disorders.  However, the clinical utility of targeting the noradrenergic system in the treatment of such disorders has been somewhat overshadowed by the availability of agents selective for the serotonin system.  A number of antidepressants with increased, but varying, selectivity for the noradrenergic system have become available in recent years, including mirtazapine, bupropion and, most recently, the first truly selective noradrenaline reuptake inhibitor, reboxetine.  This review brings together current thinking on the role of noradrenaline in the aetiology and therapy of mood disorders to encourage a rational, evidence-based approach to the treatment of such disorders, and to provide suggestions and guidelines for future research in the area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqxb9KPOdPDf3jf77P2BG3fW6udTcc2eZBPDgiL8RJ6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ovFelug%253D%253D&md5=c375997492d9ca06f765613ad71328c0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00004850-200307000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-200307000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DBrunello%26aufirst%3DN.%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DJudd%26aufirst%3DL.%2BL.%26aulast%3DMendlewicz%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DC.%2BJ.%26aulast%3DSouery%26aufirst%3DD.%26aulast%3DZohar%26aufirst%3DJ.%26aulast%3DRacagni%26aufirst%3DG.%26atitle%3DNoradrenaline%2520in%2520mood%2520and%2520anxiety%2520disorders%253A%2520basic%2520and%2520clinical%2520studies%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2003%26volume%3D18%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Laje, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassman, A. H.</span><span> </span><span class="NLM_article-title">Depression and nicotine: preclinical and clinical evidence for common mechanisms</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs11920-001-0040-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=11707160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD3MnlsVGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=470-474&author=R.+P.+Lajeauthor=J.+A.+Bermanauthor=A.+H.+Glassman&title=Depression+and+nicotine%3A+preclinical+and+clinical+evidence+for+common+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Depression and nicotine: preclinical and clinical evidence for common mechanisms</span></div><div class="casAuthors">Laje R P; Berman J A; Glassman A H</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-4</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Updated findings on the relationship between nicotine and depression are presented.  Clinical and preclinical research on nicotine use and depression suggests that nicotine may have some properties in common with antidepressants.  Updated findings involve the comorbidity of smoking and major depressive disorder (MDD), the influence of depression during withdrawal on failure to quit smoking, the course of MDD without nicotine and the neurobiology of smoking and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuM2gHDeirZBjv2lLSLOxFfW6udTcc2eZBPDgiL8RJ6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnlsVGnug%253D%253D&md5=2731939dd25d21e0802e82d099e140b8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs11920-001-0040-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-001-0040-z%26sid%3Dliteratum%253Aachs%26aulast%3DLaje%26aufirst%3DR.%2BP.%26aulast%3DBerman%26aufirst%3DJ.%2BA.%26aulast%3DGlassman%26aufirst%3DA.%2BH.%26atitle%3DDepression%2520and%2520nicotine%253A%2520preclinical%2520and%2520clinical%2520evidence%2520for%2520common%2520mechanisms%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2001%26volume%3D3%26spage%3D470%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mørk, A.; Brennum, L. T.; Fallon, S.; Bisulco, S.; Frederiksen, K.; Bang-Andersen, B.; Lassen, A. B.; Zhong, H.; Patel, J. G.; Poon, P.; Smith, D. G.; Sanchez, C.; Stensbøl, T. B.; Hogg, S.</span><span> </span><span class="NLM_article-title">Pharmacological Profile of Lu AA21004, a Novel Multi-Target Drug for the Treatment of Mood Disorders</span>. Presented at the Society for Neuroscience Meeting, Chicago, IL, October 17−21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Poster.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+M%C3%B8rk&author=L.+T.+Brennum&author=S.+Fallon&author=S.+Bisulco&author=K.+Frederiksen&author=B.+Bang-Andersen&author=A.+B.+Lassen&author=H.+Zhong&author=J.+G.+Patel&author=P.+Poon&author=D.+G.+Smith&author=C.+Sanchez&author=T.+B.+Stensb%C3%B8l&author=S.+Hogg&title=Pharmacological+Profile+of+Lu+AA21004%2C+a+Novel+Multi-Target+Drug+for+the+Treatment+of+Mood+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26atitle%3DPharmacological%2520Profile%2520of%2520Lu%2520AA21004%252C%2520a%2520Novel%2520Multi-Target%2520Drug%2520for%2520the%2520Treatment%2520of%2520Mood%2520Disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">de Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klompmakers, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westenberg, H. G. M.</span><span> </span><span class="NLM_article-title">Role of extracellular serotonin levels in the effect of 5-HT<sub>1B</sub> receptor blockade</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=153-158&author=L.+de+Grooteauthor=A.+A.+Klompmakersauthor=B.+Olivierauthor=H.+G.+M.+Westenberg&title=Role+of+extracellular+serotonin+levels+in+the+effect+of+5-HT1B+receptor+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGroote%26aufirst%3DL.%26aulast%3DKlompmakers%26aufirst%3DA.%2BA.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DWestenberg%26aufirst%3DH.%2BG.%2BM.%26atitle%3DRole%2520of%2520extracellular%2520serotonin%2520levels%2520in%2520the%2520effect%2520of%25205-HT1B%2520receptor%2520blockade%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D167%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sarkisyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>7</sub> receptor as a mediator and modulator of antidepressant-like behavior</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2010&pages=99-108&author=G.+Sarkisyanauthor=A.+J.+Robertsauthor=P.+B.+Hedlund&title=The+5-HT7+receptor+as+a+mediator+and+modulator+of+antidepressant-like+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkisyan%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DThe%25205-HT7%2520receptor%2520as%2520a%2520mediator%2520and%2520modulator%2520of%2520antidepressant-like%2520behavior%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D209%26spage%3D99%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugovic, C.</span><span> </span><span class="NLM_article-title">Selective blockade of 5-hydroxytryptamine (5-HT)<sub>7</sub> receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1124%2Fjpet.107.119404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17314195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=690-698&author=P.+Bonaventureauthor=L.+Kellyauthor=L.+Aluisioauthor=J.+Sheltonauthor=B.+Lordauthor=R.+Galiciauthor=K.+Millerauthor=J.+Atackauthor=T.+W.+Lovenbergauthor=C.+Dugovic&title=Selective+blockade+of+5-hydroxytryptamine+%285-HT%297+receptors+enhances+5-HT+transmission%2C+antidepressant-like+behavior%2C+and+rapid+eye+movement+sleep+suppression+induced+by+citalopram+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents</span></div><div class="casAuthors">Bonaventure, Pascal; Kelly, Lisa; Aluisio, Leah; Shelton, Jonathan; Lord, Brian; Galici, Ruggero; Miller, Kirsten; Atack, John; Lovenberg, Timothy W.; Dugovic, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">690-698</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Evidence has accumulated supporting a role for 5-hydroxytryptamine (5-HT)7 receptors in circadian rhythms, sleep, and mood disorders, presumably as a consequence of the modulation of 5-HT-mediated neuronal activity.  We hypothesized that a selective 5-HT7 receptor antagonist, (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine (SB-269970), should increase activity of 5-HT neurons and potentiate the effect of selective serotonin reuptake inhibitors (citalopram).  In rats, administration of 3 mg/kg s.c. citalopram alone increased the extracellular concn. of 5-HT.  This effect of citalopram on extracellular 5-HT concn. was significantly enhanced by an ineffective dose of SB-269970.  Combining this dose of SB-269970 with a low dose of citalopram also resulted in a significant increase in extracellular concn. of 5-HT, suggesting a potentiation of neurochem. effects.  In mice, citalopram and SB-269970 dose-dependently decreased immobility time in the tail suspension test.  The dose-effect curve of citalopram was shifted leftward by coadministration of an ED of SB-269970.  Furthermore, combining ineffective doses of citalopram and SB-269970 also resulted in a significant decrease of immobility time in the tail suspension test, suggesting potentiation of antidepressant-like effects.  In rats, SB-269970 potentiated the increase of rapid eye movement (REM) latency and the REM sleep decrease induced by citalopram.  SB-269970 also reversed the increase in sleep fragmentation induced by citalopram.  Rat plasma and brain concns. of citalopram were not affected by coadministration of SB-269970, arguing for a pharmacodynamic rather than a pharmacokinetic mechanism.  Overall, these results indicate that selective blockade of 5-HT7 receptors may enhance the antidepressant efficacy of citalopram and may provide a novel therapy to alleviate sleep disturbances assocd. with depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaP25kVYHm7bVg90H21EOLACvtfcHk0lhaAO2_DBcsmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehurc%253D&md5=75134e9e2434b911c6414a529bb65cee</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.119404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.119404%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DL.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DAtack%26aufirst%3DJ.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDugovic%26aufirst%3DC.%26atitle%3DSelective%2520blockade%2520of%25205-hydroxytryptamine%2520%25285-HT%25297%2520receptors%2520enhances%25205-HT%2520transmission%252C%2520antidepressant-like%2520behavior%252C%2520and%2520rapid%2520eye%2520movement%2520sleep%2520suppression%2520induced%2520by%2520citalopram%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Drevets, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furey, M. L.</span><span> </span><span class="NLM_article-title">Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression</span> <span class="citation_source-journal">Brain Struct. Funct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs00429-008-0189-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=18704495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1crjsVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2008&pages=93-118&author=W.+C.+Drevetsauthor=J.+L.+Priceauthor=M.+L.+Furey&title=Brain+structural+and+functional+abnormalities+in+mood+disorders%3A+implications+for+neurocircuitry+models+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression</span></div><div class="casAuthors">Drevets Wayne C; Price Joseph L; Furey Maura L</div><div class="citationInfo"><span class="NLM_cas:title">Brain structure & function</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">93-118</span>
        ISSN:<span class="NLM_cas:issn">1863-2653</span>.
    </div><div class="casAbstract">The neural networks that putatively modulate aspects of normal emotional behavior have been implicated in the pathophysiology of mood disorders by converging evidence from neuroimaging, neuropathological and lesion analysis studies.  These networks involve the medial prefrontal cortex (MPFC) and closely related areas in the medial and caudolateral orbital cortex (medial prefrontal network), amygdala, hippocampus, and ventromedial parts of the basal ganglia, where alterations in grey matter volume and neurophysiological activity are found in cases with recurrent depressive episodes.  Such findings hold major implications for models of the neurocircuits that underlie depression.  In particular evidence from lesion analysis studies suggests that the MPFC and related limbic and striato-pallido-thalamic structures organize emotional expression.  The MPFC is part of a larger "default system" of cortical areas that include the dorsal PFC, mid- and posterior cingulate cortex, anterior temporal cortex, and entorhinal and parahippocampal cortex, which has been implicated in self-referential functions.  Dysfunction within and between structures in this circuit may induce disturbances in emotional behavior and other cognitive aspects of depressive syndromes in humans.  Further, because the MPFC and related limbic structures provide forebrain modulation over visceral control structures in the hypothalamus and brainstem, their dysfunction can account for the disturbances in autonomic regulation and neuroendocrine responses that are associated with mood disorders.  This paper discusses these systems together with the neurochemical systems that impinge on them and form the basis for most pharmacological therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlcOXRChdLC4xhnOQkIHOxfW6udTcc2eYFlxsajfmuCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crjsVSmtw%253D%253D&md5=ffa3c4efbcca262b28d66023e065cf3e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs00429-008-0189-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00429-008-0189-x%26sid%3Dliteratum%253Aachs%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DFurey%26aufirst%3DM.%2BL.%26atitle%3DBrain%2520structural%2520and%2520functional%2520abnormalities%2520in%2520mood%2520disorders%253A%2520implications%2520for%2520neurocircuitry%2520models%2520of%2520depression%26jtitle%3DBrain%2520Struct.%2520Funct.%26date%3D2008%26volume%3D213%26spage%3D93%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Fanselow, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H. W.</span><span> </span><span class="NLM_article-title">Are the dorsal and ventral hippocampus functionally distinct structures?</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=7-19&author=M.+S.+Fanselowauthor=H.+W.+Dong&title=Are+the+dorsal+and+ventral+hippocampus+functionally+distinct+structures%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFanselow%26aufirst%3DM.%2BS.%26aulast%3DDong%26aufirst%3DH.%2BW.%26atitle%3DAre%2520the%2520dorsal%2520and%2520ventral%2520hippocampus%2520functionally%2520distinct%2520structures%253F%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreilgaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">The <i>R</i>-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2003&pages=167-173&author=A.+M%C3%B8rkauthor=M.+Kreilgaardauthor=C.+Sanchez&title=The+R-enantiomer+of+citalopram+counteracts+escitalopram-induced+increase+in+extracellular+5-HT+in+the+frontal+cortex+of+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DKreilgaard%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DThe%2520R-enantiomer%2520of%2520citalopram%2520counteracts%2520escitalopram-induced%2520increase%2520in%2520extracellular%25205-HT%2520in%2520the%2520frontal%2520cortex%2520of%2520freely%2520moving%2520rats%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D45%26spage%3D167%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boikess, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1177%2F026988110201600403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12503828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=297-304&author=C.+E.+Beyerauthor=S.+Boikessauthor=B.+Luoauthor=L.+A.+Dawson&title=Comparison+of+the+effects+of+antidepressants+on+norepinephrine+and+serotonin+concentrations+in+the+rat+frontal+cortex%3A+an+in-vivo+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span></div><div class="casAuthors">Beyer, Chad E.; Boikess, Steve; Luo, Bin; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">The present study employed in-vivo microdialysis techniques in the freely moving rat to systematically compare the neurochem. effects of various antidepressant agents on extracellular concns. of norepinephrine (NE) and serotonin (5-HT) in the frontal cortex.  We found that acute administration of the tricyclic antidepressant, desipramine (3-30 mg/kg, s.c.) and the dual serotonin/norepinephrine reuptake inhibitor, venlafaxine (3-30 mg/kg, s.c.), produced dose-dependent and robust increases in cortical NE concns. (498% and 403%, resp.).  Conversely, acute injection of the selective serotonin reuptake inhibitors, fluoxetine (30 mg/kg, s.c.) and paroxetine (1-10 mg/kg, s.c.), did not alter forebrain NE concns.  However, paroxetine did produce a significant increase in cortical NE concns. (164%) when administered at 30 mg/kg.  These changes in NE were not paralleled by 5-HT, which showed no increase following administration of desipramine, venlafaxine, paroxetine or fluoxetine.  Combination treatment with the 5-HT1A receptor antagonist, WAY-100635 (0.3 mg/kg, s.c.), significantly enhanced extracellular 5-HT concns. following venlafaxine (10 and 30 mg/kg), fluoxetine (30 mg/kg) and paroxetine (3-30 mg/kg).  Alternatively, WAY-100635 produced no augmentation of the antidepressant-induced changes in extracellular NE.  Collectively, these studies show that paroxetine, at low to intermediate doses, and fluoxetine are selective for 5-HT vs. NE systems, whereas venlafaxine produces similar effects on both 5-HT and NE levels at the EDs tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKBQ9tr1B2rVg90H21EOLACvtfcHk0lg4q6UadBrs9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D&md5=a1675211169ec4b13feb6ae7e5803f64</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F026988110201600403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600403%26sid%3Dliteratum%253Aachs%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DBoikess%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520antidepressants%2520on%2520norepinephrine%2520and%2520serotonin%2520concentrations%2520in%2520the%2520rat%2520frontal%2520cortex%253A%2520an%2520in-vivo%2520microdialysis%2520study%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2002%26volume%3D16%26spage%3D297%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sanchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storustovu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreilgard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mork, A.</span><span> </span><span class="NLM_article-title">Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2007&pages=468-476&author=C.+Sanchezauthor=L.+T.+Brennumauthor=S.+Storustovuauthor=M.+Kreilgardauthor=A.+Mork&title=Depression+and+poor+sleep%3A+the+effect+of+monoaminergic+antidepressants+in+a+pre-clinical+model+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DStorustovu%26aufirst%3DS.%26aulast%3DKreilgard%26aufirst%3DM.%26aulast%3DMork%26aufirst%3DA.%26atitle%3DDepression%2520and%2520poor%2520sleep%253A%2520the%2520effect%2520of%2520monoaminergic%2520antidepressants%2520in%2520a%2520pre-clinical%2520model%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2007%26volume%3D86%26spage%3D468%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Blier, P.</span><span> </span><span class="NLM_article-title">The pharmacology of putative early-onset antidepressant strategies</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0924-977X%2802%2900173-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12650947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitV2gurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=57-66&author=P.+Blier&title=The+pharmacology+of+putative+early-onset+antidepressant+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of putative early-onset antidepressant strategies</span></div><div class="casAuthors">Blier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review. Although selective serotonin reuptake inhibitors (SSRIs) have improved the safety and tolerability of antidepressant treatment, the delays in their onset of action have not been improved.  There is evidence to suggest that the delay in onset of therapeutic activity is a function of the drugs, rather than the disease.  This suggests that research into the biol. characteristics of depression and its treatments may yield faster-acting antidepressants.  Emerging evidence from clin. studies with mirtazapine, venlafaxine and SSRI augmentation with pindolol suggests that these treatments may relieve antidepressant symptoms more rapidly than SSRIs.  The putative mechanism of action of faster-acting antidepressant strategies presented here is that conventional antidepressants acutely increase the availability of serotonin (5-HT) or noradrenaline (NA), preferentially at the cellular level, which triggers neg. feedback mechanisms.  After continued stimulation, these feedback mechanisms become desensitized and the enhanced 5-HT availability is able to enhance 5-HT and/or NA neurotransmission.  Putative fast-onset antidepressants, on the other hand, may uncouple such feedback control mechanisms and enhance 5-HT and/or NA neurotransmission more rapidly.  Further studies are required to characterize in detail the interactions between NA and 5-HT systems and to definitively establish the early onset of candidate antidepressants such as mirtazapine, venlafaxine and pindolol augmentation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz7S-sssIDLVg90H21EOLACvtfcHk0lg4q6UadBrs9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitV2gurs%253D&md5=d69ba0b6542f355ed44a8c10cef7b541</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0924-977X%2802%2900173-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-977X%252802%252900173-6%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26atitle%3DThe%2520pharmacology%2520of%2520putative%2520early-onset%2520antidepressant%2520strategies%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2003%26volume%3D13%26spage%3D57%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagie, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillat, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1111%2Fj.1472-8206.1996.tb00145.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8900496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK28XjtFGrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=16-27&author=A.+M.+Gardierauthor=I.+Malagieauthor=A.+C.+Trillatauthor=C.+Jacquotauthor=F.+Artigas&title=Role+of+5-HT1A+autoreceptors+in+the+mechanism+of+action+of+serotoninergic+antidepressant+drugs%3A+recent+findings+from+in+vivo+microdialysis+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies</span></div><div class="casAuthors">Gardier, A. M.; Malagie, I.; Trillat, A. C.; Jacquot, C.; Artigas, F.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 88 refs., of the central serotoninergic1A mechanism of serotoninergic antidepressants which discusses: the serotoninergic synapse; in vivo microdialysis techniques; and clin. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpifa0iQo6hCbVg90H21EOLACvtfcHk0lg4q6UadBrs9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFGrurY%253D&md5=99138784a921bfa1aef361375eeb943c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1996.tb00145.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1996.tb00145.x%26sid%3Dliteratum%253Aachs%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DMalagie%26aufirst%3DI.%26aulast%3DTrillat%26aufirst%3DA.%2BC.%26aulast%3DJacquot%26aufirst%3DC.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DRole%2520of%25205-HT1A%2520autoreceptors%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520serotoninergic%2520antidepressant%2520drugs%253A%2520recent%2520findings%2520from%2520in%2520vivo%2520microdialysis%2520studies%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1996%26volume%3D10%26spage%3D16%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Scope and limitations of the Pd/BINAP-catalyzed amination of aryl bromides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9916986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1144-1157&author=J.+P.+Wolfeauthor=S.+L.+Buchwald&title=Scope+and+limitations+of+the+Pd%2FBINAP-catalyzed+amination+of+aryl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjo9916986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9916986%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DScope%2520and%2520limitations%2520of%2520the%2520Pd%252FBINAP-catalyzed%2520amination%2520of%2520aryl%2520bromides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1144%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberland, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blonda, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, M. A.</span><span> </span><span class="NLM_article-title">Antineoplastic agents: XI. <i>N</i>-Bis(2-bromoethyl)amines</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1964&pages=1699-1706&author=G.+R.+Pettitauthor=M.+R.+Chamberlandauthor=D.+S.+Blondaauthor=M.+A.+Vickers&title=Antineoplastic+agents%3A+XI.+N-Bis%282-bromoethyl%29amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChamberland%26aufirst%3DM.%2BR.%26aulast%3DBlonda%26aufirst%3DD.%2BS.%26aulast%3DVickers%26aufirst%3DM.%2BA.%26atitle%3DAntineoplastic%2520agents%253A%2520XI.%2520N-Bis%25282-bromoethyl%2529amines%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1964%26volume%3D42%26spage%3D1699%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lildRnNwAYigg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Sánchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, P. B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiborg, O.</span><span> </span><span class="NLM_article-title">Escitalopram, the <i>S</i>-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=353-362&author=C.+S%C3%A1nchezauthor=P.+B.+F.+Bergqvistauthor=L.+T.+Brennumauthor=S.+Guptaauthor=S.+Hoggauthor=A.+Larsenauthor=O.+Wiborg&title=Escitalopram%2C+the+S-%28%2B%29-enantiomer+of+citalopram%2C+is+a+selective+serotonin+reuptake+inhibitor+with+potent+effects+in+animal+models+predictive+of+antidepressant+and+anxiolytic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DBergqvist%26aufirst%3DP.%2BB.%2BF.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DA.%26aulast%3DWiborg%26aufirst%3DO.%26atitle%3DEscitalopram%252C%2520the%2520S-%2528%252B%2529-enantiomer%2520of%2520citalopram%252C%2520is%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%2520with%2520potent%2520effects%2520in%2520animal%2520models%2520predictive%2520of%2520antidepressant%2520and%2520anxiolytic%2520activities%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D167%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40a','cit40b'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 255 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Amy C. Dodds, <span class="NLM_string-name hlFld-ContribAuthor">Andrew Sutherland</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective C–H Thioarylation of Electron-Rich Arenes by Iron(III) Triflimide Catalysis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (8)
                                     , 5922-5932. <a href="https://doi.org/10.1021/acs.joc.1c00448" title="DOI URL">https://doi.org/10.1021/acs.joc.1c00448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00448%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BC%2525E2%252580%252593H%252BThioarylation%252Bof%252BElectron-Rich%252BArenes%252Bby%252BIron%252528III%252529%252BTriflimide%252BCatalysis%26aulast%3DDodds%26aufirst%3DAmy%2BC.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22022021%26date%3D30032021%26volume%3D86%26issue%3D8%26spage%3D5922%26epage%3D5932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jingyang Qin, Honghua Zuo, Yang Ni, Qile Yu, <span class="NLM_string-name hlFld-ContribAuthor">Fangrui Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Electrophilic C–H Sulfenylation of Indoles with Disulfides under Ball Milling. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2020,</strong> <em>8 </em>
                                    (33)
                                     , 12342-12347. <a href="https://doi.org/10.1021/acssuschemeng.0c03942" title="DOI URL">https://doi.org/10.1021/acssuschemeng.0c03942</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.0c03942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.0c03942%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DCatalytic%252BElectrophilic%252BC%2525E2%252580%252593H%252BSulfenylation%252Bof%252BIndoles%252Bwith%252BDisulfides%252Bunder%252BBall%252BMilling%26aulast%3DQin%26aufirst%3DJingyang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D01082020%26date%3D13082020%26date%3D07082020%26volume%3D8%26issue%3D33%26spage%3D12342%26epage%3D12347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anand Kumar Pandey, Shiv Chand, Rahul Singh, Saurabh Kumar, <span class="NLM_string-name hlFld-ContribAuthor">Krishna Nand Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-Catalyzed Synthesis of 3-Arylthioindoles Employing a 1-Aryltriazene/CS2 Combination as a New Sulfenylation Source. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (13)
                                     , 7627-7635. <a href="https://doi.org/10.1021/acsomega.0c00472" title="DOI URL">https://doi.org/10.1021/acsomega.0c00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c00472%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DIodine-Catalyzed%252BSynthesis%252Bof%252B3-Arylthioindoles%252BEmploying%252Ba%252B1-Aryltriazene%25252FCS2%252BCombination%252Bas%252Ba%252BNew%252BSulfenylation%252BSource%26aulast%3DPandey%26aufirst%3DAnand%2BKumar%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03022020%26date%3D13032020%26date%3D24032020%26volume%3D5%26issue%3D13%26spage%3D7627%26epage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yongqiang Wang, Jiedan Deng, Jinhong Chen, Fei Cao, Yongsheng Hou, Yuhang Yang, Xuemei Deng, Jinru Yang, Lingxi Wu, Xiangfeng Shao, Tao Shi, <span class="NLM_string-name hlFld-ContribAuthor">Zhen Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Dechalcogenization of Aryl Dichalcogenides to Synthesize Aryl Chalcogenides via Copper Catalysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 2707-2712. <a href="https://doi.org/10.1021/acscatal.9b04931" title="DOI URL">https://doi.org/10.1021/acscatal.9b04931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.9b04931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.9b04931%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DDechalcogenization%252Bof%252BAryl%252BDichalcogenides%252Bto%252BSynthesize%252BAryl%252BChalcogenides%252Bvia%252BCopper%252BCatalysis%26aulast%3DWang%26aufirst%3DYongqiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2020%26date%3D14112019%26date%3D05022020%26date%3D10022020%26date%3D06022020%26volume%3D10%26issue%3D4%26spage%3D2707%26epage%3D2712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nasriya
A. Witt, Benita Lee, Kaylee Ghent, Wynne Q. Zhang, Alan L. Pehrson, Connie Sánchez, <span class="NLM_string-name hlFld-ContribAuthor">Georgianna G. Gould</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine Reduces Marble Burying but Only Transiently Enhances Social Interaction Preference in Adult Male BTBR T+Itpr3tf/J Mice. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 4319-4327. <a href="https://doi.org/10.1021/acschemneuro.9b00386" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00386%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DVortioxetine%252BReduces%252BMarble%252BBurying%252Bbut%252BOnly%252BTransiently%252BEnhances%252BSocial%252BInteraction%252BPreference%252Bin%252BAdult%252BMale%252BBTBR%252BT%25252BItpr3tf%25252FJ%252BMice%26aulast%3DWitt%26aufirst%3DNasriya%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D30082019%26date%3D11092019%26date%3D30082019%26volume%3D10%26issue%3D10%26spage%3D4319%26epage%3D4327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Brian Raymer, <span class="NLM_string-name hlFld-ContribAuthor">Samit K. Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Lead-like Drugs: A Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10375-10384. <a href="https://doi.org/10.1021/acs.jmedchem.8b00407" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00407%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead-like%252BDrugs%25253A%252BA%252BPerspective%26aulast%3DRaymer%26aufirst%3DBrian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13032018%26date%3D27072018%26volume%3D61%26issue%3D23%26spage%3D10375%26epage%3D10384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maria
N. Modica, Enza Lacivita, Sebastiano Intagliata, Loredana Salerno, Giuseppe Romeo, Valeria Pittalà, <span class="NLM_string-name hlFld-ContribAuthor">Marcello Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8475-8503. <a href="https://doi.org/10.1021/acs.jmedchem.7b01898" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BTherapeutic%252BPotentials%252Bof%252B5-HT7%252BReceptor%252BLigands%25253A%252BAn%252BUpdate%26aulast%3DModica%26aufirst%3DMaria%2BN.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22122017%26date%3D05062018%26date%3D16052018%26volume%3D61%26issue%3D19%26spage%3D8475%26epage%3D8503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samuel
J. Pellock, Benjamin C. Creekmore, William G. Walton, Naimee Mehta, Kristen A. Biernat, Andrew P. Cesmat, Yamuna Ariyarathna, Zachary D. Dunn, Bo Li, Jian Jin, Lindsey I. James, <span class="NLM_string-name hlFld-ContribAuthor">Matthew R. Redinbo</span>. </span><span class="cited-content_cbyCitation_article-title">Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2018,</strong> <em>4 </em>
                                    (7)
                                     , 868-879. <a href="https://doi.org/10.1021/acscentsci.8b00239" title="DOI URL">https://doi.org/10.1021/acscentsci.8b00239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.8b00239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.8b00239%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DGut%252BMicrobial%252B%2525CE%2525B2-Glucuronidase%252BInhibition%252Bvia%252BCatalytic%252BCycle%252BInterception%26aulast%3DPellock%26aufirst%3DSamuel%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19042018%26date%3D12072018%26volume%3D4%26issue%3D7%26spage%3D868%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Joanna  Śniecikowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Anna  Gryboś</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Karolina  Pytka</span>, <span class="hlFld-ContribAuthor ">Magdalena  Jastrzębska-Więsek</span>, <span class="hlFld-ContribAuthor ">Anna  Partyka</span>, <span class="hlFld-ContribAuthor ">Anna  Wesołowska</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, and <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7483-7501. <a href="https://doi.org/10.1021/acs.jmedchem.7b00839" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B3-%2525281%25252C2%25252C3%25252C6-Tetrahydropyridin-4-yl%252529-1H-indole-Based%252BMultifunctional%252BLigands%252Bwith%252BAntipsychotic-Like%25252C%252BMood-Modulating%25252C%252Band%252BProcognitive%252BActivity%26aulast%3DBucki%26aufirst%3DAdam%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12062017%26date%3D18082017%26date%3D14092017%26date%3D01082017%26volume%3D60%26issue%3D17%26spage%3D7483%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex G.  Nackenoff</span>, <span class="hlFld-ContribAuthor ">Linda D.  Simmler</span>, <span class="hlFld-ContribAuthor ">Nicole L.  Baganz</span>, <span class="hlFld-ContribAuthor ">Alan L.  Pehrson</span>, <span class="hlFld-ContribAuthor ">Connie  Sánchez</span>, and <span class="hlFld-ContribAuthor ">Randy D.  Blakely</span>  . </span><span class="cited-content_cbyCitation_article-title">Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (5)
                                     , 1092-1100. <a href="https://doi.org/10.1021/acschemneuro.7b00038" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00038%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSerotonin%252BTransporter-Independent%252BActions%252Bof%252Bthe%252BAntidepressant%252BVortioxetine%252BAs%252BRevealed%252BUsing%252Bthe%252BSERT%252BMet172%252BMouse%26aulast%3DNackenoff%26aufirst%3DAlex%2BG.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D25012017%26date%3D08032017%26date%3D20032017%26date%3D17052017%26date%3D08032017%26volume%3D8%26issue%3D5%26spage%3D1092%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob  Andersen</span>, <span class="hlFld-ContribAuthor ">Lucy Kate  Ladefoged</span>, <span class="hlFld-ContribAuthor ">Danyang  Wang</span>, <span class="hlFld-ContribAuthor ">Trine N. Bjerre  Kristensen</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Anders S.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Birgit  Schiøtt</span>, and <span class="hlFld-ContribAuthor ">Kristian  Strømgaard</span>  . </span><span class="cited-content_cbyCitation_article-title">Binding of the Multimodal Antidepressant Drug Vortioxetine to the Human Serotonin Transporter. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 1892-1900. <a href="https://doi.org/10.1021/acschemneuro.5b00225" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00225%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBinding%252Bof%252Bthe%252BMultimodal%252BAntidepressant%252BDrug%252BVortioxetine%252Bto%252Bthe%252BHuman%252BSerotonin%252BTransporter%26aulast%3DAndersen%26aufirst%3DJacob%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D18082015%26date%3D21092015%26date%3D11102015%26date%3D18112015%26date%3D21092015%26volume%3D6%26issue%3D11%26spage%3D1892%26epage%3D1900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Pieńko</span>, <span class="hlFld-ContribAuthor ">P. P.  Taciak</span>, and <span class="hlFld-ContribAuthor ">A. P.  Mazurek</span>  . </span><span class="cited-content_cbyCitation_article-title">On the Basicity of 8-Phenylsulfanyl Quipazine Derivatives: New Potential Serotonergic Agents. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry A</span><span> <strong>2015,</strong> <em>119 </em>
                                    (27)
                                     , 6989-6999. <a href="https://doi.org/10.1021/acs.jpca.5b02908" title="DOI URL">https://doi.org/10.1021/acs.jpca.5b02908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpca.5b02908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpca.5b02908%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520A%26atitle%3DOn%252Bthe%252BBasicity%252Bof%252B8-Phenylsulfanyl%252BQuipazine%252BDerivatives%25253A%252BNew%252BPotential%252BSerotonergic%252BAgents%26aulast%3DPie%25C5%2584ko%26aufirst%3DT.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26032015%26date%3D29042015%26date%3D25062015%26date%3D09072015%26date%3D30042015%26volume%3D119%26issue%3D27%26spage%3D6989%26epage%3D6999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mia N.  Burhardt</span>, <span class="hlFld-ContribAuthor ">Rolf H.  Taaning</span>, and <span class="hlFld-ContribAuthor ">Troels  Skrydstrup</span>  . </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Thiocarbonylation with Stoichiometric Carbon Monoxide: Scope and Applications. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (4)
                                     , 948-951. <a href="https://doi.org/10.1021/ol400138m" title="DOI URL">https://doi.org/10.1021/ol400138m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol400138m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol400138m%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPd-Catalyzed%252BThiocarbonylation%252Bwith%252BStoichiometric%252BCarbon%252BMonoxide%25253A%252BScope%252Band%252BApplications%26aulast%3DBurhardt%26aufirst%3DMia%2BN.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D16012013%26date%3D05022013%26date%3D15022013%26volume%3D15%26issue%3D4%26spage%3D948%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper  Severinsen</span>, <span class="hlFld-ContribAuthor ">Johan F.  Kraft</span>, <span class="hlFld-ContribAuthor ">Heidi  Koldsø</span>, <span class="hlFld-ContribAuthor ">Katrine A.  Vinberg</span>, <span class="hlFld-ContribAuthor ">Richard B.  Rothman</span>, <span class="hlFld-ContribAuthor ">John S.  Partilla</span>, <span class="hlFld-ContribAuthor ">Ove  Wiborg</span>, <span class="hlFld-ContribAuthor ">Bruce  Blough</span>, <span class="hlFld-ContribAuthor ">Birgit  Schiøtt</span>, and <span class="hlFld-ContribAuthor ">Steffen  Sinning</span>  . </span><span class="cited-content_cbyCitation_article-title">Binding of the Amphetamine-like 1-Phenyl-piperazine to Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 693-705. <a href="https://doi.org/10.1021/cn300040f" title="DOI URL">https://doi.org/10.1021/cn300040f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300040f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300040f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBinding%252Bof%252Bthe%252BAmphetamine-like%252B1-Phenyl-piperazine%252Bto%252BMonoamine%252BTransporters%26aulast%3DSeverinsen%26aufirst%3DKasper%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D13042012%26date%3D10062012%26date%3D28062012%26date%3D19092012%26date%3D10062012%26volume%3D3%26issue%3D9%26spage%3D693%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amr M.  Emam</span>, <span class="hlFld-ContribAuthor ">Muhammad A.  Saad</span>, <span class="hlFld-ContribAuthor ">Naglaa A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Hala F.  Zaki</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine mitigates neuronal damage by restricting PERK/eIF2α/ATF4/CHOP signaling pathway in rats subjected to focal cerebral ischemia-reperfusion. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2021,</strong> <em>2016 </em>, 119865. <a href="https://doi.org/10.1016/j.lfs.2021.119865" title="DOI URL">https://doi.org/10.1016/j.lfs.2021.119865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2021.119865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2021.119865%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DVortioxetine%252Bmitigates%252Bneuronal%252Bdamage%252Bby%252Brestricting%252BPERK%25252FeIF2%2525CE%2525B1%25252FATF4%25252FCHOP%252Bsignaling%252Bpathway%252Bin%252Brats%252Bsubjected%252Bto%252Bfocal%252Bcerebral%252Bischemia-reperfusion%26aulast%3DEmam%26aufirst%3DAmr%2BM.%26date%3D2021%26volume%3D2016%26spage%3D119865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alena  Shalimova</span>, <span class="hlFld-ContribAuthor ">Viktoria  Babasieva</span>, <span class="hlFld-ContribAuthor ">Vladimir N  Chubarev</span>, <span class="hlFld-ContribAuthor ">Vadim V  Tarasov</span>, <span class="hlFld-ContribAuthor ">Helgi B  Schiöth</span>, <span class="hlFld-ContribAuthor ">Jessica  Mwinyi</span>. </span><span class="cited-content_cbyCitation_article-title">Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. </span><span class="cited-content_cbyCitation_journal-name">Pharmacogenomics</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 485-503. <a href="https://doi.org/10.2217/pgs-2020-0157" title="DOI URL">https://doi.org/10.2217/pgs-2020-0157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/pgs-2020-0157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fpgs-2020-0157%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacogenomics%26atitle%3DTherapy%252Bresponse%252Bprediction%252Bin%252Bmajor%252Bdepressive%252Bdisorder%25253A%252Bcurrent%252Band%252Bnovel%252Bgenomic%252Bmarkers%252Binfluencing%252Bpharmacokinetics%252Band%252Bpharmacodynamics%26aulast%3DShalimova%26aufirst%3DAlena%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D485%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Adamo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Pecoraro</span>, <span class="hlFld-ContribAuthor ">Noemi  Coppola</span>, <span class="hlFld-ContribAuthor ">Elena  Calabria</span>, <span class="hlFld-ContribAuthor ">Massimo  Aria</span>, <span class="hlFld-ContribAuthor ">Michele  Mignogna</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine versus other antidepressants in the treatment of burning mouth syndrome: An open‐label randomized trial. </span><span class="cited-content_cbyCitation_journal-name">Oral Diseases</span><span> <strong>2021,</strong> <em>27 </em>
                                    (4)
                                     , 1022-1041. <a href="https://doi.org/10.1111/odi.13602" title="DOI URL">https://doi.org/10.1111/odi.13602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/odi.13602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fodi.13602%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Diseases%26atitle%3DVortioxetine%252Bversus%252Bother%252Bantidepressants%252Bin%252Bthe%252Btreatment%252Bof%252Bburning%252Bmouth%252Bsyndrome%25253A%252BAn%252Bopen%2525E2%252580%252590label%252Brandomized%252Btrial%26aulast%3DAdamo%26aufirst%3DDaniela%26date%3D2021%26date%3D2020%26volume%3D27%26issue%3D4%26spage%3D1022%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie T  Mills</span>, <span class="hlFld-ContribAuthor ">Emma  Sampson</span>, <span class="hlFld-ContribAuthor ">Célia  Fourrier</span>, <span class="hlFld-ContribAuthor ">Bernhard T  Baune</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2021,</strong> <em>24 </em>
                                    (4)
                                     , 314-321. <a href="https://doi.org/10.1093/ijnp/pyaa092" title="DOI URL">https://doi.org/10.1093/ijnp/pyaa092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyaa092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyaa092%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DClinical%252BSwitching%252BStrategies%252Bof%252BVarious%252BAntidepressants%252Bto%252BVortioxetine%252Bin%252Bthe%252BPREDDICT%252BTrial%26aulast%3DMills%26aufirst%3DNatalie%2BT%26date%3D2021%26date%3D2020%26volume%3D24%26issue%3D4%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luciana  Cicco</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Dilauro</span>, <span class="hlFld-ContribAuthor ">Filippo Maria  Perna</span>, <span class="hlFld-ContribAuthor ">Paola  Vitale</span>, <span class="hlFld-ContribAuthor ">Vito  Capriati</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in deep eutectic solvents and water: applications in metal- and biocatalyzed processes, in the synthesis of APIs, and other biologically active compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (12)
                                     , 2558-2577. <a href="https://doi.org/10.1039/D0OB02491K" title="DOI URL">https://doi.org/10.1039/D0OB02491K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02491K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02491K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAdvances%252Bin%252Bdeep%252Beutectic%252Bsolvents%252Band%252Bwater%25253A%252Bapplications%252Bin%252Bmetal-%252Band%252Bbiocatalyzed%252Bprocesses%25252C%252Bin%252Bthe%252Bsynthesis%252Bof%252BAPIs%25252C%252Band%252Bother%252Bbiologically%252Bactive%252Bcompounds%26aulast%3DCicco%26aufirst%3DLuciana%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D12%26spage%3D2558%26epage%3D2577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu-Yue  Qu</span>, <span class="hlFld-ContribAuthor ">Xiao-Yue  Li</span>, <span class="hlFld-ContribAuthor ">Xia  Heng</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Qi</span>, <span class="hlFld-ContribAuthor ">Ping-Yuan  Ge</span>, <span class="hlFld-ContribAuthor ">Sai-jia  Ni</span>, <span class="hlFld-ContribAuthor ">Zeng-Ying  Yao</span>, <span class="hlFld-ContribAuthor ">Rui  Guo</span>, <span class="hlFld-ContribAuthor ">Nian-Yun  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Cao</span>, <span class="hlFld-ContribAuthor ">Qi-Chun  Zhang</span>, <span class="hlFld-ContribAuthor ">Hua-Xu  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of Antidepressant Activity of Huang-Lian Jie-Du Decoction Through Network Pharmacology and Metabolomics. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.619288" title="DOI URL">https://doi.org/10.3389/fphar.2021.619288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.619288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.619288%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAnalysis%252Bof%252BAntidepressant%252BActivity%252Bof%252BHuang-Lian%252BJie-Du%252BDecoction%252BThrough%252BNetwork%252BPharmacology%252Band%252BMetabolomics%26aulast%3DQu%26aufirst%3DShu-Yue%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Liu</span>, <span class="hlFld-ContribAuthor ">Ya-Xin  Sun</span>, <span class="hlFld-ContribAuthor ">Chen-Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xian-Qiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Nu  Ma</span>, <span class="hlFld-ContribAuthor ">Han  Wang</span>, <span class="hlFld-ContribAuthor ">Yun-Ai  Su</span>, <span class="hlFld-ContribAuthor ">Ji-Tao  Li</span>, <span class="hlFld-ContribAuthor ">Tian-Mei  Si</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine attenuates the effects of early-life stress on depression-like behaviors and monoamine transporters in female mice. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>186 </em>, 108468. <a href="https://doi.org/10.1016/j.neuropharm.2021.108468" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2021.108468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2021.108468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2021.108468%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DVortioxetine%252Battenuates%252Bthe%252Beffects%252Bof%252Bearly-life%252Bstress%252Bon%252Bdepression-like%252Bbehaviors%252Band%252Bmonoamine%252Btransporters%252Bin%252Bfemale%252Bmice%26aulast%3DLiu%26aufirst%3DXiao%26date%3D2021%26volume%3D186%26spage%3D108468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marek  Król</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Ślifirski</span>, <span class="hlFld-ContribAuthor ">Jerzy  Kleps</span>, <span class="hlFld-ContribAuthor ">Szymon  Ulenberg</span>, <span class="hlFld-ContribAuthor ">Mariusz  Belka</span>, <span class="hlFld-ContribAuthor ">Tomasz  Bączek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Stachowicz</span>, <span class="hlFld-ContribAuthor ">Bernadeta  Szewczyk</span>, <span class="hlFld-ContribAuthor ">Gabriel  Nowak</span>, <span class="hlFld-ContribAuthor ">Beata  Duszyńska</span>, <span class="hlFld-ContribAuthor ">Franciszek  Herold</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel Pyrido[1,2-c]pyrimidine Derivatives with 6-Fluoro-3-(4-piperidynyl)-1,2-benzisoxazole Moiety as Potential SSRI and 5-HT1A Receptor Ligands. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (5)
                                     , 2329. <a href="https://doi.org/10.3390/ijms22052329" title="DOI URL">https://doi.org/10.3390/ijms22052329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22052329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22052329%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%252Bof%252BNovel%252BPyrido%25255B1%25252C2-c%25255Dpyrimidine%252BDerivatives%252Bwith%252B6-Fluoro-3-%2525284-piperidynyl%252529-1%25252C2-benzisoxazole%252BMoiety%252Bas%252BPotential%252BSSRI%252Band%252B5-HT1A%252BReceptor%252BLigands%26aulast%3DKr%25C3%25B3l%26aufirst%3DMarek%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D5%26spage%3D2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hatice  Aygun</span>, <span class="hlFld-ContribAuthor ">Mustafa  Ayyildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine increases absence-like seizures in WAG/Rij rats but decreases penicillin- and pentylenetetrazole-induced seizures in Wistar rats. </span><span class="cited-content_cbyCitation_journal-name">Epilepsy & Behavior</span><span> <strong>2021,</strong> <em>116 </em>, 107797. <a href="https://doi.org/10.1016/j.yebeh.2021.107797" title="DOI URL">https://doi.org/10.1016/j.yebeh.2021.107797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yebeh.2021.107797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yebeh.2021.107797%26sid%3Dliteratum%253Aachs%26jtitle%3DEpilepsy%2520%2526%2520Behavior%26atitle%3DVortioxetine%252Bincreases%252Babsence-like%252Bseizures%252Bin%252BWAG%25252FRij%252Brats%252Bbut%252Bdecreases%252Bpenicillin-%252Band%252Bpentylenetetrazole-induced%252Bseizures%252Bin%252BWistar%252Brats%26aulast%3DAygun%26aufirst%3DHatice%26date%3D2021%26volume%3D116%26spage%3D107797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weigang  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengjun  Huang</span>, <span class="hlFld-ContribAuthor ">Zhenlei  Zou</span>, <span class="hlFld-ContribAuthor ">Zhengguang  Wu</span>, <span class="hlFld-ContribAuthor ">Shengyang  Ni</span>, <span class="hlFld-ContribAuthor ">Lingyu  Kong</span>, <span class="hlFld-ContribAuthor ">Youxuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Redox-active benzimidazolium sulfonamides as cationic thiolating reagents for reductive cross-coupling of organic halides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 2509-2514. <a href="https://doi.org/10.1039/D0SC06446G" title="DOI URL">https://doi.org/10.1039/D0SC06446G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC06446G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC06446G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DRedox-active%252Bbenzimidazolium%252Bsulfonamides%252Bas%252Bcationic%252Bthiolating%252Breagents%252Bfor%252Breductive%252Bcross-coupling%252Bof%252Borganic%252Bhalides%26aulast%3DZhang%26aufirst%3DWeigang%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D2509%26epage%3D2514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruri  Okubo</span>, <span class="hlFld-ContribAuthor ">Toshiki  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Kouji  Fukuyama</span>, <span class="hlFld-ContribAuthor ">Takashi  Shiroyama</span>, <span class="hlFld-ContribAuthor ">Motohiro  Okada</span>. </span><span class="cited-content_cbyCitation_article-title">Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fpsyt.2021.623684" title="DOI URL">https://doi.org/10.3389/fpsyt.2021.623684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2021.623684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2021.623684%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DCurrent%252BLimitations%252Band%252BCandidate%252BPotential%252Bof%252B5-HT7%252BReceptor%252BAntagonism%252Bin%252BPsychiatric%252BPharmacotherapy%26aulast%3DOkubo%26aufirst%3DRuri%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Motohiro  Okada</span>, <span class="hlFld-ContribAuthor ">Ryusuke  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Yoshimasa  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Kouji  Fukuyama</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1351. <a href="https://doi.org/10.3390/ijms22031351" title="DOI URL">https://doi.org/10.3390/ijms22031351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031351%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEffects%252Bof%252BSubchronic%252BAdministrations%252Bof%252BVortioxetine%25252C%252BLurasidone%25252C%252Band%252BEscitalopram%252Bon%252BThalamocortical%252BGlutamatergic%252BTransmission%252BAssociated%252Bwith%252BSerotonin%252B5-HT7%252BReceptor%26aulast%3DOkada%26aufirst%3DMotohiro%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongkai  Du</span>, <span class="hlFld-ContribAuthor ">Juan  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lifeng  Ning</span>, <span class="hlFld-ContribAuthor ">Shan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmaceutical salt and salt hydrates of vortioxetine with sulfonic acid to ameliorate the solubility and hygroscopicity
              via
              the charge-assisted hydrogen bond assembly. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (3)
                                     , 1474-1481. <a href="https://doi.org/10.1039/D0NJ05052K" title="DOI URL">https://doi.org/10.1039/D0NJ05052K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ05052K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ05052K%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DPharmaceutical%252Bsalt%252Band%252Bsalt%252Bhydrates%252Bof%252Bvortioxetine%252Bwith%252Bsulfonic%252Bacid%252Bto%252Bameliorate%252Bthe%252Bsolubility%252Band%252Bhygroscopicity%252Bvia%252Bthe%252Bcharge-assisted%252Bhydrogen%252Bbond%252Bassembly%26aulast%3DDu%26aufirst%3DRongkai%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D3%26spage%3D1474%26epage%3D1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodney A.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Amit  Bhowmik</span>, <span class="hlFld-ContribAuthor ">Sandhya S.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Cu and Ni-catalyzed Chan–Lam-type coupling: synthesis of diarylchalcogenides, Ar
              2
              –X (X = S, Se, Te). </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (47)
                                     , 9583-9600. <a href="https://doi.org/10.1039/D0OB02035D" title="DOI URL">https://doi.org/10.1039/D0OB02035D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02035D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02035D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAdvances%252Bin%252BCu%252Band%252BNi-catalyzed%252BChan%2525E2%252580%252593Lam-type%252Bcoupling%25253A%252Bsynthesis%252Bof%252Bdiarylchalcogenides%25252C%252BAr%252B2%252B%2525E2%252580%252593X%252B%252528X%252B%25253D%252BS%25252C%252BSe%25252C%252BTe%252529%26aulast%3DFernandes%26aufirst%3DRodney%2BA.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D47%26spage%3D9583%26epage%3D9600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gizem  Tiris</span>, <span class="hlFld-ContribAuthor ">Cansu  Alver</span>, <span class="hlFld-ContribAuthor ">Nevin  Erk</span>. </span><span class="cited-content_cbyCitation_article-title">A novel stability-indicating method for determination of a new antidepressant effect of vortioxetine in a pharmaceutical formulation by using RP-HPLC. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2020,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43094-020-00135-w" title="DOI URL">https://doi.org/10.1186/s43094-020-00135-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43094-020-00135-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43094-020-00135-w%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DA%252Bnovel%252Bstability-indicating%252Bmethod%252Bfor%252Bdetermination%252Bof%252Ba%252Bnew%252Bantidepressant%252Beffect%252Bof%252Bvortioxetine%252Bin%252Ba%252Bpharmaceutical%252Bformulation%252Bby%252Busing%252BRP-HPLC%26aulast%3DTiris%26aufirst%3DGizem%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gao‐Bo  Lv</span>, <span class="hlFld-ContribAuthor ">Ting‐Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Hai‐Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Hong‐Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Wen  Sun</span>, <span class="hlFld-ContribAuthor ">Li‐Feng  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine induces apoptosis and autophagy of gastric cancer AGS cells via the PI3K/AKT pathway. </span><span class="cited-content_cbyCitation_journal-name">FEBS Open Bio</span><span> <strong>2020,</strong> <em>10 </em>
                                    (10)
                                     , 2157-2165. <a href="https://doi.org/10.1002/2211-5463.12944" title="DOI URL">https://doi.org/10.1002/2211-5463.12944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/2211-5463.12944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F2211-5463.12944%26sid%3Dliteratum%253Aachs%26jtitle%3DFEBS%2520Open%2520Bio%26atitle%3DVortioxetine%252Binduces%252Bapoptosis%252Band%252Bautophagy%252Bof%252Bgastric%252Bcancer%252BAGS%252Bcells%252Bvia%252Bthe%252BPI3K%25252FAKT%252Bpathway%26aulast%3DLv%26aufirst%3DGao%25E2%2580%2590Bo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D10%26spage%3D2157%26epage%3D2165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magda El  Henawee</span>, <span class="hlFld-ContribAuthor ">Hanaa  Saleh</span>, <span class="hlFld-ContribAuthor ">Emad Mohamed  Hussien</span>, <span class="hlFld-ContribAuthor ">Abeer Rashad  Derar</span>. </span><span class="cited-content_cbyCitation_article-title">Green Adsorptive Stripping Electrochemical Methods for Determination of Vortioxetine Hydrobromide at Graphite Pencil Electrode. </span><span class="cited-content_cbyCitation_journal-name">IEEE Sensors Journal</span><span> <strong>2020,</strong> <em>20 </em>
                                    (19)
                                     , 11090-11096. <a href="https://doi.org/10.1109/JSEN.2020.2997738" title="DOI URL">https://doi.org/10.1109/JSEN.2020.2997738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/JSEN.2020.2997738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FJSEN.2020.2997738%26sid%3Dliteratum%253Aachs%26jtitle%3DIEEE%2520Sensors%2520Journal%26atitle%3DGreen%252BAdsorptive%252BStripping%252BElectrochemical%252BMethods%252Bfor%252BDetermination%252Bof%252BVortioxetine%252BHydrobromide%252Bat%252BGraphite%252BPencil%252BElectrode%26aulast%3DHenawee%26aufirst%3DMagda%2BEl%26date%3D2020%26volume%3D20%26issue%3D19%26spage%3D11090%26epage%3D11096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleftherios  Zarkadas</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Wensheng  Cai</span>, <span class="hlFld-ContribAuthor ">Gregory  Effantin</span>, <span class="hlFld-ContribAuthor ">Jonathan  Perot</span>, <span class="hlFld-ContribAuthor ">Jacques  Neyton</span>, <span class="hlFld-ContribAuthor ">Christophe  Chipot</span>, <span class="hlFld-ContribAuthor ">Guy  Schoehn</span>, <span class="hlFld-ContribAuthor ">Francois  Dehez</span>, <span class="hlFld-ContribAuthor ">Hugues  Nury</span>. </span><span class="cited-content_cbyCitation_article-title">The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 1131-1140.e4. <a href="https://doi.org/10.1016/j.str.2020.07.004" title="DOI URL">https://doi.org/10.1016/j.str.2020.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2020.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2020.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DThe%252BBinding%252Bof%252BPalonosetron%252Band%252BOther%252BAntiemetic%252BDrugs%252Bto%252Bthe%252BSerotonin%252B5-HT3%252BReceptor%26aulast%3DZarkadas%26aufirst%3DEleftherios%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D1131%26epage%3D1140.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vera  De Carlo</span>, <span class="hlFld-ContribAuthor ">Matteo  Vismara</span>, <span class="hlFld-ContribAuthor ">Benedetta  Grancini</span>, <span class="hlFld-ContribAuthor ">Beatrice  Benatti</span>, <span class="hlFld-ContribAuthor ">Monica Francesca  Bosi</span>, <span class="hlFld-ContribAuthor ">Anna  Colombo</span>, <span class="hlFld-ContribAuthor ">Caterina Adele  Viganò</span>, <span class="hlFld-ContribAuthor ">Bernardo  Dell'Osso</span>. </span><span class="cited-content_cbyCitation_article-title">Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study. </span><span class="cited-content_cbyCitation_journal-name">Human Psychopharmacology: Clinical and Experimental</span><span> <strong>2020,</strong> <em>35 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/hup.2750" title="DOI URL">https://doi.org/10.1002/hup.2750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hup.2750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhup.2750%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Psychopharmacology%253A%2520Clinical%2520and%2520Experimental%26atitle%3DEffectiveness%25252C%252Btolerability%25252C%252Band%252Bdropout%252Brates%252Bof%252Bvortioxetine%252Bin%252Bcomorbid%252Bdepression%25253A%252BA%252Bnaturalistic%252Bstudy%26aulast%3DDe%2BCarlo%26aufirst%3DVera%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radomir  Juza</span>, <span class="hlFld-ContribAuthor ">Premysl  Vlcek</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Kamil  Musilek</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances with 5‐HT
              3
              modulators for neuropsychiatric and gastrointestinal disorders. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (5)
                                     , 1593-1678. <a href="https://doi.org/10.1002/med.21666" title="DOI URL">https://doi.org/10.1002/med.21666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21666%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252Badvances%252Bwith%252B5%2525E2%252580%252590HT%252B3%252Bmodulators%252Bfor%252Bneuropsychiatric%252Band%252Bgastrointestinal%252Bdisorders%26aulast%3DJuza%26aufirst%3DRadomir%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D5%26spage%3D1593%26epage%3D1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarjuna Chary  Ragi</span>, <span class="hlFld-ContribAuthor ">Ganga Reddy  Velma</span>, <span class="hlFld-ContribAuthor ">Pavan Kumar  Pallerla</span>, <span class="hlFld-ContribAuthor ">Sana  Siddiqua</span>, <span class="hlFld-ContribAuthor ">Veeresham  Alugonda</span>, <span class="hlFld-ContribAuthor ">Hari Krishna Reddy  Rachamalla</span>, <span class="hlFld-ContribAuthor ">Srihari  Pabbaraja</span>, <span class="hlFld-ContribAuthor ">Prabhakar  Sripadi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>188 </em>, 113442. <a href="https://doi.org/10.1016/j.jpba.2020.113442" title="DOI URL">https://doi.org/10.1016/j.jpba.2020.113442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2020.113442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2020.113442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DIdentification%252Band%252Bcharacterization%252Bof%252Bforced%252Bdegradation%252Bproducts%252Bof%252Bvortioxetine%252Bby%252BLC%25252FMS%25252FMS%252Band%252BNMR%26aulast%3DRagi%26aufirst%3DNagarjuna%2BChary%26date%3D2020%26volume%3D188%26spage%3D113442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stavroula A.  Zisopoulou</span>, <span class="hlFld-ContribAuthor ">Anastasia E.  Pafili</span>, <span class="hlFld-ContribAuthor ">Petros  Gkizis</span>, <span class="hlFld-ContribAuthor ">Thanos  Andreou</span>, <span class="hlFld-ContribAuthor ">Theoharis V.  Koftis</span>, <span class="hlFld-ContribAuthor ">Alexandra  Lithadioti</span>, <span class="hlFld-ContribAuthor ">Efstratios  Neokosmidis</span>, <span class="hlFld-ContribAuthor ">John K.  Gallos</span>. </span><span class="cited-content_cbyCitation_article-title">Environmentally Benign Large-Scale Synthesis of a Precursor to Vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2020,</strong> <em>52 </em>
                                    (18)
                                     , 2662-2666. <a href="https://doi.org/10.1055/s-0040-1707823" title="DOI URL">https://doi.org/10.1055/s-0040-1707823</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1707823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1707823%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DEnvironmentally%252BBenign%252BLarge-Scale%252BSynthesis%252Bof%252Ba%252BPrecursor%252Bto%252BVortioxetine%26aulast%3DZisopoulou%26aufirst%3DStavroula%2BA.%26date%3D2020%26date%3D2020%26volume%3D52%26issue%3D18%26spage%3D2662%26epage%3D2666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Di Nicola</span>, <span class="hlFld-ContribAuthor ">Maria  Pepe</span>, <span class="hlFld-ContribAuthor ">Isabella  Panaccione</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Moccia</span>, <span class="hlFld-ContribAuthor ">Luigi  Dattoli</span>, <span class="hlFld-ContribAuthor ">Marzia  Molinaro</span>, <span class="hlFld-ContribAuthor ">Gabriele  Sani</span>, <span class="hlFld-ContribAuthor ">Luigi  Janiri</span>, <span class="hlFld-ContribAuthor ">Roger S.  McIntyre</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis. </span><span class="cited-content_cbyCitation_journal-name">CNS Spectrums</span><span> <strong>2020,</strong> <em>21 </em>, 1-9. <a href="https://doi.org/10.1017/S109285292000173X" title="DOI URL">https://doi.org/10.1017/S109285292000173X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S109285292000173X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS109285292000173X%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Spectrums%26atitle%3DEffect%252Bof%252Bvortioxetine%252Bin%252Bsubjects%252Bwith%252Bmajor%252Bdepressive%252Band%252Balcohol%252Buse%252Bdisorders%25253A%252Ba%252B6-month%252Bretrospective%252Banalysis%26aulast%3DDi%2BNicola%26aufirst%3DMarco%26date%3D2020%26date%3D2020%26volume%3D21%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Qiang  Chu</span>, <span class="hlFld-ContribAuthor ">Ting  Xie</span>, <span class="hlFld-ContribAuthor ">Ya-Wen  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang-Rui  Li</span>, <span class="hlFld-ContribAuthor ">Weidong  Rao</span>, <span class="hlFld-ContribAuthor ">Haiyan  Xu</span>, <span class="hlFld-ContribAuthor ">Zhi-Liang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of di(hetero)aryl sulfides by defluorinative sulfenylation of polyfluoroalkyl ketones with sodium sulfinates or arylsulfonyl chlorides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (61)
                                     , 8699-8702. <a href="https://doi.org/10.1039/D0CC03303K" title="DOI URL">https://doi.org/10.1039/D0CC03303K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC03303K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC03303K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Bof%252Bdi%252528hetero%252529aryl%252Bsulfides%252Bby%252Bdefluorinative%252Bsulfenylation%252Bof%252Bpolyfluoroalkyl%252Bketones%252Bwith%252Bsodium%252Bsulfinates%252Bor%252Barylsulfonyl%252Bchlorides%26aulast%3DChu%26aufirst%3DXue-Qiang%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D61%26spage%3D8699%26epage%3D8702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Tingting  Fu</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zheng</span>, <span class="hlFld-ContribAuthor ">Gao  Tu</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fengyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Lin  Tao</span>, <span class="hlFld-ContribAuthor ">Lixia  Yao</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (23)
                                     , 3830-3876. <a href="https://doi.org/10.2174/0929867325666181009123218" title="DOI URL">https://doi.org/10.2174/0929867325666181009123218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666181009123218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666181009123218%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Band%252BChallenges%252Bof%252Bthe%252BDrugs%252BActing%252Bon%252BMonoamine%252BTransporters%26aulast%3DXue%26aufirst%3DWeiwei%26date%3D2020%26volume%3D27%26issue%3D23%26spage%3D3830%26epage%3D3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul R.  Mahableshwarkar</span>, <span class="hlFld-ContribAuthor ">John  Affinito</span>, <span class="hlFld-ContribAuthor ">Elin Heldbo  Reines</span>, <span class="hlFld-ContribAuthor ">Judith  Xu</span>, <span class="hlFld-ContribAuthor ">George  Nomikos</span>, <span class="hlFld-ContribAuthor ">Paula L.  Jacobsen</span>. </span><span class="cited-content_cbyCitation_article-title">Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials. </span><span class="cited-content_cbyCitation_journal-name">CNS Spectrums</span><span> <strong>2020,</strong> <em>25 </em>
                                    (3)
                                     , 352-362. <a href="https://doi.org/10.1017/S109285291900097X" title="DOI URL">https://doi.org/10.1017/S109285291900097X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S109285291900097X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS109285291900097X%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Spectrums%26atitle%3DSuicidal%252Bideation%252Band%252Bbehavior%252Bin%252Badults%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%252Btreated%252Bwith%252Bvortioxetine%25253A%252Bpost%252Bhoc%252Bpooled%252Banalyses%252Bof%252Brandomized%25252C%252Bplacebo-controlled%25252C%252Bshort-term%252Band%252Bopen-label%25252C%252Blong-term%252Bextension%252Btrials%26aulast%3DMahableshwarkar%26aufirst%3DAtul%2BR.%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D3%26spage%3D352%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Mitsudo</span>, <span class="hlFld-ContribAuthor ">Ren  Matsuo</span>, <span class="hlFld-ContribAuthor ">Toki  Yonezawa</span>, <span class="hlFld-ContribAuthor ">Haruka  Inoue</span>, <span class="hlFld-ContribAuthor ">Hiroki  Mandai</span>, <span class="hlFld-ContribAuthor ">Seiji  Suga</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Synthesis of Thienoacene Derivatives: Transition‐Metal‐Free Dehydrogenative C−S Coupling Promoted by a Halogen Mediator. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (20)
                                     , 7877-7881. <a href="https://doi.org/10.1002/ange.202001149" title="DOI URL">https://doi.org/10.1002/ange.202001149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202001149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202001149%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DElectrochemical%252BSynthesis%252Bof%252BThienoacene%252BDerivatives%25253A%252BTransition%2525E2%252580%252590Metal%2525E2%252580%252590Free%252BDehydrogenative%252BC%2525E2%252588%252592S%252BCoupling%252BPromoted%252Bby%252Ba%252BHalogen%252BMediator%26aulast%3DMitsudo%26aufirst%3DKoichi%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D20%26spage%3D7877%26epage%3D7881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Mitsudo</span>, <span class="hlFld-ContribAuthor ">Ren  Matsuo</span>, <span class="hlFld-ContribAuthor ">Toki  Yonezawa</span>, <span class="hlFld-ContribAuthor ">Haruka  Inoue</span>, <span class="hlFld-ContribAuthor ">Hiroki  Mandai</span>, <span class="hlFld-ContribAuthor ">Seiji  Suga</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical Synthesis of Thienoacene Derivatives: Transition‐Metal‐Free Dehydrogenative C−S Coupling Promoted by a Halogen Mediator. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (20)
                                     , 7803-7807. <a href="https://doi.org/10.1002/anie.202001149" title="DOI URL">https://doi.org/10.1002/anie.202001149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202001149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202001149%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DElectrochemical%252BSynthesis%252Bof%252BThienoacene%252BDerivatives%25253A%252BTransition%2525E2%252580%252590Metal%2525E2%252580%252590Free%252BDehydrogenative%252BC%2525E2%252588%252592S%252BCoupling%252BPromoted%252Bby%252Ba%252BHalogen%252BMediator%26aulast%3DMitsudo%26aufirst%3DKoichi%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D20%26spage%3D7803%26epage%3D7807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Jacobsen</span>, <span class="hlFld-ContribAuthor ">Wei  Zhong</span>, <span class="hlFld-ContribAuthor ">Rengyi  Xu</span>, <span class="hlFld-ContribAuthor ">George  Nomikos</span>. </span><span class="cited-content_cbyCitation_article-title">A novel study design for investigating relapse prevention in major depressive disorder: Preliminary data from the open-label period of a phase 4 vortioxetine study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Affective Disorders</span><span> <strong>2020,</strong> <em>266 </em>, 173-181. <a href="https://doi.org/10.1016/j.jad.2020.01.090" title="DOI URL">https://doi.org/10.1016/j.jad.2020.01.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jad.2020.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jad.2020.01.090%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Affective%2520Disorders%26atitle%3DA%252Bnovel%252Bstudy%252Bdesign%252Bfor%252Binvestigating%252Brelapse%252Bprevention%252Bin%252Bmajor%252Bdepressive%252Bdisorder%25253A%252BPreliminary%252Bdata%252Bfrom%252Bthe%252Bopen-label%252Bperiod%252Bof%252Ba%252Bphase%252B4%252Bvortioxetine%252Bstudy%26aulast%3DJacobsen%26aufirst%3DPaula%26date%3D2020%26volume%3D266%26spage%3D173%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">Gillian  Grafton</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Powell</span>, <span class="hlFld-ContribAuthor ">Kristian  Brock</span>, <span class="hlFld-ContribAuthor ">Chunlin  Chen</span>, <span class="hlFld-ContribAuthor ">Dejian  Xie</span>, <span class="hlFld-ContribAuthor ">Jinkun  Huang</span>, <span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Alison J.  Cooper</span>, <span class="hlFld-ContribAuthor ">Catherine A.  Brady</span>, <span class="hlFld-ContribAuthor ">Omar  Qureshi</span>, <span class="hlFld-ContribAuthor ">Zania  Stamataki</span>, <span class="hlFld-ContribAuthor ">David D.  Manning</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Moore</span>, <span class="hlFld-ContribAuthor ">Bruce J.  Sargent</span>, <span class="hlFld-ContribAuthor ">Peter R.  Guzzo</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Barnes</span>. </span><span class="cited-content_cbyCitation_article-title">CSTI-300 (SMP-100); a Novel 5-HT
              3
              Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>373 </em>
                                    (1)
                                     , 122-134. <a href="https://doi.org/10.1124/jpet.119.261008" title="DOI URL">https://doi.org/10.1124/jpet.119.261008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.261008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.261008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCSTI-300%252B%252528SMP-100%252529%25253B%252Ba%252BNovel%252B5-HT%252B3%252BReceptor%252BPartial%252BAgonist%252Bwith%252BPotential%252Bto%252BTreat%252BPatients%252Bwith%252BIrritable%252BBowel%252BSyndrome%252Bor%252BCarcinoid%252BSyndrome%26aulast%3DRoberts%26aufirst%3DAlexander%26date%3D2020%26date%3D2020%26volume%3D373%26issue%3D1%26spage%3D122%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia  Malikowska-Racia</span>, <span class="hlFld-ContribAuthor ">Piotr  Popik</span>, <span class="hlFld-ContribAuthor ">Kinga  Sałat</span>. </span><span class="cited-content_cbyCitation_article-title">Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2020,</strong> <em>381 </em>, 112380. <a href="https://doi.org/10.1016/j.bbr.2019.112380" title="DOI URL">https://doi.org/10.1016/j.bbr.2019.112380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2019.112380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2019.112380%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DBehavioral%252Beffects%252Bof%252Bbuspirone%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bposttraumatic%252Bstress%252Bdisorder%26aulast%3DMalikowska-Racia%26aufirst%3DNatalia%26date%3D2020%26volume%3D381%26spage%3D112380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingyue  Yi</span>, <span class="hlFld-ContribAuthor ">Guanghui  Ren</span>, <span class="hlFld-ContribAuthor ">Ming  Zheng</span>, <span class="hlFld-ContribAuthor ">Di  Zhao</span>, <span class="hlFld-ContribAuthor ">Ning  Li</span>, <span class="hlFld-ContribAuthor ">Xijng  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous determination of deuterated vortioxetine and its major metabolite in human plasma by UPLC-MS/MS and application to a pharmacokinetic study in healthy volunteers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography B</span><span> <strong>2020,</strong> <em>1138 </em>, 121955. <a href="https://doi.org/10.1016/j.jchromb.2019.121955" title="DOI URL">https://doi.org/10.1016/j.jchromb.2019.121955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jchromb.2019.121955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jchromb.2019.121955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520B%26atitle%3DSimultaneous%252Bdetermination%252Bof%252Bdeuterated%252Bvortioxetine%252Band%252Bits%252Bmajor%252Bmetabolite%252Bin%252Bhuman%252Bplasma%252Bby%252BUPLC-MS%25252FMS%252Band%252Bapplication%252Bto%252Ba%252Bpharmacokinetic%252Bstudy%252Bin%252Bhealthy%252Bvolunteers%26aulast%3DYi%26aufirst%3DYingyue%26date%3D2020%26volume%3D1138%26spage%3D121955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula L.  Jacobsen</span>, <span class="hlFld-ContribAuthor ">George G.  Nomikos</span>, <span class="hlFld-ContribAuthor ">Wei  Zhong</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Cutler</span>, <span class="hlFld-ContribAuthor ">John  Affinito</span>, <span class="hlFld-ContribAuthor ">Anita  Clayton</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. </span><span class="cited-content_cbyCitation_journal-name">CNS Spectrums</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 50-63. <a href="https://doi.org/10.1017/S1092852919000750" title="DOI URL">https://doi.org/10.1017/S1092852919000750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S1092852919000750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS1092852919000750%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Spectrums%26atitle%3DClinical%252Bimplications%252Bof%252Bdirectly%252Bswitching%252Bantidepressants%252Bin%252Bwell-treated%252Bdepressed%252Bpatients%252Bwith%252Btreatment-emergent%252Bsexual%252Bdysfunction%25253A%252Ba%252Bcomparison%252Bbetween%252Bvortioxetine%252Band%252Bescitalopram%26aulast%3DJacobsen%26aufirst%3DPaula%2BL.%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D50%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Inoue</span>, <span class="hlFld-ContribAuthor ">Kiyofumi  Sasai</span>, <span class="hlFld-ContribAuthor ">Tadayuki  Kitagawa</span>, <span class="hlFld-ContribAuthor ">Akira  Nishimura</span>, <span class="hlFld-ContribAuthor ">Isao  Inada</span>. </span><span class="cited-content_cbyCitation_article-title">Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder. </span><span class="cited-content_cbyCitation_journal-name">Psychiatry and Clinical Neurosciences</span><span> <strong>2020,</strong> <em>74 </em>
                                    (2)
                                     , 140-148. <a href="https://doi.org/10.1111/pcn.12956" title="DOI URL">https://doi.org/10.1111/pcn.12956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcn.12956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcn.12956%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatry%2520and%2520Clinical%2520Neurosciences%26atitle%3DRandomized%25252C%252Bdouble%2525E2%252580%252590blind%25252C%252Bplacebo%2525E2%252580%252590controlled%252Bstudy%252Bto%252Bassess%252Bthe%252Befficacy%252Band%252Bsafety%252Bof%252Bvortioxetine%252Bin%252BJapanese%252Bpatients%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%26aulast%3DInoue%26aufirst%3DTakeshi%26date%3D2020%26date%3D2019%26volume%3D74%26issue%3D2%26spage%3D140%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pitsillou</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Bresnehan</span>, <span class="hlFld-ContribAuthor ">Evan A.  Kagarakis</span>, <span class="hlFld-ContribAuthor ">Stevano J.  Wijoyo</span>, <span class="hlFld-ContribAuthor ">Julia  Liang</span>, <span class="hlFld-ContribAuthor ">Andrew  Hung</span>, <span class="hlFld-ContribAuthor ">Tom C.  Karagiannis</span>. </span><span class="cited-content_cbyCitation_article-title">The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. </span><span class="cited-content_cbyCitation_journal-name">Molecular Biology Reports</span><span> <strong>2020,</strong> <em>47 </em>
                                    (1)
                                     , 753-770. <a href="https://doi.org/10.1007/s11033-019-05129-3" title="DOI URL">https://doi.org/10.1007/s11033-019-05129-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11033-019-05129-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11033-019-05129-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Biology%2520Reports%26atitle%3DThe%252Bcellular%252Band%252Bmolecular%252Bbasis%252Bof%252Bmajor%252Bdepressive%252Bdisorder%25253A%252Btowards%252Ba%252Bunified%252Bmodel%252Bfor%252Bunderstanding%252Bclinical%252Bdepression%26aulast%3DPitsillou%26aufirst%3DEleni%26date%3D2020%26date%3D2019%26volume%3D47%26issue%3D1%26spage%3D753%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas Dahl  Nissen</span>, <span class="hlFld-ContribAuthor ">Bettina  Laursen</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Viardot</span>, <span class="hlFld-ContribAuthor ">Philippe  l'Hostis</span>, <span class="hlFld-ContribAuthor ">Philippe  Danjou</span>, <span class="hlFld-ContribAuthor ">Lasse Breuning  Sluth</span>, <span class="hlFld-ContribAuthor ">Mikkel  Gram</span>, <span class="hlFld-ContribAuthor ">Jesper Frank  Bastlund</span>, <span class="hlFld-ContribAuthor ">Søren Rahn  Christensen</span>, <span class="hlFld-ContribAuthor ">Asbjørn Mohr  Drewes</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings – A Randomized, Crossover Trial in Healthy Males. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2020,</strong> <em>424 </em>, 172-181. <a href="https://doi.org/10.1016/j.neuroscience.2019.09.039" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2019.09.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2019.09.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2019.09.039%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DEffects%252Bof%252BVortioxetine%252Band%252BEscitalopram%252Bon%252BElectroencephalographic%252BRecordings%252B%2525E2%252580%252593%252BA%252BRandomized%25252C%252BCrossover%252BTrial%252Bin%252BHealthy%252BMales%26aulast%3DNissen%26aufirst%3DThomas%2BDahl%26date%3D2020%26volume%3D424%26spage%3D172%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Ratajczak</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Kus</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Zielińska-Przyjemska</span>, <span class="hlFld-ContribAuthor ">Beata  Skórczewska</span>, <span class="hlFld-ContribAuthor ">Tomasz  Zaprutko</span>, <span class="hlFld-ContribAuthor ">Dorota  Kopciuch</span>, <span class="hlFld-ContribAuthor ">Anna  Paczkowska</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Nowakowska</span>. </span><span class="cited-content_cbyCitation_article-title">Antistress and antidepressant properties of dapoxetine and vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Acta Neurobiologiae Experimentalis</span><span> <strong>2020,</strong> <em>80 </em>
                                    (3)
                                     , 217-224. <a href="https://doi.org/10.21307/ane-2020-020" title="DOI URL">https://doi.org/10.21307/ane-2020-020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.21307/ane-2020-020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.21307%2Fane-2020-020%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neurobiologiae%2520Experimentalis%26atitle%3DAntistress%252Band%252Bantidepressant%252Bproperties%252Bof%252Bdapoxetine%252Band%252Bvortioxetine%26aulast%3DRatajczak%26aufirst%3DPiotr%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D3%26spage%3D217%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn R.  Cullen</span>, <span class="hlFld-ContribAuthor ">Laura E.  Padilla</span>, <span class="hlFld-ContribAuthor ">Victoria N.  Papke</span>, <span class="hlFld-ContribAuthor ">Bonnie  Klimes-Dougan</span>. </span><span class="cited-content_cbyCitation_article-title">New Somatic Treatments for Child and Adolescent Depression. </span><span class="cited-content_cbyCitation_journal-name">Current Treatment Options in Psychiatry</span><span> <strong>2019,</strong> <em>6 </em>
                                    (4)
                                     , 380-400. <a href="https://doi.org/10.1007/s40501-019-00194-8" title="DOI URL">https://doi.org/10.1007/s40501-019-00194-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40501-019-00194-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40501-019-00194-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Treatment%2520Options%2520in%2520Psychiatry%26atitle%3DNew%252BSomatic%252BTreatments%252Bfor%252BChild%252Band%252BAdolescent%252BDepression%26aulast%3DCullen%26aufirst%3DKathryn%2BR.%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D4%26spage%3D380%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Qian</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao-Wen  Chen</span>, <span class="hlFld-ContribAuthor ">Jian-Qi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antidepressant-like activity of novel alkoxy-piperidine derivatives targeting SSRI/5-HT1A/5-HT7. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (24)
                                     , 126769. <a href="https://doi.org/10.1016/j.bmcl.2019.126769" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126769%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantidepressant-like%252Bactivity%252Bof%252Bnovel%252Balkoxy-piperidine%252Bderivatives%252Btargeting%252BSSRI%25252F5-HT1A%25252F5-HT7%26aulast%3DWang%26aufirst%3DWen-Tao%26date%3D2019%26volume%3D29%26issue%3D24%26spage%3D126769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Talia  Zeppelin</span>, <span class="hlFld-ContribAuthor ">Lucy Kate  Ladefoged</span>, <span class="hlFld-ContribAuthor ">Steffen  Sinning</span>, <span class="hlFld-ContribAuthor ">Birgit  Schiøtt</span>. </span><span class="cited-content_cbyCitation_article-title">Substrate and inhibitor binding to the serotonin transporter: Insights from computational, crystallographic, and functional studies. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>161 </em>, 107548. <a href="https://doi.org/10.1016/j.neuropharm.2019.02.030" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DSubstrate%252Band%252Binhibitor%252Bbinding%252Bto%252Bthe%252Bserotonin%252Btransporter%25253A%252BInsights%252Bfrom%252Bcomputational%25252C%252Bcrystallographic%25252C%252Band%252Bfunctional%252Bstudies%26aulast%3DZeppelin%26aufirst%3DTalia%26date%3D2019%26volume%3D161%26spage%3D107548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone B.  Sartori</span>, <span class="hlFld-ContribAuthor ">Nicolas  Singewald</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>204 </em>, 107402. <a href="https://doi.org/10.1016/j.pharmthera.2019.107402" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107402%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DNovel%252Bpharmacological%252Btargets%252Bin%252Bdrug%252Bdevelopment%252Bfor%252Bthe%252Btreatment%252Bof%252Banxiety%252Band%252Banxiety-related%252Bdisorders%26aulast%3DSartori%26aufirst%3DSimone%2BB.%26date%3D2019%26volume%3D204%26spage%3D107402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Motohiro  Okada</span>, <span class="hlFld-ContribAuthor ">Ruri  Okubo</span>, <span class="hlFld-ContribAuthor ">Kouji  Fukuyama</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (24)
                                     , 6235. <a href="https://doi.org/10.3390/ijms20246235" title="DOI URL">https://doi.org/10.3390/ijms20246235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20246235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20246235%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DVortioxetine%252BSubchronically%252BActivates%252BSerotonergic%252BTransmission%252Bvia%252BDesensitization%252Bof%252BSerotonin%252B5-HT1A%252BReceptor%252Bwith%252B5-HT3%252BReceptor%252BInhibition%252Bin%252BRats%26aulast%3DOkada%26aufirst%3DMotohiro%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D24%26spage%3D6235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel  Kleemann</span>. </span><span class="cited-content_cbyCitation_article-title">Antidepressants (N06A). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-13. <a href="https://doi.org/10.1002/14356007.p02_p01.pub2" title="DOI URL">https://doi.org/10.1002/14356007.p02_p01.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/14356007.p02_p01.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F14356007.p02_p01.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAntidepressants%252B%252528N06A%252529%26aulast%3DKleemann%26aufirst%3DAxel%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D13%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DUllmann%252527s%252BEncyclopedia%252Bof%252BIndustrial%252BChemistry%26date%3D2000%26date%3D2000%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra M.  Sharp</span>, <span class="hlFld-ContribAuthor ">Suphada  Lertphinyowong</span>, <span class="hlFld-ContribAuthor ">Samantha S.  Yee</span>, <span class="hlFld-ContribAuthor ">Denisse  Paredes</span>, <span class="hlFld-ContribAuthor ">Jonathan  Gelfond</span>, <span class="hlFld-ContribAuthor ">Teresa L.  Johnson-Pais</span>, <span class="hlFld-ContribAuthor ">Robin J.  Leach</span>, <span class="hlFld-ContribAuthor ">Michael  Liss</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">Anna C.  Sullivan</span>, <span class="hlFld-ContribAuthor ">Ian M.  Thompson</span>, <span class="hlFld-ContribAuthor ">David A.  Morilak</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2019,</strong> <em>236 </em>
                                    (11)
                                     , 3183-3195. <a href="https://doi.org/10.1007/s00213-019-05274-4" title="DOI URL">https://doi.org/10.1007/s00213-019-05274-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-019-05274-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-019-05274-4%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3DVortioxetine%252Breverses%252Bmedial%252Bprefrontal%252Bcortex-mediated%252Bcognitive%252Bdeficits%252Bin%252Bmale%252Brats%252Binduced%252Bby%252Bcastration%252Bas%252Ba%252Bmodel%252Bof%252Bandrogen%252Bdeprivation%252Btherapy%252Bfor%252Bprostate%252Bcancer%26aulast%3DSharp%26aufirst%3DAlexandra%2BM.%26date%3D2019%26date%3D2019%26volume%3D236%26issue%3D11%26spage%3D3183%26epage%3D3195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Miao</span>, <span class="hlFld-ContribAuthor ">Gang  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Hou</span>, <span class="hlFld-ContribAuthor ">Johan  Areberg</span>, <span class="hlFld-ContribAuthor ">Yan  Zhao</span>, <span class="hlFld-ContribAuthor ">Astrid-Maria  Højer</span>, <span class="hlFld-ContribAuthor ">Anders  Ettrup</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and Safety of Vortioxetine in the Chinese Population. </span><span class="cited-content_cbyCitation_journal-name">Advances in Therapy</span><span> <strong>2019,</strong> <em>36 </em>
                                    (11)
                                     , 3134-3146. <a href="https://doi.org/10.1007/s12325-019-01092-4" title="DOI URL">https://doi.org/10.1007/s12325-019-01092-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12325-019-01092-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12325-019-01092-4%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520in%2520Therapy%26atitle%3DPharmacokinetics%252Band%252BSafety%252Bof%252BVortioxetine%252Bin%252Bthe%252BChinese%252BPopulation%26aulast%3DMiao%26aufirst%3DJia%26date%3D2019%26date%3D2019%26volume%3D36%26issue%3D11%26spage%3D3134%26epage%3D3146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. E.  Mazo</span>, <span class="hlFld-ContribAuthor ">A. O.  Kibitov</span>. </span><span class="cited-content_cbyCitation_article-title">Anhedonia as a basic syndrome and a target for treatment for depressive disorder. </span><span class="cited-content_cbyCitation_journal-name">V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</span><span> <strong>2019,</strong> <em> </em>
                                    (3)
                                     , 10-18. <a href="https://doi.org/10.31363/2313-7053-2019-3-10-18" title="DOI URL">https://doi.org/10.31363/2313-7053-2019-3-10-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.31363/2313-7053-2019-3-10-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.31363%2F2313-7053-2019-3-10-18%26sid%3Dliteratum%253Aachs%26jtitle%3DV.M.%2520BEKHTEREV%2520REVIEW%2520OF%2520PSYCHIATRY%2520AND%2520MEDICAL%2520PSYCHOLOGY%26atitle%3DAnhedonia%252Bas%252Ba%252Bbasic%252Bsyndrome%252Band%252Ba%252Btarget%252Bfor%252Btreatment%252Bfor%252Bdepressive%252Bdisorder%26aulast%3DMazo%26aufirst%3DG.%2BE.%26date%3D2019%26date%3D2019%26issue%3D3%26spage%3D10%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Xi-Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Chong  Feng</span>, <span class="hlFld-ContribAuthor ">Quan  Bao</span>, <span class="hlFld-ContribAuthor ">Hong-Ran  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Psychiatry in Clinical Practice</span><span> <strong>2019,</strong> <em>23 </em>
                                    (4)
                                     , 245-250. <a href="https://doi.org/10.1080/13651501.2017.1397700" title="DOI URL">https://doi.org/10.1080/13651501.2017.1397700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13651501.2017.1397700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13651501.2017.1397700%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Psychiatry%2520in%2520Clinical%2520Practice%26atitle%3DEfficacy%252Band%252Bsafety%252Bof%252Bvortioxetine%252Bfor%252Bthe%252Btreatment%252Bof%252Bmajor%252Bdepressive%252Bdisorder%25253A%252Ba%252Brandomised%252Bdouble-blind%252Bplacebo-controlled%252Bstudy%26aulast%3DWang%26aufirst%3DJing%26date%3D2019%26date%3D2017%26volume%3D23%26issue%3D4%26spage%3D245%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai-Chun  Yang</span>, <span class="hlFld-ContribAuthor ">Vladimir  Stepanov</span>, <span class="hlFld-ContribAuthor ">Nahid  Amini</span>, <span class="hlFld-ContribAuthor ">Stefan  Martinsson</span>, <span class="hlFld-ContribAuthor ">Akihiro  Takano</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Connie  Sanchez</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Lars  Farde</span>, <span class="hlFld-ContribAuthor ">Sjoerd J.  Finnema</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of clinically relevant doses of vortioxetine and citalopram on serotonergic PET markers in the nonhuman primate brain. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (10)
                                     , 1706-1713. <a href="https://doi.org/10.1038/s41386-019-0442-4" title="DOI URL">https://doi.org/10.1038/s41386-019-0442-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0442-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0442-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DEffect%252Bof%252Bclinically%252Brelevant%252Bdoses%252Bof%252Bvortioxetine%252Band%252Bcitalopram%252Bon%252Bserotonergic%252BPET%252Bmarkers%252Bin%252Bthe%252Bnonhuman%252Bprimate%252Bbrain%26aulast%3DYang%26aufirst%3DKai-Chun%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D10%26spage%3D1706%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Romigi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Vitrani</span>, <span class="hlFld-ContribAuthor ">Marco  Caccamo</span>, <span class="hlFld-ContribAuthor ">Diego  Centonze</span>. </span><span class="cited-content_cbyCitation_article-title">Restless Legs Syndrome Related to Vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Psychopharmacology</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 514-516. <a href="https://doi.org/10.1097/JCP.0000000000001092" title="DOI URL">https://doi.org/10.1097/JCP.0000000000001092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/JCP.0000000000001092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FJCP.0000000000001092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Psychopharmacology%26atitle%3DRestless%252BLegs%252BSyndrome%252BRelated%252Bto%252BVortioxetine%26aulast%3DRomigi%26aufirst%3DAndrea%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D514%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M.  Rajathei</span>, <span class="hlFld-ContribAuthor ">Subbiah  Parthasarathy</span>, <span class="hlFld-ContribAuthor ">Samuel  Selvaraj</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR Analysis of Multimodal Antidepressants Vortioxetine Analogs Using Physicochemical Descriptors and MLR Modeling. </span><span class="cited-content_cbyCitation_journal-name">Current Computer-Aided Drug Design</span><span> <strong>2019,</strong> <em>15 </em>
                                    (4)
                                     , 294-307. <a href="https://doi.org/10.2174/1573409914666181011144810" title="DOI URL">https://doi.org/10.2174/1573409914666181011144810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573409914666181011144810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573409914666181011144810%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Computer-Aided%2520Drug%2520Design%26atitle%3DQSAR%252BAnalysis%252Bof%252BMultimodal%252BAntidepressants%252BVortioxetine%252BAnalogs%252BUsing%252BPhysicochemical%252BDescriptors%252Band%252BMLR%252BModeling%26aulast%3DRajathei%26aufirst%3DDavid%2BM.%26date%3D2019%26volume%3D15%26issue%3D4%26spage%3D294%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoltán  Boros</span>, <span class="hlFld-ContribAuthor ">László  Nagy-Győr</span>, <span class="hlFld-ContribAuthor ">Katalin  Kátai-Fadgyas</span>, <span class="hlFld-ContribAuthor ">Imre  Kőhegyi</span>, <span class="hlFld-ContribAuthor ">István  Ling</span>, <span class="hlFld-ContribAuthor ">Tamás  Nagy</span>, <span class="hlFld-ContribAuthor ">Zoltán  Iványi</span>, <span class="hlFld-ContribAuthor ">Márk  Oláh</span>, <span class="hlFld-ContribAuthor ">György  Ruzsics</span>, <span class="hlFld-ContribAuthor ">Ottó  Temesi</span>, <span class="hlFld-ContribAuthor ">Balázs  Volk</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous flow production in the final step of vortioxetine synthesis. Piperazine ring formation on a flow platform with a focus on productivity and scalability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Flow Chemistry</span><span> <strong>2019,</strong> <em>9 </em>
                                    (2)
                                     , 101-113. <a href="https://doi.org/10.1007/s41981-019-00036-x" title="DOI URL">https://doi.org/10.1007/s41981-019-00036-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41981-019-00036-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41981-019-00036-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Flow%2520Chemistry%26atitle%3DContinuous%252Bflow%252Bproduction%252Bin%252Bthe%252Bfinal%252Bstep%252Bof%252Bvortioxetine%252Bsynthesis.%252BPiperazine%252Bring%252Bformation%252Bon%252Ba%252Bflow%252Bplatform%252Bwith%252Ba%252Bfocus%252Bon%252Bproductivity%252Band%252Bscalability%26aulast%3DBoros%26aufirst%3DZolt%25C3%25A1n%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D2%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Brivio</span>, <span class="hlFld-ContribAuthor ">Giulia  Corsini</span>, <span class="hlFld-ContribAuthor ">Marco Andrea  Riva</span>, <span class="hlFld-ContribAuthor ">Francesca  Calabrese</span>. </span><span class="cited-content_cbyCitation_article-title">Chronic vortioxetine treatment improves the responsiveness to an acute stress acting through the ventral hippocampus in a glucocorticoid-dependent way. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2019,</strong> <em>142 </em>, 14-21. <a href="https://doi.org/10.1016/j.phrs.2019.02.006" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DChronic%252Bvortioxetine%252Btreatment%252Bimproves%252Bthe%252Bresponsiveness%252Bto%252Ban%252Bacute%252Bstress%252Bacting%252Bthrough%252Bthe%252Bventral%252Bhippocampus%252Bin%252Ba%252Bglucocorticoid-dependent%252Bway%26aulast%3DBrivio%26aufirst%3DPaola%26date%3D2019%26volume%3D142%26spage%3D14%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morena M.  Zugliani</span>, <span class="hlFld-ContribAuthor ">Mariana C.  Cabo</span>, <span class="hlFld-ContribAuthor ">Antonio E.  Nardi</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Perna</span>, <span class="hlFld-ContribAuthor ">Rafael C.  Freire</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Psychiatry Investigation</span><span> <strong>2019,</strong> <em>16 </em>
                                    (1)
                                     , 50-58. <a href="https://doi.org/10.30773/pi.2018.12.21.1" title="DOI URL">https://doi.org/10.30773/pi.2018.12.21.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.30773/pi.2018.12.21.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.30773%2Fpi.2018.12.21.1%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatry%2520Investigation%26atitle%3DPharmacological%252Band%252BNeuromodulatory%252BTreatments%252Bfor%252BPanic%252BDisorder%25253A%252BClinical%252BTrials%252Bfrom%252B2010%252Bto%252B2018%26aulast%3DZugliani%26aufirst%3DMorena%2BM.%26date%3D2019%26volume%3D16%26issue%3D1%26spage%3D50%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xenia  Gonda</span>, <span class="hlFld-ContribAuthor ">Samata R.  Sharma</span>, <span class="hlFld-ContribAuthor ">Frank I.  Tarazi</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (1)
                                     , 81-89. <a href="https://doi.org/10.1080/17460441.2019.1546691" title="DOI URL">https://doi.org/10.1080/17460441.2019.1546691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1546691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1546691%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DVortioxetine%25253A%252Ba%252Bnovel%252Bantidepressant%252Bfor%252Bthe%252Btreatment%252Bof%252Bmajor%252Bdepressive%252Bdisorder%26aulast%3DGonda%26aufirst%3DXenia%26date%3D2019%26date%3D2018%26volume%3D14%26issue%3D1%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raymond W.  Lam</span>, <span class="hlFld-ContribAuthor ">Carol  Persad</span>. </span><span class="cited-content_cbyCitation_article-title">Cognitive Dysfunction in the Workplace: Focus on Depression. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 99-110. <a href="https://doi.org/10.1007/978-3-030-04266-0_7" title="DOI URL">https://doi.org/10.1007/978-3-030-04266-0_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-04266-0_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-04266-0_7%26sid%3Dliteratum%253Aachs%26atitle%3DCognitive%252BDysfunction%252Bin%252Bthe%252BWorkplace%25253A%252BFocus%252Bon%252BDepression%26aulast%3DLam%26aufirst%3DRaymond%2BW.%26date%3D2019%26date%3D2019%26spage%3D99%26epage%3D110%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMental%252BHealth%252Bin%252Bthe%252BWorkplace%26aulast%3DRiba%26aufirst%3DMichelle%2BB.%26date%3D2019%26volume%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George G.  Nomikos</span>. </span><span class="cited-content_cbyCitation_article-title">Unmet Medical Needs in the Treatment of Depression and the Clinical Development of a Differentiated Antidepressant: A Translational Line of Evidence. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 383-387. <a href="https://doi.org/10.1016/B978-0-12-803161-2.00027-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-803161-2.00027-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803161-2.00027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803161-2.00027-8%26sid%3Dliteratum%253Aachs%26atitle%3DUnmet%252BMedical%252BNeeds%252Bin%252Bthe%252BTreatment%252Bof%252BDepression%252Band%252Bthe%252BClinical%252BDevelopment%252Bof%252Ba%252BDifferentiated%252BAntidepressant%25253A%252BA%252BTranslational%252BLine%252Bof%252BEvidence%26aulast%3DNomikos%26aufirst%3DGeorge%2BG.%26date%3D2019%26spage%3D383%26epage%3D387%26pub%3DElsevier%26atitle%3DTranslational%252BMedicine%252Bin%252BCNS%252BDrug%252BDevelopment%26date%3D2019%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trisha  Chakrabarty</span>, <span class="hlFld-ContribAuthor ">David  Sarfati</span>, <span class="hlFld-ContribAuthor ">Raymond W.  Lam</span>. </span><span class="cited-content_cbyCitation_article-title">Neurobiological Aspects of Functional Recovery in Major Depressive Disorder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 277-284. <a href="https://doi.org/10.1016/B978-0-12-813333-0.00024-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-813333-0.00024-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813333-0.00024-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813333-0.00024-X%26sid%3Dliteratum%253Aachs%26atitle%3DNeurobiological%252BAspects%252Bof%252BFunctional%252BRecovery%252Bin%252BMajor%252BDepressive%252BDisorder%26aulast%3DChakrabarty%26aufirst%3DTrisha%26date%3D2019%26spage%3D277%26epage%3D284%26pub%3DElsevier%26atitle%3DNeurobiology%252Bof%252BDepression%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su  Guan</span>, <span class="hlFld-ContribAuthor ">Yake  Zou</span>, <span class="hlFld-ContribAuthor ">Bingjie  Jia</span>, <span class="hlFld-ContribAuthor ">Lvying  Wu</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Yuan</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic and metabolic studies of Vortioxetine in rats using ultra high performance liquid chromatography with tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Separation Science</span><span> <strong>2018,</strong> <em>41 </em>
                                    (24)
                                     , 4469-4479. <a href="https://doi.org/10.1002/jssc.201800607" title="DOI URL">https://doi.org/10.1002/jssc.201800607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jssc.201800607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjssc.201800607%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Separation%2520Science%26atitle%3DPharmacokinetic%252Band%252Bmetabolic%252Bstudies%252Bof%252BVortioxetine%252Bin%252Brats%252Busing%252Bultra%252Bhigh%252Bperformance%252Bliquid%252Bchromatography%252Bwith%252Btandem%252Bmass%252Bspectrometry%26aulast%3DGuan%26aufirst%3DSu%26date%3D2018%26date%3D2018%26volume%3D41%26issue%3D24%26spage%3D4469%26epage%3D4479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy Kate  Ladefoged</span>, <span class="hlFld-ContribAuthor ">Lachlan  Munro</span>, <span class="hlFld-ContribAuthor ">Anders J.  Pedersen</span>, <span class="hlFld-ContribAuthor ">Sarah C. R.  Lummis</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Thomas  Balle</span>, <span class="hlFld-ContribAuthor ">Birgit  Schiøtt</span>, <span class="hlFld-ContribAuthor ">Anders S.  Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling and Mutational Analysis of the Binding Mode for the Multimodal Antidepressant Drug Vortioxetine to the Human 5-HT
              3A
              Receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2018,</strong> <em>94 </em>
                                    (6)
                                     , 1421-1434. <a href="https://doi.org/10.1124/mol.118.113530" title="DOI URL">https://doi.org/10.1124/mol.118.113530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.118.113530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.118.113530%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DModeling%252Band%252BMutational%252BAnalysis%252Bof%252Bthe%252BBinding%252BMode%252Bfor%252Bthe%252BMultimodal%252BAntidepressant%252BDrug%252BVortioxetine%252Bto%252Bthe%252BHuman%252B5-HT%252B3A%252BReceptor%26aulast%3DLadefoged%26aufirst%3DLucy%2BKate%26date%3D2018%26date%3D2018%26volume%3D94%26issue%3D6%26spage%3D1421%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imon  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Newer Updates in Psychiatry: Focus on Vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Indian Journal of Private Psychiatry</span><span> <strong>2018,</strong> <em>12 </em>
                                    (2)
                                     , 62-65. <a href="https://doi.org/10.5005/jp-journals-10067-0024" title="DOI URL">https://doi.org/10.5005/jp-journals-10067-0024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5005/jp-journals-10067-0024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5005%2Fjp-journals-10067-0024%26sid%3Dliteratum%253Aachs%26jtitle%3DIndian%2520Journal%2520of%2520Private%2520Psychiatry%26atitle%3DNewer%252BUpdates%252Bin%252BPsychiatry%25253A%252BFocus%252Bon%252BVortioxetine%26aulast%3DPaul%26aufirst%3DImon%26date%3D2018%26date%3D2018%26volume%3D12%26issue%3D2%26spage%3D62%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheuk Ngen  Chin</span>, <span class="hlFld-ContribAuthor ">Azhar  Zain</span>, <span class="hlFld-ContribAuthor ">Solaphat  Hemrungrojn</span>, <span class="hlFld-ContribAuthor ">Eng Khean  Ung</span>, <span class="hlFld-ContribAuthor ">Patanon  Kwansanit</span>, <span class="hlFld-ContribAuthor ">Koon Choong  Au Yong</span>, <span class="hlFld-ContribAuthor ">Marvin Swee Woon  Chong</span>, <span class="hlFld-ContribAuthor ">Chalowat  Inpa</span>, <span class="hlFld-ContribAuthor ">Teck Hoe  Yen</span>, <span class="hlFld-ContribAuthor ">Boon Beng David  Yeoh</span>, <span class="hlFld-ContribAuthor ">Liam Kai  Tay</span>, <span class="hlFld-ContribAuthor ">Carmina  Bernardo</span>, <span class="hlFld-ContribAuthor ">Lionel Chee-Chong  Lim</span>, <span class="hlFld-ContribAuthor ">Chin Hong  Yap</span>, <span class="hlFld-ContribAuthor ">Calvin  Fones</span>, <span class="hlFld-ContribAuthor ">Ashwini  Nayak</span>, <span class="hlFld-ContribAuthor ">Lars  Nelleman</span>. </span><span class="cited-content_cbyCitation_article-title">Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA). </span><span class="cited-content_cbyCitation_journal-name">Current Medical Research and Opinion</span><span> <strong>2018,</strong> <em>34 </em>
                                    (11)
                                     , 1975-1984. <a href="https://doi.org/10.1080/03007995.2018.1477746" title="DOI URL">https://doi.org/10.1080/03007995.2018.1477746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03007995.2018.1477746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03007995.2018.1477746%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medical%2520Research%2520and%2520Opinion%26atitle%3DResults%252Bof%252Ba%252Breal-world%252Bstudy%252Bon%252Bvortioxetine%252Bin%252Bpatients%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%252Bin%252BSouth%252BEast%252BAsia%252B%252528REVIDA%252529%26aulast%3DChin%26aufirst%3DCheuk%2BNgen%26date%3D2018%26date%3D2018%26volume%3D34%26issue%3D11%26spage%3D1975%26epage%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace  Chen</span>, <span class="hlFld-ContribAuthor ">George G.  Nomikos</span>, <span class="hlFld-ContribAuthor ">John  Affinito</span>, <span class="hlFld-ContribAuthor ">William  Jacobson</span>, <span class="hlFld-ContribAuthor ">Zhen  Zhao</span>, <span class="hlFld-ContribAuthor ">Shining  Wang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Intrinsic Factors on the Clinical Pharmacokinetics of Vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2018,</strong> <em>7 </em>
                                    (8)
                                     , 880-888. <a href="https://doi.org/10.1002/cpdd.577" title="DOI URL">https://doi.org/10.1002/cpdd.577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.577%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DEffects%252Bof%252BIntrinsic%252BFactors%252Bon%252Bthe%252BClinical%252BPharmacokinetics%252Bof%252BVortioxetine%26aulast%3DChen%26aufirst%3DGrace%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D8%26spage%3D880%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Fiorillo</span>, <span class="hlFld-ContribAuthor ">Bernardo  Carpiniello</span>, <span class="hlFld-ContribAuthor ">Serafino  De Giorgi</span>, <span class="hlFld-ContribAuthor ">Silvestro  La Pia</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Maina</span>, <span class="hlFld-ContribAuthor ">Gaia  Sampogna</span>, <span class="hlFld-ContribAuthor ">Edoardo  Spina</span>, <span class="hlFld-ContribAuthor ">Alfonso  Tortorella</span>, <span class="hlFld-ContribAuthor ">Antonio  Vita</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fpsyt.2018.00493" title="DOI URL">https://doi.org/10.3389/fpsyt.2018.00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2018.00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2018.00493%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DAssessment%252Band%252BManagement%252Bof%252BCognitive%252Band%252BPsychosocial%252BDysfunctions%252Bin%252BPatients%252BWith%252BMajor%252BDepressive%252BDisorder%25253A%252BA%252BClinical%252BReview%26aulast%3DFiorillo%26aufirst%3DAndrea%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Staroń</span>, <span class="hlFld-ContribAuthor ">Ryszard  Bugno</span>, <span class="hlFld-ContribAuthor ">Adam S.  Hogendorf</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>. </span><span class="cited-content_cbyCitation_article-title">5-HT1A receptor ligands and their therapeutic applications: review of new patents. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2018,</strong> <em>28 </em>
                                    (9)
                                     , 679-689. <a href="https://doi.org/10.1080/13543776.2018.1514011" title="DOI URL">https://doi.org/10.1080/13543776.2018.1514011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2018.1514011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2018.1514011%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3D5-HT1A%252Breceptor%252Bligands%252Band%252Btheir%252Btherapeutic%252Bapplications%25253A%252Breview%252Bof%252Bnew%252Bpatents%26aulast%3DStaro%25C5%2584%26aufirst%3DJakub%26date%3D2018%26date%3D2018%26volume%3D28%26issue%3D9%26spage%3D679%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morten  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Kim  Christensen</span>, <span class="hlFld-ContribAuthor ">Martin  Juhl</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine and Early Drug Development Considerations at the Interface of R&D. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 125-144. <a href="https://doi.org/10.1002/9783527801756.ch6" title="DOI URL">https://doi.org/10.1002/9783527801756.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527801756.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527801756.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DVortioxetine%252Band%252BEarly%252BDrug%252BDevelopment%252BConsiderations%252Bat%252Bthe%252BInterface%252Bof%252BR%252526D%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DMorten%26date%3D2018%26date%3D2018%26spage%3D125%26epage%3D144%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DEarly%252BDrug%252BDevelopment%26aulast%3DGiordanetto%26aufirst%3DFabrizio%2BGiordanetto%26date%3D2018%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace  Chen</span>, <span class="hlFld-ContribAuthor ">Astrid-Maria  Højer</span>, <span class="hlFld-ContribAuthor ">Johan  Areberg</span>, <span class="hlFld-ContribAuthor ">George  Nomikos</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacokinetics</span><span> <strong>2018,</strong> <em>57 </em>
                                    (6)
                                     , 673-686. <a href="https://doi.org/10.1007/s40262-017-0612-7" title="DOI URL">https://doi.org/10.1007/s40262-017-0612-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40262-017-0612-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40262-017-0612-7%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacokinetics%26atitle%3DVortioxetine%25253A%252BClinical%252BPharmacokinetics%252Band%252BDrug%252BInteractions%26aulast%3DChen%26aufirst%3DGrace%26date%3D2018%26date%3D2017%26volume%3D57%26issue%3D6%26spage%3D673%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Dale</span>, <span class="hlFld-ContribAuthor ">Morten  Grunnet</span>, <span class="hlFld-ContribAuthor ">Alan L.  Pehrson</span>, <span class="hlFld-ContribAuthor ">Kristen  Frederiksen</span>, <span class="hlFld-ContribAuthor ">Peter H.  Larsen</span>, <span class="hlFld-ContribAuthor ">Jacob  Nielsen</span>, <span class="hlFld-ContribAuthor ">Tine B.  Stensbøl</span>, <span class="hlFld-ContribAuthor ">Bjarke  Ebert</span>, <span class="hlFld-ContribAuthor ">Haolan  Yin</span>, <span class="hlFld-ContribAuthor ">Dunguo  Lu</span>, <span class="hlFld-ContribAuthor ">Huiquing  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas N.  Jensen</span>, <span class="hlFld-ContribAuthor ">Charles R.  Yang</span>, <span class="hlFld-ContribAuthor ">Connie  Sanchez</span>. </span><span class="cited-content_cbyCitation_article-title">The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT3 receptor expressing interneurons: An in vitro study in rat hippocampus slices. </span><span class="cited-content_cbyCitation_journal-name">Brain Research</span><span> <strong>2018,</strong> <em>1689 </em>, 1-11. <a href="https://doi.org/10.1016/j.brainres.2017.12.025" title="DOI URL">https://doi.org/10.1016/j.brainres.2017.12.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainres.2017.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainres.2017.12.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%26atitle%3DThe%252Bmultimodal%252Bantidepressant%252Bvortioxetine%252Bmay%252Bfacilitate%252Bpyramidal%252Bcell%252Bfiring%252Bby%252Binhibition%252Bof%252B5-HT3%252Breceptor%252Bexpressing%252Binterneurons%25253A%252BAn%252Bin%252Bvitro%252Bstudy%252Bin%252Brat%252Bhippocampus%252Bslices%26aulast%3DDale%26aufirst%3DElena%26date%3D2018%26volume%3D1689%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George I.  Papakostas</span>, <span class="hlFld-ContribAuthor ">Rebecca Z.  Nielsen</span>, <span class="hlFld-ContribAuthor ">Marianne  Dragheim</span>, <span class="hlFld-ContribAuthor ">Brigitte  Tonnoir</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychiatric Research</span><span> <strong>2018,</strong> <em>101 </em>, 72-79. <a href="https://doi.org/10.1016/j.jpsychires.2018.02.017" title="DOI URL">https://doi.org/10.1016/j.jpsychires.2018.02.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpsychires.2018.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpsychires.2018.02.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychiatric%2520Research%26atitle%3DEfficacy%252Band%252Btolerability%252Bof%252Bvortioxetine%252Bversus%252Bagomelatine%25252C%252Bcategorized%252Bby%252Bprevious%252Btreatment%25252C%252Bin%252Bpatients%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%252Bswitched%252Bafter%252Ban%252Binadequate%252Bresponse%26aulast%3DPapakostas%26aufirst%3DGeorge%2BI.%26date%3D2018%26volume%3D101%26spage%3D72%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mario Gennaro  Mazza</span>, <span class="hlFld-ContribAuthor ">Aurora  Rossetti</span>, <span class="hlFld-ContribAuthor ">Eugenia Rossana  Botti</span>, <span class="hlFld-ContribAuthor ">Massimo  Clerici</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine overdose in a suicidal attempt. </span><span class="cited-content_cbyCitation_journal-name">Medicine</span><span> <strong>2018,</strong> <em>97 </em>
                                    (25)
                                     , e10788. <a href="https://doi.org/10.1097/MD.0000000000010788" title="DOI URL">https://doi.org/10.1097/MD.0000000000010788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/MD.0000000000010788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FMD.0000000000010788%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%26atitle%3DVortioxetine%252Boverdose%252Bin%252Ba%252Bsuicidal%252Battempt%26aulast%3DMazza%26aufirst%3DMario%2BGennaro%26date%3D2018%26volume%3D97%26issue%3D25%26spage%3De10788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kumi  Matsuno</span>, <span class="hlFld-ContribAuthor ">Koki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yutaka  Aritomi</span>, <span class="hlFld-ContribAuthor ">Akira  Nishimura</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2018,</strong> <em>7 </em>
                                    (3)
                                     , 319-331. <a href="https://doi.org/10.1002/cpdd.381" title="DOI URL">https://doi.org/10.1002/cpdd.381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.381%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DPharmacokinetics%25252C%252BSafety%25252C%252Band%252BTolerability%252Bof%252BVortioxetine%252BFollowing%252BSingle-%252Band%252BMultiple-Dose%252BAdministration%252Bin%252BHealthy%252BJapanese%252BAdults%26aulast%3DMatsuno%26aufirst%3DKumi%26date%3D2018%26date%3D2017%26volume%3D7%26issue%3D3%26spage%3D319%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernhard T.  Baune</span>, <span class="hlFld-ContribAuthor ">Lasse B.  Sluth</span>, <span class="hlFld-ContribAuthor ">Christina K.  Olsen</span>. </span><span class="cited-content_cbyCitation_article-title">The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: A short-term, randomized, double-blind, exploratory study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Affective Disorders</span><span> <strong>2018,</strong> <em>229 </em>, 421-428. <a href="https://doi.org/10.1016/j.jad.2017.12.056" title="DOI URL">https://doi.org/10.1016/j.jad.2017.12.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jad.2017.12.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jad.2017.12.056%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Affective%2520Disorders%26atitle%3DThe%252Beffects%252Bof%252Bvortioxetine%252Bon%252Bcognitive%252Bperformance%252Bin%252Bworking%252Bpatients%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%25253A%252BA%252Bshort-term%25252C%252Brandomized%25252C%252Bdouble-blind%25252C%252Bexploratory%252Bstudy%26aulast%3DBaune%26aufirst%3DBernhard%2BT.%26date%3D2018%26volume%3D229%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Przemysław Paweł  Taciak</span>, <span class="hlFld-ContribAuthor ">Natalia  Lysenko</span>, <span class="hlFld-ContribAuthor ">Aleksander Paweł  Mazurek</span>. </span><span class="cited-content_cbyCitation_article-title">Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2018,</strong> <em>70 </em>
                                    (1)
                                     , 37-46. <a href="https://doi.org/10.1016/j.pharep.2017.07.011" title="DOI URL">https://doi.org/10.1016/j.pharep.2017.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharep.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharep.2017.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DDrugs%252Bwhich%252Binfluence%252Bserotonin%252Btransporter%252Band%252Bserotonergic%252Breceptors%25253A%252BPharmacological%252Band%252Bclinical%252Bproperties%252Bin%252Bthe%252Btreatment%252Bof%252Bdepression%26aulast%3DTaciak%26aufirst%3DPrzemys%25C5%2582aw%2BPawe%25C5%2582%26date%3D2018%26volume%3D70%26issue%3D1%26spage%3D37%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert L.  Findling</span>, <span class="hlFld-ContribAuthor ">Adelaide S.  Robb</span>, <span class="hlFld-ContribAuthor ">Melissa P.  DelBello</span>, <span class="hlFld-ContribAuthor ">Michael  Huss</span>, <span class="hlFld-ContribAuthor ">Nora K.  McNamara</span>, <span class="hlFld-ContribAuthor ">Elias H.  Sarkis</span>, <span class="hlFld-ContribAuthor ">Russell E.  Scheffer</span>, <span class="hlFld-ContribAuthor ">Lis H.  Poulsen</span>, <span class="hlFld-ContribAuthor ">Grace  Chen</span>, <span class="hlFld-ContribAuthor ">Ole M.  Lemming</span>, <span class="hlFld-ContribAuthor ">Philippe  Auby</span>. </span><span class="cited-content_cbyCitation_article-title">A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Child and Adolescent Psychopharmacology</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 47-54. <a href="https://doi.org/10.1089/cap.2017.0047" title="DOI URL">https://doi.org/10.1089/cap.2017.0047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/cap.2017.0047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcap.2017.0047%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Child%2520and%2520Adolescent%2520Psychopharmacology%26atitle%3DA%252B6-Month%252BOpen-Label%252BExtension%252BStudy%252Bof%252BVortioxetine%252Bin%252BPediatric%252BPatients%252Bwith%252BDepressive%252Bor%252BAnxiety%252BDisorders%26aulast%3DFindling%26aufirst%3DRobert%2BL.%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D47%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akira  Nishimura</span>, <span class="hlFld-ContribAuthor ">Yutaka  Aritomi</span>, <span class="hlFld-ContribAuthor ">Kiyofumi  Sasai</span>, <span class="hlFld-ContribAuthor ">Tadayuki  Kitagawa</span>, <span class="hlFld-ContribAuthor ">Atul R.  Mahableshwarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder. </span><span class="cited-content_cbyCitation_journal-name">Psychiatry and Clinical Neurosciences</span><span> <strong>2018,</strong> <em>72 </em>
                                    (2)
                                     , 64-72. <a href="https://doi.org/10.1111/pcn.12565" title="DOI URL">https://doi.org/10.1111/pcn.12565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcn.12565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcn.12565%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatry%2520and%2520Clinical%2520Neurosciences%26atitle%3DRandomized%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%252B8-week%252Btrial%252Bof%252Bthe%252Befficacy%25252C%252Bsafety%25252C%252Band%252Btolerability%252Bof%252B5%25252C%252B10%25252C%252Band%252B20%2525E2%252580%252589mg%25252Fday%252Bvortioxetine%252Bin%252Badults%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%26aulast%3DNishimura%26aufirst%3DAkira%26date%3D2018%26date%3D2017%26volume%3D72%26issue%3D2%26spage%3D64%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Inoue</span>, <span class="hlFld-ContribAuthor ">Akira  Nishimura</span>, <span class="hlFld-ContribAuthor ">Kiyofumi  Sasai</span>, <span class="hlFld-ContribAuthor ">Tadayuki  Kitagawa</span>. </span><span class="cited-content_cbyCitation_article-title">Randomized, 8-week, double-blind, placebo-controlled trial of vortioxetine in Japanese adults with major depressive disorder, followed by a 52-week open-label extension trial. </span><span class="cited-content_cbyCitation_journal-name">Psychiatry and Clinical Neurosciences</span><span> <strong>2018,</strong> <em>72 </em>
                                    (2)
                                     , 103-115. <a href="https://doi.org/10.1111/pcn.12623" title="DOI URL">https://doi.org/10.1111/pcn.12623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/pcn.12623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpcn.12623%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatry%2520and%2520Clinical%2520Neurosciences%26atitle%3DRandomized%25252C%252B8-week%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%252Btrial%252Bof%252Bvortioxetine%252Bin%252BJapanese%252Badults%252Bwith%252Bmajor%252Bdepressive%252Bdisorder%25252C%252Bfollowed%252Bby%252Ba%252B52-week%252Bopen-label%252Bextension%252Btrial%26aulast%3DInoue%26aufirst%3DTakeshi%26date%3D2018%26date%3D2017%26volume%3D72%26issue%3D2%26spage%3D103%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eduard  Vieta</span>, <span class="hlFld-ContribAuthor ">Lasse B.  Sluth</span>, <span class="hlFld-ContribAuthor ">Christina K.  Olsen</span>. </span><span class="cited-content_cbyCitation_article-title">The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram. </span><span class="cited-content_cbyCitation_journal-name">Journal of Affective Disorders</span><span> <strong>2018,</strong> <em>227 </em>, 803-809. <a href="https://doi.org/10.1016/j.jad.2017.11.053" title="DOI URL">https://doi.org/10.1016/j.jad.2017.11.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jad.2017.11.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jad.2017.11.053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Affective%2520Disorders%26atitle%3DThe%252Beffects%252Bof%252Bvortioxetine%252Bon%252Bcognitive%252Bdysfunction%252Bin%252Bpatients%252Bwith%252Binadequate%252Bresponse%252Bto%252Bcurrent%252Bantidepressants%252Bin%252Bmajor%252Bdepressive%252Bdisorder%25253A%252BA%252Bshort-term%25252C%252Brandomized%25252C%252Bdouble-blind%25252C%252Bexploratory%252Bstudy%252Bversus%252Bescitalopram%26aulast%3DVieta%26aufirst%3DEduard%26date%3D2018%26volume%3D227%26spage%3D803%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael Cronquist  Christensen</span>, <span class="hlFld-ContribAuthor ">Henrik  Loft</span>, <span class="hlFld-ContribAuthor ">Roger S.  McIntyre</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Affective Disorders</span><span> <strong>2018,</strong> <em>227 </em>, 787-794. <a href="https://doi.org/10.1016/j.jad.2017.11.081" title="DOI URL">https://doi.org/10.1016/j.jad.2017.11.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jad.2017.11.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jad.2017.11.081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Affective%2520Disorders%26atitle%3DVortioxetine%252Bimproves%252Bsymptomatic%252Band%252Bfunctional%252Boutcomes%252Bin%252Bmajor%252Bdepressive%252Bdisorder%25253A%252BA%252Bnovel%252Bdual%252Boutcome%252Bmeasure%252Bin%252Bdepressive%252Bdisorders%26aulast%3DChristensen%26aufirst%3DMichael%2BCronquist%26date%3D2018%26volume%3D227%26spage%3D787%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sid  Topiol</span>. </span><span class="cited-content_cbyCitation_article-title">Current and Future Challenges in GPCR Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 1-21. <a href="https://doi.org/10.1007/978-1-4939-7465-8_1" title="DOI URL">https://doi.org/10.1007/978-1-4939-7465-8_1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7465-8_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7465-8_1%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252Band%252BFuture%252BChallenges%252Bin%252BGPCR%252BDrug%252BDiscovery%26aulast%3DTopiol%26aufirst%3DSid%26date%3D2018%26date%3D2017%26spage%3D1%26epage%3D21%26pub%3DSpringer%2520New%2520York%26atitle%3DComputational%252BMethods%252Bfor%252BGPCR%252BDrug%252BDiscovery%26aulast%3DHeifetz%26aufirst%3DAlexander%26date%3D2018%26volume%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Cuomo</span>, <span class="hlFld-ContribAuthor ">Arianna  Goracci</span>, <span class="hlFld-ContribAuthor ">Andrea  Fagiolini</span>. </span><span class="cited-content_cbyCitation_article-title">Medication-Associated Sexual Dysfunction in Patients with Mental Illness. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 251-262. <a href="https://doi.org/10.1007/978-3-319-68306-5_21" title="DOI URL">https://doi.org/10.1007/978-3-319-68306-5_21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-68306-5_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-68306-5_21%26sid%3Dliteratum%253Aachs%26atitle%3DMedication-Associated%252BSexual%252BDysfunction%252Bin%252BPatients%252Bwith%252BMental%252BIllness%26aulast%3DCuomo%26aufirst%3DAlessandro%26date%3D2018%26date%3D2018%26spage%3D251%26epage%3D262%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSexual%252BDysfunctions%252Bin%252BMentally%252BIll%252BPatients%26aulast%3DJannini%26aufirst%3DEmmanuele%2BA.%26date%3D2018%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hairong  He</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Lyu</span>, <span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Liyang  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaofang  An</span>, <span class="hlFld-ContribAuthor ">Yajuan  Fan</span>, <span class="hlFld-ContribAuthor ">Xiancang  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy and tolerability of different doses of three new antidepressants for treating major depressive disorder: A PRISMA-compliant meta-analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychiatric Research</span><span> <strong>2018,</strong> <em>96 </em>, 247-259. <a href="https://doi.org/10.1016/j.jpsychires.2017.10.018" title="DOI URL">https://doi.org/10.1016/j.jpsychires.2017.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpsychires.2017.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpsychires.2017.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychiatric%2520Research%26atitle%3DEfficacy%252Band%252Btolerability%252Bof%252Bdifferent%252Bdoses%252Bof%252Bthree%252Bnew%252Bantidepressants%252Bfor%252Btreating%252Bmajor%252Bdepressive%252Bdisorder%25253A%252BA%252BPRISMA-compliant%252Bmeta-analysis%26aulast%3DHe%26aufirst%3DHairong%26date%3D2018%26volume%3D96%26spage%3D247%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estela  Salagre</span>, <span class="hlFld-ContribAuthor ">Iria  Grande</span>, <span class="hlFld-ContribAuthor ">Brisa  Solé</span>, <span class="hlFld-ContribAuthor ">Jose  Sanchez-Moreno</span>, <span class="hlFld-ContribAuthor ">Eduard  Vieta</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetina: una nueva alternativa en el trastorno depresivo mayor. </span><span class="cited-content_cbyCitation_journal-name">Revista de Psiquiatría y Salud Mental</span><span> <strong>2018,</strong> <em>11 </em>
                                    (1)
                                     , 48-59. <a href="https://doi.org/10.1016/j.rpsm.2017.06.006" title="DOI URL">https://doi.org/10.1016/j.rpsm.2017.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.rpsm.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.rpsm.2017.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DRevista%2520de%2520Psiquiatr%25C3%25ADa%2520y%2520Salud%2520Mental%26atitle%3DVortioxetina%25253A%252Buna%252Bnueva%252Balternativa%252Ben%252Bel%252Btrastorno%252Bdepresivo%252Bmayor%26aulast%3DSalagre%26aufirst%3DEstela%26date%3D2018%26volume%3D11%26issue%3D1%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estela  Salagre</span>, <span class="hlFld-ContribAuthor ">Iria  Grande</span>, <span class="hlFld-ContribAuthor ">Brisa  Solé</span>, <span class="hlFld-ContribAuthor ">Jose  Sanchez-Moreno</span>, <span class="hlFld-ContribAuthor ">Eduard  Vieta</span>. </span><span class="cited-content_cbyCitation_article-title">Vortioxetine: A new alternative for the treatment of major depressive disorder. </span><span class="cited-content_cbyCitation_journal-name">Revista de Psiquiatría y Salud Mental (English Edition)</span><span> <strong>2018,</strong> <em>11 </em>
                                    (1)
                                     , 48-59. <a href="https://doi.org/10.1016/j.rpsmen.2018.02.005" title="DOI URL">https://doi.org/10.1016/j.rpsmen.2018.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.rpsmen.2018.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.rpsmen.2018.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DRevista%2520de%2520Psiquiatr%25C3%25ADa%2520y%2520Salud%2520Mental%2520%2528English%2520Edition%2529%26atitle%3DVortioxetine%25253A%252BA%252Bnew%252Balternative%252Bfor%252Bthe%252Btreatment%252Bof%252Bmajor%252Bdepressive%252Bdisorder%26aulast%3DSalagre%26aufirst%3DEstela%26date%3D2018%26volume%3D11%26issue%3D1%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei  Qin</span>, <span class="hlFld-ContribAuthor ">Hong-qun  Qiao</span>, <span class="hlFld-ContribAuthor ">Yan-juan  Yuan</span>, <span class="hlFld-ContribAuthor ">Qing  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">A quantitative LC-MS/MS method for simultaneous determination of deuvortioxetine, vortioxetine and their carboxylic acid metabolite in rat plasma, and its application to a toxicokinetic study. </span><span class="cited-content_cbyCitation_journal-name">Analytical Methods</span><span> <strong>2018,</strong> <em>10 </em>
                                    (9)
                                     , 1023-1031. <a href="https://doi.org/10.1039/C7AY02642K" title="DOI URL">https://doi.org/10.1039/C7AY02642K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7AY02642K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7AY02642K%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Methods%26atitle%3DA%252Bquantitative%252BLC-MS%25252FMS%252Bmethod%252Bfor%252Bsimultaneous%252Bdetermination%252Bof%252Bdeuvortioxetine%25252C%252Bvortioxetine%252Band%252Btheir%252Bcarboxylic%252Bacid%252Bmetabolite%252Bin%252Brat%252Bplasma%25252C%252Band%252Bits%252Bapplication%252Bto%252Ba%252Btoxicokinetic%252Bstudy%26aulast%3DQin%26aufirst%3DMei%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D9%26spage%3D1023%26epage%3D1031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Kucwaj-Brysz</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Ewa  Żesławska</span>, <span class="hlFld-ContribAuthor ">Annamaria  Lubelska</span>, <span class="hlFld-ContribAuthor ">Małgorzata Anna  Marć</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Wojciech  Nitek</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kieć-Kononowicz</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Handzlik</span>. </span><span class="cited-content_cbyCitation_article-title">The role of aryl-topology in balancing between selective and dual 5-HT
              7
              R/5-HT
              1A
              actions of 3,5-substituted hydantoins. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 1033-1044. <a href="https://doi.org/10.1039/C8MD00168E" title="DOI URL">https://doi.org/10.1039/C8MD00168E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00168E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00168E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DThe%252Brole%252Bof%252Baryl-topology%252Bin%252Bbalancing%252Bbetween%252Bselective%252Band%252Bdual%252B5-HT%252B7%252BR%25252F5-HT%252B1A%252Bactions%252Bof%252B3%25252C5-substituted%252Bhydantoins%26aulast%3DKucwaj-Brysz%26aufirst%3DKatarzyna%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D6%26spage%3D1033%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Ebrahimzadeh</span>, <span class="hlFld-ContribAuthor ">Mostafa  El Mansari</span>, <span class="hlFld-ContribAuthor ">Pierre  Blier</span>. </span><span class="cited-content_cbyCitation_article-title">Partial inhibition of catecholamine activity and enhanced responsiveness to NMDA after sustained administration of vortioxetine. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2018,</strong> <em>128 </em>, 425-432. <a href="https://doi.org/10.1016/j.neuropharm.2017.10.036" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2017.10.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2017.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2017.10.036%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPartial%252Binhibition%252Bof%252Bcatecholamine%252Bactivity%252Band%252Benhanced%252Bresponsiveness%252Bto%252BNMDA%252Bafter%252Bsustained%252Badministration%252Bof%252Bvortioxetine%26aulast%3DEbrahimzadeh%26aufirst%3DMohammad%26date%3D2018%26volume%3D128%26spage%3D425%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica A.  Waller</span>, <span class="hlFld-ContribAuthor ">Sara Holm  Nygaard</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Kristian Gaarn  du Jardin</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Tamm</span>, <span class="hlFld-ContribAuthor ">Aicha  Abdourahman</span>, <span class="hlFld-ContribAuthor ">Betina  Elfving</span>, <span class="hlFld-ContribAuthor ">Alan L.  Pehrson</span>, <span class="hlFld-ContribAuthor ">Connie  Sánchez</span>, <span class="hlFld-ContribAuthor ">Rasmus  Wernersson</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents. </span><span class="cited-content_cbyCitation_journal-name">BMC Neuroscience</span><span> <strong>2017,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12868-017-0376-x" title="DOI URL">https://doi.org/10.1186/s12868-017-0376-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12868-017-0376-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12868-017-0376-x%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Neuroscience%26atitle%3DNeuroplasticity%252Bpathways%252Band%252Bprotein-interaction%252Bnetworks%252Bare%252Bmodulated%252Bby%252Bvortioxetine%252Bin%252Brodents%26aulast%3DWaller%26aufirst%3DJessica%2BA.%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm101459g&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm101459g%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=255&amp;pagesCount=3&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0014.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of citalopram (<b>1</b>), buspirone (<b>2</b>), ondansetron (<b>3</b>), target compounds (<b>4-6</b>) and <b>5m</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Target Compounds by Method A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0013.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Target Compounds by Method B</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Calculated relationships between the occupancy levels at 5-HT<sub>1A</sub> or 5-HT<sub>3</sub> receptors relative to serotonin (5-HT) transporter (SERT) occupancy. The line with circles (−●−) shows the relationship between the occupancies if the ratio between the SERT and 5-HT<sub>1A</sub> or 5-HT<sub>3</sub> is 1. The line with triangles (−▲−) shows the relationship when the ratio is 5, and the line with squares (−◼−) shows the relationship when the ratio is 15; i.e., a compound with occupancy of 80% at SERT would give occupancy of 45% at 5-HT<sub>1A</sub> receptors if the affinity at 5-HT<sub>1A</sub> receptors is 5-fold lower than at SERT, whereas only 20% occupancy would be obtained if the 5-HT<sub>1A</sub> receptors affinity is 15-fold lower than at SERT. The two hatched areas depict estimated clinically relevant occupancy levels at 5-HT<sub>1A</sub> and 5-HT<sub>3</sub> receptors based on these considerations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>5m</b> and ondansetron (<b>3</b>) were tested for antagonistic effects on human (h) and rat (r) 5-HT<sub>3A</sub> receptors expressed in oocytes. Compound <b>5m</b> inhibited the h5-HT<sub>3A</sub> and r5-HT<sub>3A</sub> receptors with IC<sub>50</sub> equal to 12 and 0.18 nM, respectively. Ondansetron (<b>3</b>) showed similar inhibition of both h5-HT<sub>3A</sub> and r5-HT<sub>3A</sub> receptors with IC<sub>50</sub> ≈ 0.1 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>5m</b> displayed an agonistic response on human (h) 5-HT<sub>3A</sub> receptors (arrowhead) but not on rat (r) 5-HT<sub>3A</sub> receptors (arrow). At h5-HT<sub>3A</sub> receptors, <b>5m</b> had an EC<sub>50</sub> of 2100 nM, reaching a maximal response of 64% compared with the maximal response with 5-HT. Note that after only one application of <b>5m</b> for 30 s, the subsequent application of either <b>5m</b> or 5-HT (10 μM) did not induce any response at all, indicating that <b>5m</b> induces functional antagonism. That means that it is only possible to test one concentration of <b>5m</b> on each oocyte, so the agonism dose-reponse curves for <b>5m</b> has been obtained from a test of each single concentration of <b>5m</b> using three to six separate oocytes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose relationship depicting potency and intrinsic activity (IA) of <b>5m</b>, buspirone, and 5-OH DPAT in a [<sup>35</sup>S]guanosine 5′-<i>O</i>-(3-thio)triphosphate ([<sup>35</sup>S]GTPγS) binding assay in CHO membranes expressing h5-HT<sub>1A</sub> receptors. IA<sub>max</sub> was defined by 5-HT binding. Raw data were obtained by MDS Pharmaservices and were then analyzed by sigmoidal dose response curve-fittings using GraphPad Prism 4 to generate EC<sub>50</sub> and intrinsic activity (IA) results. Data shown in the graph were averaged from <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of administration of <b>5m</b> (2.5, 5, and 10 mg/kg) or vehicle subcutaneous on extracellular 5-HT levels in the rat ventral hippocampus. Data are expressed as the mean ± SEM. There was a dose and time-dependent increase in extracellular 5-HT following drug administration [<i>F</i>(27,159) = 7.081; <i>P</i> < 0.001]. Extracellular concentrations of 5-HT were significantly increased relative to baseline from <i>t</i> = 60 until <i>t</i> = 120 min after administration of 2.5 mg/kg <b>5m</b> and from <i>t</i> = 40 until <i>t</i> = 180 min after 5 or 10 mg/kg <b>5m</b> (<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/medium/jm-2010-01459g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of 3-day treatment with vehicle or <b>5m</b> (5 or 10 mg/kg sc) on extracellular 5-HT levels in the rat medial prefrontal cortex (mPFC) and SERT occupancy. Data are expressed as the mean ± SEM. Three days of treatment with <b>5m</b> (5 or 10 (mg/kg)/day) resulted in significantly higher basal levels of 5-HT in the mPFC compared to animals treated with vehicle (<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm101459g/production/images/large/jm-2010-01459g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101459g&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, E. E.</span><span> </span><span class="NLM_article-title">Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1001%2Farchpsyc.62.6.593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15939837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ptlSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2005&pages=593-602&author=R.+C.+Kesslerauthor=P.+Berglundauthor=O.+Demlerauthor=R.+Jinauthor=K.+R.+Merikangasauthor=E.+E.+Walters&title=Lifetime+prevalence+and+age-of-onset+distributions+of+DSM-IV+disorders+in+the+National+Comorbidity+Survey+Replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication</span></div><div class="casAuthors">Kessler Ronald C; Berglund Patricia; Demler Olga; Jin Robert; Merikangas Kathleen R; Walters Ellen E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">593-602</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">CONTEXT:  Little is known about lifetime prevalence or age of onset of DSM-IV disorders.  OBJECTIVE:  To estimate lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the recently completed National Comorbidity Survey Replication.  DESIGN AND SETTING:  Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using the fully structured World Health Organization World Mental Health Survey version of the Composite International Diagnostic Interview.  PARTICIPANTS:  Nine thousand two hundred eighty-two English-speaking respondents aged 18 years and older.  MAIN OUTCOME MEASURES:  Lifetime DSM-IV anxiety, mood, impulse-control, and substance use disorders.  RESULTS:  Lifetime prevalence estimates are as follows: anxiety disorders, 28.8%; mood disorders, 20.8%; impulse-control disorders, 24.8%; substance use disorders, 14.6%; any disorder, 46.4%.  Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders.  Half of all lifetime cases start by age 14 years and three fourths by age 24 years.  Later onsets are mostly of comorbid conditions, with estimated lifetime risk of any disorder at age 75 years (50.8%) only slightly higher than observed lifetime prevalence (46.4%).  Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.  CONCLUSIONS:  About half of Americans will meet the criteria for a DSM-IV disorder sometime in their life, with first onset usually in childhood or adolescence.  Interventions aimed at prevention or early treatment need to focus on youth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG4lFrjFq_mTdblLE_E9PWfW6udTcc2eZKCoBArlLumLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ptlSqtQ%253D%253D&md5=79d6630df98f374c22ebe3965880ec4d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.62.6.593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.62.6.593%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DBerglund%26aufirst%3DP.%26aulast%3DDemler%26aufirst%3DO.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DWalters%26aufirst%3DE.%2BE.%26atitle%3DLifetime%2520prevalence%2520and%2520age-of-onset%2520distributions%2520of%2520DSM-IV%2520disorders%2520in%2520the%2520National%2520Comorbidity%2520Survey%2520Replication%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2005%26volume%3D62%26spage%3D593%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Murray, C. J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. D.</span><span> </span><span class="NLM_article-title">Evidence-based health policy: lessons from the Global Burden of Disease Study</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">740</span><span class="NLM_x">–</span> <span class="NLM_lpage">743</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=740-743&author=C.+J.+L.+Murrayauthor=A.+D.+Lopez&title=Evidence-based+health+policy%3A+lessons+from+the+Global+Burden+of+Disease+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26atitle%3DEvidence-based%2520health%2520policy%253A%2520lessons%2520from%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D740%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Bauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montejo, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dantchev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demyttenaere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Cebrian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grassi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perahia, D. G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tylee, A.</span><span> </span><span class="NLM_article-title">Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study</span> <span class="citation_source-journal">Eur. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.eurpsy.2007.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=18164600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1c7nsVOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=66-73&author=M.+Bauerauthor=B.+U.+Monzauthor=A.+L.+Montejoauthor=D.+Quailauthor=N.+Dantchevauthor=K.+Demyttenaereauthor=A.+Garcia-Cebrianauthor=L.+Grassiauthor=D.+G.+S.+Perahiaauthor=C.+Reedauthor=A.+Tylee&title=Prescribing+patterns+of+antidepressants+in+Europe%3A+results+from+the+Factors+Influencing+Depression+Endpoints+Research+%28FINDER%29+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study</span></div><div class="casAuthors">Bauer Michael; Monz Brigitta U; Montejo Angel L; Quail Deborah; Dantchev Nicolas; Demyttenaere Koen; Garcia-Cebrian Ana; Grassi Luigi; Perahia David G S; Reed Catherine; Tylee Andre</div><div class="citationInfo"><span class="NLM_cas:title">European psychiatry : the journal of the Association of European Psychiatrists</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">66-73</span>
        ISSN:<span class="NLM_cas:issn">0924-9338</span>.
    </div><div class="casAbstract">Antidepressant prescribing patterns and factors influencing the choice of antidepressant for the treatment of depression were examined in the Factors Influencing Depression Endpoints Research (FINDER) study, a prospective, observational study in 12 European countries of 3468 adults about to start antidepressant medication for their first episode of depression or a new episode of recurrent depression.  Selective serotonin reuptake inhibitors (SSRIs) were the most commonly prescribed antidepressant (63.3% patients), followed by serotonin-norepinephrine reuptake inhibitors (SNRIs, 13.6%), but there was considerable variation across countries.  Notably, tricyclic and tetracyclic antidepressants (TCAs) were prescribed for 26.5% patients in Germany.  The choice of the antidepressant prescribed was strongly influenced by the previous use of antidepressants, which was significantly associated with the prescription of a SSRI (OR 0.64; 95% CI 0.54, 0.76), a SNRI (OR 1.49; 95% CI 1.18, 1.88) or a combination of antidepressants (OR 2.78; 95% CI 1.96, 3.96).  Physician factors (age, gender, speciality) and patient factors (severity of depression, age, education, smoking, number of current physical conditions and functional syndromes) were associated with initial antidepressant choice in some models.  In conclusion, the prescribing of antidepressants varies by country, and the type of antidepressant chosen is influenced by physician- as well as patient-related factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfvr0P35AyhU2yPDyEFiigfW6udTcc2eZMDDpl7Lv7ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7nsVOhsQ%253D%253D&md5=75d04868ebb5158193257bcb3e4ea592</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.eurpsy.2007.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eurpsy.2007.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DM.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DMontejo%26aufirst%3DA.%2BL.%26aulast%3DQuail%26aufirst%3DD.%26aulast%3DDantchev%26aufirst%3DN.%26aulast%3DDemyttenaere%26aufirst%3DK.%26aulast%3DGarcia-Cebrian%26aufirst%3DA.%26aulast%3DGrassi%26aufirst%3DL.%26aulast%3DPerahia%26aufirst%3DD.%2BG.%2BS.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DTylee%26aufirst%3DA.%26atitle%3DPrescribing%2520patterns%2520of%2520antidepressants%2520in%2520Europe%253A%2520results%2520from%2520the%2520Factors%2520Influencing%2520Depression%2520Endpoints%2520Research%2520%2528FINDER%2529%2520study%26jtitle%3DEur.%2520Psychiatry%26date%3D2008%26volume%3D23%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khawaja, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajarao, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malberg, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Differentiating antidepressants of the future: efficacy and safety</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.pharmthera.2006.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17010443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=134-153&author=S.+Rosenzweig-Lipsonauthor=C.+E.+Beyerauthor=Z.+A.+Hughesauthor=X.+Khawajaauthor=S.+J.+Rajaraoauthor=J.+E.+Malbergauthor=Z.+Rahmanauthor=R.+H.+Ringauthor=L.+E.+Schechter&title=Differentiating+antidepressants+of+the+future%3A+efficacy+and+safety"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating antidepressants of the future: Efficacy and safety</span></div><div class="casAuthors">Rosenzweig-Lipson, Sharon; Beyer, Chad E.; Hughes, Zoe A.; Khawaja, Xavier; Rajarao, Somana J.; Malberg, Jessica E.; Rahman, Zia; Ring, Robert H.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-153</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There have been significant advances in the treatment of depression since the serendipitous discovery that modulating monoaminergic neurotransmission may be a pathol. underpinning of the disease.  Despite these advances, particularly over the last 15 years with the introduction of selective serotonin and/or norepinephrine reuptake inhibitors (SNRI), there still remain multiple unmet clin. needs that would represent substantial improvements to current treatment regimens.  In terms of efficacy there have been improvements in the percentage of patients achieving remission but this can still be dramatically improved and, in fact, issues still remain with relapse.  Furthermore, advances are still required in terms of improving the onset of efficacy as well as addressing the large proportion of patients who remain treatment resistant.  While this is not well understood, collective research in the area suggests the disease is heterogeneous in terms of the multiple parameters related to etiol., pathol. and response to pharmacol. agents.  In addn. to efficacy further therapeutic advances will also need to address such issues as cognitive impairment, pain, sexual dysfunction, nausea and emesis, wt. gain and potential cardiovascular effects.  With these unmet needs in mind, the next generation of antidepressants will need to differentiate themselves from the current array of therapeutics for depression.  There are multiple strategies for addressing unmet needs that are currently being investigated.  These range from combination monoaminergic approaches to subtype selective agents to novel targets that include mechanisms to modulate neuropeptides and excitatory amino acids (EAA).  This review will discuss the many facets of differentiation and potential strategies for the development of novel antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKfWRF69kPI7Vg90H21EOLACvtfcHk0lizqmeKr5z6_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCktQ%253D%253D&md5=a5cd4a022dd082dcaffc4dfe360660ca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DKhawaja%26aufirst%3DX.%26aulast%3DRajarao%26aufirst%3DS.%2BJ.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DDifferentiating%2520antidepressants%2520of%2520the%2520future%253A%2520efficacy%2520and%2520safety%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D134%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Papakostas, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, R. C.</span><span> </span><span class="NLM_article-title">Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2Fj.biopsych.2007.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17588546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ymu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2007&pages=1217-1227&author=G.+I.+Papakostasauthor=M.+E.+Thaseauthor=M.+Favaauthor=J.+C.+Nelsonauthor=R.+C.+Shelton&title=Are+antidepressant+drugs+that+combine+serotonergic+and+noradrenergic+mechanisms+of+action+more+effective+than+the+selective+serotonin+reuptake+inhibitors+in+treating+major+depressive+disorder%3F+A+meta-analysis+of+studies+of+newer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents</span></div><div class="casAuthors">Papakostas, George I.; Thase, Michael E.; Fava, Maurizio; Nelson, J. Craig; Shelton, Richard C.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1217-1227</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Recent studies suggest that the treatment of major depressive disorder (MDD) with newer antidepressant drugs that simultaneously enhance norepinephrine and serotonin neurotransmission might result in higher response and remission rates than the selective serotonin reuptake inhibitors (SSRIs).  The goal of our work was to compare response rates among patients with MDD treated with either of these two broad categories of antidepressant drugs.  Methods: Medline/Pubmed, EMBase, clin. trial registries, program syllabi from major psychiatric meetings held since 1995, and documents from relevant pharmaceutical companies were searched for double-blind, randomized trials comparing a newer serotonergic-noradrenergic antidepressant drug (venlafaxine, duloxetine, milnacipran, mirtazapine, mianserin, or moclobemide) with an SSRI for MDD.  Results: Ninety-three trials (n = 17,036) were combined using a random-effects model.  Treatment with serotonergic + noradrenergic antidepressant drugs was more likely to result in clin. response than the SSRIs (risk ratio [RR] = 1.059; response rates 63.6% vs. 59.3%; p = .003).  There was no evidence for heterogeneity among studies combined (p = 1.0).  Excluding each individual agent did not significantly alter the pooled RR.  With the exception of duloxetine (.985), RRs for response for each individual serotonergic + noradrenergic antidepressant drug were within the 95% confidence interval of the pooled RR (1.019-1.101).  Conclusions: Serotonergic-noradrenergic antidepressant drugs seem to have a modest efficacy advantage compared with SSRIs in MDD.  With the No. Needed to Treat (NNT) statistic as one indicator of clin. significance, nearly 24 patients would need to be treated with dual-action antidepressant drugs instead of SSRIs in order to obtain one addnl. responder.  This difference falls well below the mark of NNT = 10 suggested by the United Kingdom's National Institute of Clin. Excellence but nonetheless might be of public health relevance given the large no. of depressed patients treated with SSRI /serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant drugs.  Further research is needed to examine whether larger differences between classes of antidepressant drugs might exist in specific MDD sub-populations or for specific MDD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFTcv5V6MlT7Vg90H21EOLACvtfcHk0ljuW6eZHzfWRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ymu7jI&md5=4c4bd9fe021e6fab91cb3a18b779c4e5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2007.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2007.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DPapakostas%26aufirst%3DG.%2BI.%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DFava%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DJ.%2BC.%26aulast%3DShelton%26aufirst%3DR.%2BC.%26atitle%3DAre%2520antidepressant%2520drugs%2520that%2520combine%2520serotonergic%2520and%2520noradrenergic%2520mechanisms%2520of%2520action%2520more%2520effective%2520than%2520the%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520in%2520treating%2520major%2520depressive%2520disorder%253F%2520A%2520meta-analysis%2520of%2520studies%2520of%2520newer%2520agents%26jtitle%3DBiol.%2520Psychiatry%26date%3D2007%26volume%3D62%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Trivedi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nierenberg, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warden, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norquist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howland, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebowitz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shores-Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasubramani, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span> </span><span class="NLM_article-title">Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fappi.ajp.163.1.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16390886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FgsVaksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2006&pages=28-40&author=M.+H.+Trivediauthor=A.+J.+Rushauthor=S.+R.+Wisniewskiauthor=A.+A.+Nierenbergauthor=D.+Wardenauthor=L.+Ritzauthor=G.+Norquistauthor=R.+H.+Howlandauthor=B.+Lebowitzauthor=P.+J.+McGrathauthor=K.+Shores-Wilsonauthor=M.+M.+Biggsauthor=G.+K.+Balasubramaniauthor=M.+Fava&title=Evaluation+of+outcomes+with+citalopram+for+depression+using+measurement-based+care+in+STAR*D%3A+implications+for+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice</span></div><div class="casAuthors">Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Warden Diane; Ritz Louise; Norquist Grayson; Howland Robert H; Lebowitz Barry; McGrath Patrick J; Shores-Wilson Kathy; Biggs Melanie M; Balasubramani G K; Fava Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-40</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat depression, but the rates, timing, and baseline predictors of remission in "real world" patients are not established.  The authors' primary objectives in this study were to evaluate the effectiveness of citalopram, an SSRI, using measurement-based care in actual practice, and to identify predictors of symptom remission in outpatients with major depressive disorder.  METHOD:  This clinical study included outpatients with major depressive disorder who were treated in 23 psychiatric and 18 primary care "real world" settings.  The patients received flexible doses of citalopram prescribed by clinicians for up to 14 weeks.  The clinicians were assisted by a clinical research coordinator in the application of measurement-based care, which included the routine measurement of symptoms and side effects at each treatment visit and the use of a treatment manual that described when and how to modify medication doses based on these measures.  Remission was defined as an exit score of <or=7 on the 17-item Hamilton Depression Rating Scale (HAM-D) (primary outcome) or a score of <or=5 on the 16-item Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR) (secondary outcome).  Response was defined as a reduction of >or=50% in baseline QIDS-SR score.  RESULTS:  Nearly 80% of the 2,876 outpatients in the analyzed sample had chronic or recurrent major depression; most also had a number of comorbid general medical and psychiatric conditions.  The mean exit citalopram dose was 41.8 mg/day.  Remission rates were 28% (HAM-D) and 33% (QIDS-SR).  The response rate was 47% (QIDS-SR).  Patients in primary and psychiatric care settings did not differ in remission or response rates.  A substantial portion of participants who achieved either response or remission at study exit did so at or after 8 weeks of treatment.  Participants who were Caucasian, female, employed, or had higher levels of education or income had higher HAM-D remission rates; longer index episodes, more concurrent psychiatric disorders (especially anxiety disorders or drug abuse), more general medical disorders, and lower baseline function and quality of life were associated with lower HAM-D remission rates.  CONCLUSIONS:  The response and remission rates in this highly generalizable sample with substantial axis I and axis III comorbidity closely resemble those seen in 8-week efficacy trials.  The systematic use of easily implemented measurement-based care procedures may have assisted in achieving these results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0p9Gt0lootWx8TEN9K18QfW6udTcc2eaiDt5DQtdaW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FgsVaksA%253D%253D&md5=818ae4f8032b21462aa63c14942a0942</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.163.1.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.163.1.28%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DM.%2BH.%26aulast%3DRush%26aufirst%3DA.%2BJ.%26aulast%3DWisniewski%26aufirst%3DS.%2BR.%26aulast%3DNierenberg%26aufirst%3DA.%2BA.%26aulast%3DWarden%26aufirst%3DD.%26aulast%3DRitz%26aufirst%3DL.%26aulast%3DNorquist%26aufirst%3DG.%26aulast%3DHowland%26aufirst%3DR.%2BH.%26aulast%3DLebowitz%26aufirst%3DB.%26aulast%3DMcGrath%26aufirst%3DP.%2BJ.%26aulast%3DShores-Wilson%26aufirst%3DK.%26aulast%3DBiggs%26aufirst%3DM.%2BM.%26aulast%3DBalasubramani%26aufirst%3DG.%2BK.%26aulast%3DFava%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520outcomes%2520with%2520citalopram%2520for%2520depression%2520using%2520measurement-based%2520care%2520in%2520STAR%252AD%253A%2520implications%2520for%2520clinical%2520practice%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2006%26volume%3D163%26spage%3D28%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Moltzen, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span> </span><span class="NLM_article-title">Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century—a medicinal chemistry survey</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.2174%2F156802606778249810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17017959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVClurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1801-1823&author=E.+K.+Moltzenauthor=B.+Bang-Andersen&title=Serotonin+reuptake+inhibitors%3A+the+corner+stone+in+treatment+of+depression+for+half+a+century%E2%80%94a+medicinal+chemistry+survey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century - a medicinal chemistry survey</span></div><div class="casAuthors">Moltzen, Ejner K.; Bang-Andersen, Benny</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1801-1823</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Inhibition of serotonin (5-HT) reuptake has been a central theme in the therapy of depression for half a century.  Through the years these therapies have improved, particularly with regard to side effects, and today's selective serotonin reuptake inhibitors (SSRIs) constitute a reasonably effective offer for the patients.  However, there is still room for major improvement and considering that almost 20% of the population in the western world will experience a depressive period in their lifetime, there is a large need for improved therapies.  A large spectrum of targets and strategies are currently being pursued, but so far none of these new approaches have been successful, mainly due to lack of a deeper understanding of the disease biol.  Since inhibition of 5-HT reuptake ensures a certain degree of antidepressant efficacy, there has been a large interest in various combinations with serotonin reuptake inhibitors (SRIs) in order to improve on the shortcomings of treatment with SSRIs.  Some of these approaches have resulted in marketed antidepressants, e.g., combinations of SRI with norepinephrine (NE) reuptake inhibition, whereas other approaches are still at an exptl. stage.  This review attempts to present the current status of these add-on/combination approaches with particular focus on the medicinal chem. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjBrSvGISmFbVg90H21EOLACvtfcHk0lgiE8Z7agOslg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVClurjL&md5=2699173808138c2c85f8712992ab9afe</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F156802606778249810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606778249810%26sid%3Dliteratum%253Aachs%26aulast%3DMoltzen%26aufirst%3DE.%2BK.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DSerotonin%2520reuptake%2520inhibitors%253A%2520the%2520corner%2520stone%2520in%2520treatment%2520of%2520depression%2520for%2520half%2520a%2520century%25E2%2580%2594a%2520medicinal%2520chemistry%2520survey%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1801%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mathew, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Novel drugs and therapeutic targets for severe mood disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2080</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=2080-2092&author=S.+J.+Mathewauthor=H.+K.+Manjiauthor=D.+S.+Charney&title=Novel+drugs+and+therapeutic+targets+for+severe+mood+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathew%26aufirst%3DS.%2BJ.%26aulast%3DManji%26aufirst%3DH.%2BK.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520drugs%2520and%2520therapeutic%2520targets%2520for%2520severe%2520mood%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D2080%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span> </span><span class="NLM_article-title">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1001%2Farchpsyc.1994.03950030084009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8122960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=248-251&author=F.+Artigasauthor=V.+Perezauthor=E.+Alvarez&title=Pindolol+induces+a+rapid+improvement+of+depressed+patients+treated+with+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors</span></div><div class="casAuthors">Artigas F; Perez V; Alvarez E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-51</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8elF--uOnsj69zv1FsJFMfW6udTcc2eYItmrj6Ka0e7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7mvVGitw%253D%253D&md5=19dc44e630d37442b5707cc26daa4a90</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030084009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030084009%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DV.%26aulast%3DAlvarez%26aufirst%3DE.%26atitle%3DPindolol%2520induces%2520a%2520rapid%2520improvement%2520of%2520depressed%2520patients%2520treated%2520with%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D248%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Artigas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celada, P.</span><span> </span><span class="NLM_article-title">Pindolol augmentation of antidepressant response</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.2174%2F138945006775515446" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16475955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1Ghsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=139-147&author=F.+Artigasauthor=A.+Adellauthor=P.+Celada&title=Pindolol+augmentation+of+antidepressant+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pindolol augmentation of antidepressant response</span></div><div class="casAuthors">Artigas, Francesc; Adell, Albert; Celada, Pau</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Pindolol, a partial β-adrenoceptor/5-HT1A receptor antagonist was first used to accelerate the onset of action of antidepressant drugs in 1994.  Since then, it has been used in more than a dozen controlled trials to examine whether it can reduce the lag to clin. improvement, and/or improve the clin. response in treatment-resistant patients.  A recent metaanal. concluded that pindolol accelerates the antidepressant response but does not increase the effectiveness of SSRIs in unresponsive patients.  Several studies have examd. the pharmacol. of pindolol to clarify the neurobiol. basis of its clin. action.  Pindolol was initially used due to its ability to block 5-HT1A receptor-mediated responses and to enhance the neurochem. effects of SSRIs.  In transfected cells, however, pindolol is a weak (20-25%) partial agonist at 5-HT1A receptors and, as such, its actions greatly depend on the system used.  In line with this, other reports have also shown that pindolol can reduce serotonergic cell firing when given alone.  Positron emission tomog. (PET) scan studies have shown that pindolol displays a preferential occupancy of pre- vs. postsynaptic 5-HT1A receptors, although the overall occupancy is lower than desirable, which suggests that higher doses (e.g., 15 mg/day) may be more effective than the currently used 7.5 mg daily dosage.  However, given the complex pharmacol. of pindolol, it is hoped that new developments in this field can proceed through the use of (a) selective and silent 5-HT1A receptor antagonists in combination with SSRIs, or (b) dual action agents (SSRI + 5-HT1A receptor blockers).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnn4ribHJkybVg90H21EOLACvtfcHk0lgl4nL1RhdMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1Ghsrw%253D&md5=abcdcbeb45be139d18db5b08342e0848</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F138945006775515446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006775515446%26sid%3Dliteratum%253Aachs%26aulast%3DArtigas%26aufirst%3DF.%26aulast%3DAdell%26aufirst%3DA.%26aulast%3DCelada%26aufirst%3DP.%26atitle%3DPindolol%2520augmentation%2520of%2520antidepressant%2520response%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lgl4nL1RhdMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs</span> <span class="citation_source-journal">Neurotherapeutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=53-77&author=M.+J.+Millan&title=Dual-+and+triple-acting+agents+for+treating+core+and+co-morbid+symptoms+of+major+depression%3A+novel+concepts%2C+new+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DDual-%2520and%2520triple-acting%2520agents%2520for%2520treating%2520core%2520and%2520co-morbid%2520symptoms%2520of%2520major%2520depression%253A%2520novel%2520concepts%252C%2520new%2520drugs%26jtitle%3DNeurotherapeutics%26date%3D2009%26volume%3D6%26spage%3D53%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cremers, T. I. F. H.; Wikström, H. V.; Den Boer, J. A.; Bosker, F. J.; Westerink, B. H.; Bøgesø, K. P.; Hogg, S.</span><span> </span><span class="NLM_article-title">The Combination of a Serotonin Reuptake Inhibitor and a 5-HT<sub>2C</sub> Antagonist, Inverse Agonist or Partial Agonist</span>. WO 200141701 (A2),<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=T.+I.+F.+H.+Cremers&author=H.+V.+Wikstr%C3%B6m&author=J.+A.+Den+Boer&author=F.+J.+Bosker&author=B.+H.+Westerink&author=K.+P.+B%C3%B8ges%C3%B8&author=S.+Hogg&title=The+Combination+of+a+Serotonin+Reuptake+Inhibitor+and+a+5-HT2C+Antagonist%2C+Inverse+Agonist+or+Partial+Agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCremers%26aufirst%3DT.%2BI.%2BF.%2BH.%26atitle%3DThe%2520Combination%2520of%2520a%2520Serotonin%2520Reuptake%2520Inhibitor%2520and%2520a%25205-HT2C%2520Antagonist%252C%2520Inverse%2520Agonist%2520or%2520Partial%2520Agonist%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cremers, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosker, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bøgesø, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerink, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">den Boer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span> </span><span class="NLM_article-title">Inactivation of 5-HT<sub>2C</sub> receptors potentiates consequences of serotonin reuptake blockade</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1782</span><span class="NLM_x">–</span> <span class="NLM_lpage">1789</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1782-1789&author=T.+I.+Cremersauthor=M.+Giorgettiauthor=F.+J.+Boskerauthor=S.+Hoggauthor=J.+Arntauthor=A.+M%C3%B8rkauthor=G.+Honigauthor=K.+P.+B%C3%B8ges%C3%B8author=B.+H.+Westerinkauthor=H.+den+Boerauthor=H.+V.+Wikstr%C3%B6mauthor=L.+H.+Tecott&title=Inactivation+of+5-HT2C+receptors+potentiates+consequences+of+serotonin+reuptake+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCremers%26aufirst%3DT.%2BI.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DBosker%26aufirst%3DF.%2BJ.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DArnt%26aufirst%3DJ.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DHonig%26aufirst%3DG.%26aulast%3DB%25C3%25B8ges%25C3%25B8%26aufirst%3DK.%2BP.%26aulast%3DWesterink%26aufirst%3DB.%2BH.%26aulast%3Dden%2BBoer%26aufirst%3DH.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%2BV.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26atitle%3DInactivation%2520of%25205-HT2C%2520receptors%2520potentiates%2520consequences%2520of%2520serotonin%2520reuptake%2520blockade%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1782%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nutt, D. J.</span><span> </span><span class="NLM_article-title">Beyond psychoanaleptics—can we improve antidepressant drug nomenclature?</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1177%2F0269881109105498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=19433474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1MzjslKjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=343-345&author=D.+J.+Nutt&title=Beyond+psychoanaleptics%E2%80%94can+we+improve+antidepressant+drug+nomenclature%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?</span></div><div class="casAuthors">Nutt D J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychopharmacology (Oxford, England)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-5</span>
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwhiAlcDLSF_IW7hznt0zpfW6udTcc2eZYs6Y5FKphcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzjslKjtQ%253D%253D&md5=b252fd880909f98dec8bf3153df6c40e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F0269881109105498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881109105498%26sid%3Dliteratum%253Aachs%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DBeyond%2520psychoanaleptics%25E2%2580%2594can%2520we%2520improve%2520antidepressant%2520drug%2520nomenclature%253F%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2009%26volume%3D23%26spage%3D343%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fava, M.</span><span> </span><span class="NLM_article-title">The future of psychopharmacology of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.4088%2FJCP.10m06223blu" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=20797377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOrtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2010&pages=971-975&author=T.+Changauthor=M.+Fava&title=The+future+of+psychopharmacology+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The future of psychopharmacology of depression</span></div><div class="casAuthors">Chang, Trina; Fava, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">971-975</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  There are clear limitations to the currently approved pharmacotherapies of depression, including the fact that they are all essentially monoamine-based, have modest efficacy and a relatively slow onset of efficacy, and suffer from significant tolerability issues, particularly in the long term, including sexual dysfunction, wt. gain, and cognitive impairments.  This article reviews some of the most promising novel mechanisms that are not represented in compds. currently approved for depression in either the United States or Europe and that may represent the future of the psychopharmacol. treatment of depression, potentially addressing some of the efficacy and tolerability issues of antidepressants on the market.  These potential antidepressant treatments include the multimodal serotonergic agents, the triple uptake inhibitors, the neurokinin-based novel therapies, the glutamatergic treatments, the nicotinic receptor-based treatments, the neurogenesis-based treatments, and antiglucocorticoid therapies.  Some of these mechanisms appear to be more advanced in terms of drug development than others, but they all contribute to the global effort to develop more effective and better tolerated treatments for major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFe_QjvHixsrVg90H21EOLACvtfcHk0ljT68fppfUT2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOrtL7O&md5=4487816d52472e18fdc52e923fda88b7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4088%2FJCP.10m06223blu&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4088%252FJCP.10m06223blu%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DT.%26aulast%3DFava%26aufirst%3DM.%26atitle%3DThe%2520future%2520of%2520psychopharmacology%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2010%26volume%3D71%26spage%3D971%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, N. M.</span><span> </span><span class="NLM_article-title">Is there a role for 5-HT<sub>1A</sub> agonists in the treatment of depression?</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0006-3223%2802%2901643-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12559651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=193-203&author=P.+Blierauthor=N.+M.+Ward&title=Is+there+a+role+for+5-HT1A+agonists+in+the+treatment+of+depression%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Is there a role for 5-HT1A agonists in the treatment of depression?</span></div><div class="casAuthors">Blier, Pierre; Ward, Nick M.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-203</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The role of serotonin (5-hydroxytryptamine; 5-HT) in the treatment of depressive and anxiety disorders is underscored by the therapeutic action of selective 5-HT reuptake inhibitors acting to enhance the degree of activation of various 5-HT receptor subtypes.  The 5-HT1A receptors are particularly relevant to the antidepressant and anxiolytic responses in human beings.  They are located presynaptically in the raphe nuclei, where they act as cell body autoreceptors to inhibit the firing rate of 5-HT neurons, and are located postsynaptically in limbic and cortical regions, where they also attenuate firing activity.  The azapirones are full agonists at 5-HT1A autoreceptors and are generally, but not exclusively, partial agonists at postsynaptic 5-HT1A receptors.  Some of these drugs, including gepirone and other 5-HT1A agonists such as buspirone, have been reported to exert anxiolytic and antidepressive activity in double-blind, placebo-controlled, and comparative trials.  Their delayed therapeutic activity is believed to result from increased activation of postsynaptic 5-HT1A receptors occurring only after 5-HT neurons regain their normal firing activity.  The recovery of this parameter, which is attributable to 5-HT1A autoreceptor desensitization, also restores 5-HT release.  At this point, the summed effects of a normalized level of synaptic 5-HT and the exogenous 5-HT1A agonist can be exerted on postsynaptic 5-HT1A receptors.  The widespread recognition of the clin. efficacy of such agents has largely been hampered by their undesirable pharmacokinetic properties.  Most 5-HT1A agonists are indeed readily absorbed but are also rapidly eliminated, thereby often producing either suboptimal therapeutic responses at low doses, or cumbersome adverse effects at higher doses.  Extended-release formulations allow once-daily dosing regimens, thus avoiding sharp peak plasma concns.  This improves compliance and permits the use of higher dosages, which may be assocd. with enhanced efficacy and better tolerability relative to the immediate-release formulations.  In sum, 5-HT1A receptor agonism represents a valuable and efficacious therapeutic approach to major depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqave4phsEojLVg90H21EOLACvtfcHk0lhu1FWPcXWvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVOruw%253D%253D&md5=94f64a33cbc40a67fc0a4ae347dc36bd</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2802%2901643-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252802%252901643-8%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DN.%2BM.%26atitle%3DIs%2520there%2520a%2520role%2520for%25205-HT1A%2520agonists%2520in%2520the%2520treatment%2520of%2520depression%253F%26jtitle%3DBiol.%2520Psychiatry%26date%3D2003%26volume%3D53%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Selective activation of postsynaptic 5-HT<sub>1A</sub> receptors induces rapid antidepressant response</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0893-133X%2896%2900242-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9109104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2sXivVegur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=333-338&author=P.+Blierauthor=R.+Bergeronauthor=C.+de+Montigny&title=Selective+activation+of+postsynaptic+5-HT1A+receptors+induces+rapid+antidepressant+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response</span></div><div class="casAuthors">Blier, Pierre; Bergeron, Richard; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">333-338</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It has been reported that the 5-HT1A autoreceptor antagonist pindolol can accelerate the antidepressant response to the selective serotonin (5-HT) reuptake inhibitor (SSRI) paroxetine, presumably by preventing the initial decrease in firing activity of 5-HT neurons produced by the SSRI.  The present study was aimed at further exploring this treatment strategy in three groups of 10 patients with unipolar major depression allocated sequentially to three treatment arms for 28 days.  The administration of the selective 5-HT1A agonist buspirone (20 mg/day for 1 wk and 30 mg/day thereafter) with pindolol (2.5 mg TID) was used to activate selectively postsynaptic 5-HT1A receptors.  This combination produced a greater than 50% redn. of depressive symptoms in the first week in 8 of 10 patients and the response was sustained for the remainder of the trial.  In contrast, the combination of tricyclic antidepressant drugs devoid of effect on the 5-HT reuptake process (desipramine or trimipramine, 75 mg/day for 1 wk and 150 mg/day thereafter) with pindolol resulted in only one of ten patients achieving a 50% improvement after 28/ days.  The combination of the SSRI fluvoxamine (50 mg/day for 1 wk and 100 mg/day thereafter) with pindolol produced a marked antidepressant effect but did not act as rapidly as the buspirone plus pindolol combination with none, four, and eight patients achieving a 50% amelioration after 7, 14, and 21 days of treatment, resp.  These results provide further evidence that pindolol may accelerate the antidepressant effect of drugs that alter the function of the 5-HT neurons and that the selective activation of postsynaptic 5-HT1A receptors may induce a rapid and robust antidepressant response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXhCQficgy9bVg90H21EOLACvtfcHk0lhu1FWPcXWvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVegur0%253D&md5=813015b45930966c582cd141b0adf113</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0893-133X%2896%2900242-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0893-133X%252896%252900242-4%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DSelective%2520activation%2520of%2520postsynaptic%25205-HT1A%2520receptors%2520induces%2520rapid%2520antidepressant%2520response%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D16%26spage%3D333%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Giovannini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandina, P.</span><span> </span><span class="NLM_article-title">Serotonergic modulation of acetylcholine release from cortex of freely moving rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9618425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFCmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1998&pages=1219-1225&author=M.+G.+Giovanniniauthor=I.+Ceccarelliauthor=B.+Molinariauthor=M.+Cecchiauthor=J.+Goldfarbauthor=P.+Blandina&title=Serotonergic+modulation+of+acetylcholine+release+from+cortex+of+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonergic modulation of acetylcholine release from cortex of freely moving rats</span></div><div class="casAuthors">Giovannini, Maria Grazia; Ceccarelli, Ilaria; Molinari, Beatrice; Cecchi, Marco; Goldfarb, Joseph; Blandina, Patrizio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1219-1225</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The modulation of acetylcholine (ACh) release by 5-HT3 receptor activation was studied using in vivo microdialysis.  Spontaneous and K+-stimulated ACh release were measured in frontoparietal cortex and hippocampus of freely moving rats.  Two consecutive exposures to high K+ produced ACh release of similar magnitude.  In the cortex, serotonin (5-HT) failed to alter spontaneous ACh release, but caused a concn.-dependent decrease of K+-evoked ACh release.  Phenylbiguanide (PBG) and m-chlorophenylbiguanide, two selective 5-HT3 agonists, mimicked the 5-HT responses, but 8-hydroxy-2-(di-n-propylamino)tetralin, a selective 5-HT1A agonist, was without effect.  However, PBG failed to modify K+-evoked ACh release from the hippocampus.  Systemic and local administration of a highly selective 5-HT3 antagonist, tropisetron ((3-α-tropanyl)1H-indole-carboxylic acid ester) blocked the effect of both 5-HT and PBG.  The inhibition of ACh release by PBG was sensitive to tetrodotoxin.  These observations provide direct evidence that, in rat cortex, 5-HT modulates in-vivo release of ACh through activation of 5-HT3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuhnBwWkibK7Vg90H21EOLACvtfcHk0lhu1FWPcXWvkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFCmurg%253D&md5=e6b5668f5cc5567eec154c805374ee6b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiovannini%26aufirst%3DM.%2BG.%26aulast%3DCeccarelli%26aufirst%3DI.%26aulast%3DMolinari%26aufirst%3DB.%26aulast%3DCecchi%26aufirst%3DM.%26aulast%3DGoldfarb%26aufirst%3DJ.%26aulast%3DBlandina%26aufirst%3DP.%26atitle%3DSerotonergic%2520modulation%2520of%2520acetylcholine%2520release%2520from%2520cortex%2520of%2520freely%2520moving%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D285%26spage%3D1219%26epage%3D1225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span> </span><span class="NLM_article-title">Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=7891314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2MXktl2ksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1995&pages=1044-1051&author=M.+Matsumotoauthor=M.+Yoshiokaauthor=H.+Togashiauthor=M.+Tochiharaauthor=T.+Ikedaauthor=H.+Saito&title=Modulation+of+norepinephrine+release+by+serotonergic+receptors+in+the+rat+hippocampus+as+measured+by+in+vivo+microdialysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis</span></div><div class="casAuthors">Matsumoto, Machiko; Yoshioka, Mitsuhiro; Togashi, Hiroko; Tochihara, Masahiro; Ikeda, Toshiya; Saito, Hideya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1044-51</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The functional modulation of norepinephrine (NE) release by serotonergic receptors in the hippocampus of freely moving rats was studied by use of in vivo microdialysis.  To stimulate NE release from the nerve terminals, a high concn. of potassium (K+, 120 mM) was added through the perfusion system.  The K+-evoked NE release was inhibited in a concn.-dependent manner when serotonin (5-HT, 0.01-10 μM) was coperfused with K+.  A selective 5-HT3 receptor agonist, 2-methyl-5-HT, mimicked the 5-HT response at a concn. of 0.01 to 10 μM.  The 5-HT-induced (1 μM) inhibition of NE release was blocked by pretreatment with ondansetron (1 and 10 μM), a 5-HT3 receptor antagonist.  K+-evoked NE release was also reduced by coperfusion with the 5-HT reuptake inhibitor, fluoxetine (10 μM), which caused increases in the dialyzate 5-HT concn.  The fluoxetine-induced (10 μM) decreases in the K+-evoked NE release were prevented by serotonergic denervation caused by pretreatment with 5,7-dihydroxytryptamine (200 μg/rat i.c.v.).  These results indicate that the inhibition on NE release by fluoxetine was due to increased synaptic concns. of endogenous 5-HT.  The fluoxetine-induced inhibitory effect was furthermore abolished by pretreatment with ondansetron (1 and 10 μM).  These findings indicate the possibility that both exogenous and endogenous 5-HT inhibit NE release occurs from the rat hippocampus by 5-HT3 receptors.  Thus, the present study suggests that the functional modulation of NE release by 5-HT3 receptors exists in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj4AzM_4yN27Vg90H21EOLACvtfcHk0lgN4yPVmwi4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXktl2ksrY%253D&md5=2a973f041a5910d56e41c8d826bed935</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DTogashi%26aufirst%3DH.%26aulast%3DTochihara%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DH.%26atitle%3DModulation%2520of%2520norepinephrine%2520release%2520by%2520serotonergic%2520receptors%2520in%2520the%2520rat%2520hippocampus%2520as%2520measured%2520by%2520in%2520vivo%2520microdialysis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D272%26spage%3D1044%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Morales, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lecea, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, F. E.</span><span> </span><span class="NLM_article-title">The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">731</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2F0006-8993%2896%2900557-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8883870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK28XkvFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=731&publication_year=1996&pages=199-202&author=M.+Moralesauthor=E.+Battenbergauthor=L.+de+Leceaauthor=F.+E.+Bloom&title=The+type+3+serotonin+receptor+is+expressed+in+a+subpopulation+of+GABAergic+neurons+in+the+rat+neocortex+and+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus</span></div><div class="casAuthors">Morales, Marisela; Battenberg, Elena; de Lecea, Luis; Bloom, Floyd E.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">731</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">199-202</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The authors used in situ hybridization and immunocytochem. to investigate the presence of GABA in neurons that express the type 3 serotonin receptor (5-HT3R).  Quant. anal. indicated that more than 90 of 5-HT3R expressing cells are GABAergic in the neocortex and hippocampus.  The co-existence of 5-HT3R and GABA in cortical and hippocampal neurons indicates that serotonin, via 5-HT3R, can affect GABA release and suggests the participation of 5-HT3R in the inhibitory regulation of forebrain neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnEQctOYV6ArVg90H21EOLACvtfcHk0lgN4yPVmwi4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFSku7g%253D&md5=36e269c55f5f1fdfa32aa5e97a8d73e5</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2896%2900557-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252896%252900557-4%26sid%3Dliteratum%253Aachs%26aulast%3DMorales%26aufirst%3DM.%26aulast%3DBattenberg%26aufirst%3DE.%26aulast%3Dde%2BLecea%26aufirst%3DL.%26aulast%3DBloom%26aufirst%3DF.%2BE.%26atitle%3DThe%2520type%25203%2520serotonin%2520receptor%2520is%2520expressed%2520in%2520a%2520subpopulation%2520of%2520GABAergic%2520neurons%2520in%2520the%2520rat%2520neocortex%2520and%2520hippocampus%26jtitle%3DBrain%2520Res.%26date%3D1996%26volume%3D731%26spage%3D199%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Yan, Z.</span><span> </span><span class="NLM_article-title">Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1385%2FMN%3A26%3A2-3%3A203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12428756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD38XovF2rtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2002&pages=203-216&author=Z.+Yan&title=Regulation+of+GABAergic+inhibition+by+serotonin+signaling+in+prefrontal+cortex%3A+molecular+mechanisms+and+functional+implications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications</span></div><div class="casAuthors">Yan, Zhen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">203-216</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonergic neurotransmission in prefrontal cortex (PFC) plays a key role in regulating emotion and cognition under normal and pathol. conditions.  Increasing evidence suggests that serotonin receptors are involved in the complex regulation of GABAergic inhibitory transmission in PFC.  Activation of postsynaptic 5-HT2 receptors in PFC pyramidal neurons inhibits GABAA-receptor currents via phosphorylation of GABAA receptor γ2 subunits by RACK1-anchored PKC.  In contrast, activation of postsynaptic 5-HT4 receptors produces an activity-dependent bi-directional regulation of GABA-evoked currents in PFC pyramidal neurons, which is mediated through phosphorylation of GABAA-receptor β subunits by anchored PKA.  On the presynaptic side, GABAergic inhibition is regulated by 5-HT through the activation of 5-HT2, 5-HT1, and 5-HT3 receptors on GABAergic interneurons.  These data provide a mol. and cellular mechanism for serotonin to dynamically regulate synaptic transmission and neuronal excitability in the PFC network, which may underlie the actions of many antidepressant and antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fSU-xegY2LVg90H21EOLACvtfcHk0lgN4yPVmwi4AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovF2rtb8%253D&md5=61f4a131e1aa0ba08755b1b6953ce9b8</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1385%2FMN%3A26%3A2-3%3A203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A26%253A2-3%253A203%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26atitle%3DRegulation%2520of%2520GABAergic%2520inhibition%2520by%2520serotonin%2520signaling%2520in%2520prefrontal%2520cortex%253A%2520molecular%2520mechanisms%2520and%2520functional%2520implications%26jtitle%3DMol.%2520Neurobiol.%26date%3D2002%26volume%3D26%26spage%3D203%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Angel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prouteau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garreau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, S. Z.</span><span> </span><span class="NLM_article-title">Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT<sub>3</sub> receptor antagonist and antiemetic properties</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2F0014-2999%2893%2990767-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8385615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=1993&pages=139-145&author=I.+Angelauthor=H.+Schoemakerauthor=M.+Prouteauauthor=M.+Garreauauthor=S.+Z.+Langer&title=Litoxetine%3A+a+selective+5-HT+uptake+inhibitor+with+concomitant+5-HT3+receptor+antagonist+and+antiemetic+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties</span></div><div class="casAuthors">Angel, I.; Schoemaker, H.; Prouteau, M.; Garreau, M.; Langer, S. Z.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">139-45</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The antidepressant litoxetine (SL 81.0385) has also antiemetic properties in the ferret.  Litoxetine at 1 and 10 mg/kg i.v. dose-dependently reduced the no. of retches and vomiting as well as the no. of emetic episodes induced by cisplatin (10 mg/kg i.v.) and delayed the onset of emesis in ferrets.  Fluoxetine at 1 or 10 mg/kg i.v. failed to inhibit the cisplatin-induced emetic responses and increased the no. of retches and vomiting and accelerated the onset of emesis.  The antiemetic effects of litoxetine may be mediated through an interaction with serotoninergic 5HT3 receptors.  This was studied using [3H]quipazine or [3H]BRL-43694 to label the 5HT3 receptors.  Litoxetine had moderate affinity for the cerebral 5HT3 receptors (Ki = 85 nM), while fluoxetine, similar to other 5HT uptake inhibitors, had only negligible affinity for this receptor (Ki = 6.5 μM).  Litoxetine may inhibit the cisplatin-induced emetic responses due to its moderate 5HT3 antagonist properties.  The clin. use of serotonergic antidepressants is assocd. with gastrointestinal discomfort, particularly nausea and vomiting, as a major side-effect.  If nausea and vomiting assocd. with the use of 5 HT uptake inhibitors are due to the stimulation of 5HT3 receptors, the concomitant 5HT3 antagonism of litoxetine may limit the gastrointestinal side-effects of this novel antidepressant and thus offer an important clin. advantage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFy5NcXRJkm7Vg90H21EOLACvtfcHk0ljnYfYdSt2KZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGisrg%253D&md5=4978c9f16d13e9b57d69864b9bb04c49</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2893%2990767-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252893%252990767-C%26sid%3Dliteratum%253Aachs%26aulast%3DAngel%26aufirst%3DI.%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DProuteau%26aufirst%3DM.%26aulast%3DGarreau%26aufirst%3DM.%26aulast%3DLanger%26aufirst%3DS.%2BZ.%26atitle%3DLitoxetine%253A%2520a%2520selective%25205-HT%2520uptake%2520inhibitor%2520with%2520concomitant%25205-HT3%2520receptor%2520antagonist%2520and%2520antiemetic%2520properties%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1993%26volume%3D232%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Bergeron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span> </span><span class="NLM_article-title">Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fajp.151.7.1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8010370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADyaK2c3nvFOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1994&pages=1084-1086&author=R.+Bergeronauthor=P.+Blier&title=Cisapride+for+the+treatment+of+nausea+produced+by+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Bergeron R; Blier P</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1084-6</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">A low dose of cisapride (5 mg b.i.d.) produced rapid relief from nausea elicited by the initiation of treatment with a selective serotonin reuptake inhibitor in eight patients.  This effect of cisapride is presumably related to its serotonin3 antagonistic property.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQU3wXaEjfbYiM8MEzWGjS9fW6udTcc2eZ6_pDTQlCU1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c3nvFOgtg%253D%253D&md5=0fbecfcd15da5f3dd59abdfe73003090</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1176%2Fajp.151.7.1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.151.7.1084%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%26aulast%3DBlier%26aufirst%3DP.%26atitle%3DCisapride%2520for%2520the%2520treatment%2520of%2520nausea%2520produced%2520by%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1994%26volume%3D151%26spage%3D1084%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gray, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dounay, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boroski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probert, A.</span><span> </span><span class="NLM_article-title">Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6604</span><span class="NLM_x">–</span> <span class="NLM_lpage">6607</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6604-6607&author=D.+L.+Grayauthor=W.+Xuauthor=B.+M.+Campbellauthor=A.+B.+Dounayauthor=N.+Bartaauthor=S.+Boroskiauthor=L.+Dennyauthor=L.+Evansauthor=N.+Stratmanauthor=A.+Probert&title=Discovery+and+pharmacological+characterization+of+aryl+piperazine+and+piperidine+ethers+as+dual+acting+norepinephrine+reuptake+inhibitors+and+5-HT1A+partial+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DD.%2BL.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DDounay%26aufirst%3DA.%2BB.%26aulast%3DBarta%26aufirst%3DN.%26aulast%3DBoroski%26aufirst%3DS.%26aulast%3DDenny%26aufirst%3DL.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DStratman%26aufirst%3DN.%26aulast%3DProbert%26aufirst%3DA.%26atitle%3DDiscovery%2520and%2520pharmacological%2520characterization%2520of%2520aryl%2520piperazine%2520and%2520piperidine%2520ethers%2520as%2520dual%2520acting%2520norepinephrine%2520reuptake%2520inhibitors%2520and%25205-HT1A%2520partial%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6604%26epage%3D6607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ruhland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, K.</span><span> </span><span class="NLM_article-title">Iron-assisted nucleophilic aromatic substitution on solid phase</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5257</span><span class="NLM_x">–</span> <span class="NLM_lpage">5268</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo025721q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=5257-5268&author=T.+Ruhlandauthor=K.+S.+Bangauthor=K.+Andersen&title=Iron-assisted+nucleophilic+aromatic+substitution+on+solid+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo025721q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo025721q%26sid%3Dliteratum%253Aachs%26aulast%3DRuhland%26aufirst%3DT.%26aulast%3DBang%26aufirst%3DK.%2BS.%26aulast%3DAndersen%26aufirst%3DK.%26atitle%3DIron-assisted%2520nucleophilic%2520aromatic%2520substitution%2520on%2520solid%2520phase%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D5257%26epage%3D5268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ruhland, T.; Smith, G. P.; Bang-Andersen, B.; Pueschl, A.; Moltzen, E. K.; Andersen, K.</span><span> </span><span class="NLM_article-title">Phenyl-piperazine Derivatives as Serotonin Reuptake Inhibitors</span>. WO 2003029232 (A1),<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Ruhland&author=G.+P.+Smith&author=B.+Bang-Andersen&author=A.+Pueschl&author=E.+K.+Moltzen&author=K.+Andersen&title=Phenyl-piperazine+Derivatives+as+Serotonin+Reuptake+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRuhland%26aufirst%3DT.%26atitle%3DPhenyl-piperazine%2520Derivatives%2520as%2520Serotonin%2520Reuptake%2520Inhibitors%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Louie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed synthesis of arylamines from aryl halides: mechanistic studies lead to coupling in the absence of tin reagents</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3609</span><span class="NLM_x">–</span> <span class="NLM_lpage">3612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=3609-3612&author=J.+Louieauthor=J.+F.+Hartwig&title=Palladium-catalyzed+synthesis+of+arylamines+from+aryl+halides%3A+mechanistic+studies+lead+to+coupling+in+the+absence+of+tin+reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLouie%26aufirst%3DJ.%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520synthesis%2520of%2520arylamines%2520from%2520aryl%2520halides%253A%2520mechanistic%2520studies%2520lead%2520to%2520coupling%2520in%2520the%2520absence%2520of%2520tin%2520reagents%26jtitle%3DTetrahedron%2520Lett.%26date%3D1995%26volume%3D36%26spage%3D3609%26epage%3D3612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Guram, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennels, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">A simple catalytic method for the conversion of aryl bromides to arylamines</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1002%2Fanie.199513481" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=1348-1350&author=A.+S.+Guramauthor=R.+A.+Rennelsauthor=S.+L.+Buchwald&title=A+simple+catalytic+method+for+the+conversion+of+aryl+bromides+to+arylamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A simple catalytic method for the conversion of aryl bromides to arylamines</span></div><div class="casAuthors">Guram, Anil S.; Rennels, Roger A.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition in English</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1348-50</span>CODEN:
                <span class="NLM_cas:coden">ACIEAY</span>;
        ISSN:<span class="NLM_cas:issn">0570-0833</span>.
    
            (<span class="NLM_cas:orgname">VCH</span>)
        </div><div class="casAbstract">Aryl bromides reacted with amines in the presence of NaOCMe3 and a catalytic amt. of PdCl2[P(o-tolyl)3]2 or Pd(dba)2/2P(o-tolyl)3 to give arylamines in good yields.  Also, cyclization of 2-XC6H4CH2(CH2)nNHCH2Ph (X = Br, iodo; n = 1, 2, 3) in the presence of NaOCMe3 and a catalytic amt. of Pd(PPh3)4 gave good yields of the N heterocycles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXDC5Vhs2d57Vg90H21EOLACvtfcHk0lj3dxTQ8FJ1yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvV2msr8%253D&md5=d435e21c3f535757455d53e12417596b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fanie.199513481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.199513481%26sid%3Dliteratum%253Aachs%26aulast%3DGuram%26aufirst%3DA.%2BS.%26aulast%3DRennels%26aufirst%3DR.%2BA.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DA%2520simple%2520catalytic%2520method%2520for%2520the%2520conversion%2520of%2520aryl%2520bromides%2520to%2520arylamines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D1348%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Larsen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, M.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed monoamination of dihalogenated benzenes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2938</span><span class="NLM_x">–</span> <span class="NLM_lpage">2950</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2008&pages=2938-2950&author=S.+B.+Larsenauthor=B.+Bang-Andersenauthor=T.+N.+Johansenauthor=M.+J%C3%B8rgensen&title=Palladium-catalyzed+monoamination+of+dihalogenated+benzenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DS.%2BB.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DJohansen%26aufirst%3DT.%2BN.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DM.%26atitle%3DPalladium-catalyzed%2520monoamination%2520of%2520dihalogenated%2520benzenes%26jtitle%3DTetrahedron%26date%3D2008%26volume%3D64%26spage%3D2938%26epage%3D2950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Schopfer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlapbach, A.</span><span> </span><span class="NLM_article-title">A general palladium-catalysed synthesis of aromatic and heteroaromatic thioethers</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3069</span><span class="NLM_x">–</span> <span class="NLM_lpage">3073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=3069-3073&author=U.+Schopferauthor=A.+Schlapbach&title=A+general+palladium-catalysed+synthesis+of+aromatic+and+heteroaromatic+thioethers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DA%2520general%2520palladium-catalysed%2520synthesis%2520of%2520aromatic%2520and%2520heteroaromatic%2520thioethers%26jtitle%3DTetrahedron%26date%3D2001%26volume%3D57%26spage%3D3069%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lenox, R. H.; Frazer, A.</span><span> </span><span class="NLM_article-title">Mechanism of Action of Antidepressants and Mood Stabilizers</span>. In  <span class="citation_source-book">Neuropsychopharmacology: The Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology </span>; <span class="NLM_contrib-group">Davis, K. L.; Charney, D.; Coyle, J. T.; Nemeroff, C.</span>, Eds.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1139</span>− <span class="NLM_lpage">1163</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=1139-1163&author=R.+H.+Lenox&author=A.+Frazerauthor=K.+L.+Davis&author=D.+Charney&author=J.+T.+Coyle&author=C.+Nemeroff&title=Neuropsychopharmacology%3A+The+Fifth+Generation+of+Progress%3A+An+Official+Publication+of+the+American+College+of+Neuropsychopharmacology+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLenox%26aufirst%3DR.%2BH.%26atitle%3DMechanism%2520of%2520Action%2520of%2520Antidepressants%2520and%2520Mood%2520Stabilizers%26btitle%3DNeuropsychopharmacology%253A%2520The%2520Fifth%2520Generation%2520of%2520Progress%253A%2520An%2520Official%2520Publication%2520of%2520the%2520American%2520College%2520of%2520Neuropsychopharmacology%2520%26aulast%3DDavis%26aufirst%3DK.%2BL.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2002%26spage%3D1139%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Meyer, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagrati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheok, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span> </span><span class="NLM_article-title">Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [<sup>11</sup>C]DASB positron emission tomography study</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1176%2Fappi.ajp.161.5.826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15121647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itFygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=826-835&author=J.+H.+Meyerauthor=A.+A.+Wilsonauthor=S.+Sagratiauthor=D.+Husseyauthor=A.+Carellaauthor=W.+Z.+Potterauthor=N.+Ginovartauthor=E.+P.+Spencerauthor=A.+Cheokauthor=S.+Houle&title=Serotonin+transporter+occupancy+of+five+selective+serotonin+reuptake+inhibitors+at+different+doses%3A+an+%5B11C%5DDASB+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study</span></div><div class="casAuthors">Meyer Jeffrey H; Wilson Alan A; Sagrati Sandra; Hussey Doug; Carella Anna; Potter William Z; Ginovart Nathalie; Spencer Edgar P; Cheok Andy; Houle Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">826-35</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Minimum therapeutic doses of paroxetine and citalopram produce 80% occupancy for the serotonin (5-HT) transporter (5-HTT).  The authors used [(11)C]DASB positron emission tomography to measure occupancies of three other selective serotonin reuptake inhibitors (SSRIs) at minimum therapeutic doses.  The relationship between dose and occupancy was also investigated.  METHOD:  Striatal 5-HTT binding potential was measured in 77 subjects before and after 4 weeks of medication administration.  Binding potential is proportional to the density of receptors not blocked by medication.  Subjects received citalopram, fluoxetine, sertraline, paroxetine, or extended-release venlafaxine.  Healthy subjects received subtherapeutic doses; subjects with mood and anxiety disorders received therapeutic doses.  Percent reduction in 5-HTT binding potential for each medication and dose was calculated.  To obtain test-retest data, binding potential was measured before and after 4 weeks in six additional healthy subjects.  RESULTS:  Substantial occupancy occurred at subtherapeutic doses for all SSRIs.  Compared to test-retest data, each drug at the minimum therapeutic dose had a significant effect on striatal 5-HTT binding potential.  Mean occupancy at this dose was 76%-85%.  At higher plasma SSRI concentrations, 5-HTT occupancy tended to increase above 80%.  For each drug, as the dose (or plasma level) increased, occupancy increased nonlinearly, with a plateau for higher doses.  CONCLUSIONS:  At tolerable doses, SSRIs have increasing occupancy with increasing plasma concentration or dose.  Occupancy of 80% across five SSRIs occurs at minimum therapeutic doses.  This suggests that 80% 5-HTT blockade is important for therapeutic effect.  Occupancy should be measured during development of antidepressant compounds targeting the 5-HTT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo4wIPTXNjlWhHGZei4OW9fW6udTcc2ebSdZUDpxvKVLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itFygsg%253D%253D&md5=55e6a09757b936684a41c80798c57f1b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.5.826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.5.826%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DSagrati%26aufirst%3DS.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DCarella%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DSpencer%26aufirst%3DE.%2BP.%26aulast%3DCheok%26aufirst%3DA.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DSerotonin%2520transporter%2520occupancy%2520of%2520five%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520at%2520different%2520doses%253A%2520an%2520%255B11C%255DDASB%2520positron%2520emission%2520tomography%2520study%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D826%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Larsen, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, P. H.</span><span> </span><span class="NLM_article-title">Selectivity of [<sup>3</sup>H]MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1038%2Fsj.bjp.0705693" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=14993096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVKitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2004&pages=1015-1023&author=A.+K.+Larsenauthor=L.+T.+Brennumauthor=J.+Egebjergauthor=C.+S%C3%A1nchezauthor=C.+Halldinauthor=P.+H.+Andersen&title=Selectivity+of+%5B3H%5DMADAM+binding+to+5-hydroxytryptamine+transporters+in+vitro+and+in+vivo+in+mice%3B+correlation+with+behavioural+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of 3H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioral effects</span></div><div class="casAuthors">Larsen, A. K.; Brennum, L. T.; Egebjerg, J.; Sanchez, C.; Halldin, C.; Andersen, P. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1015-1023</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding of the novel radioligand 3H-2-(2-dimethylaminomethyl-phenylsulfanyl)-5-methylphenylamine (3H-MADAM) to the serotonin transporter (SERT) was used to characterize a range of selective serotonin reuptake inhibitors (SSRIs) in vitro and in vivo.  3H-MADAM bound with high affinity in a saturable manner to both human SERT expressed in CHO cells (Kd=0.20 nM (pKd=9.74±0.12), Bmax=35±4 fmol mg-1 protein) and mouse cerebral cortex membranes (Kd=0.21 nM (pKd=9.66±0.10), Bmax=50±24 fmol mg-1 protein).  Binding of 3H-MADAM was highly selective for SERT in vitro as demonstrated by the in vitro profile of MADAM tested at 75 different receptors, ion channels and transporters.  This was further substantiated by the pharmacol. profile of the binding.  Hence, the binding of 3H-MADAM was potently inhibited by SSRIs but not by selective inhibitors of noradrenaline transport and dopamine transport.  Likewise, a 5-HT2A/2C receptor antagonist did not inhibit 3H-MADAM binding.  3H-MADAM binding in vivo was inhibited only by compds. which also inhibited the binding of 3H-MADAM in vitro (the SSRIs, mixed SERT/noradrenaline transport inhibitors and clomipramine), confirming the selectivity of 3H-MADAM for SERT also in vivo.  Moreover, compds. effective in inhibiting 3H-MADAM binding were the only ones found to be active in the mouse 5-HTP potentiation test confirming the model as a behavioral correlate to in vivo 5-HT uptake.  Finally, it was found that a SERT occupancy of 85-95% was necessary to produce 50% of the max. behavioral response (ED50).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohfnNM-lprSrVg90H21EOLACvtfcHk0ljHEtUWPhfYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVKitLg%253D&md5=ceb57d2eca6de216464989a4dc3952ff</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705693%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DA.%2BK.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DP.%2BH.%26atitle%3DSelectivity%2520of%2520%255B3H%255DMADAM%2520binding%2520to%25205-hydroxytryptamine%2520transporters%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520mice%253B%2520correlation%2520with%2520behavioural%2520effects%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D141%26spage%3D1015%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Owens, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krulewicz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plott, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeroff, C. B.</span><span> </span><span class="NLM_article-title">Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">3201</span><span class="NLM_x">–</span> <span class="NLM_lpage">3212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=3201-3212&author=M.+J.+Owensauthor=S.+Krulewiczauthor=J.+S.+Simonauthor=D.+V.+Sheehanauthor=M.+E.+Thaseauthor=D.+J.+Carpenterauthor=S.+J.+Plottauthor=C.+B.+Nemeroff&title=Estimates+of+serotonin+and+norepinephrine+transporter+inhibition+in+depressed+patients+treated+with+paroxetine+or+venlafaxine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwens%26aufirst%3DM.%2BJ.%26aulast%3DKrulewicz%26aufirst%3DS.%26aulast%3DSimon%26aufirst%3DJ.%2BS.%26aulast%3DSheehan%26aufirst%3DD.%2BV.%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DD.%2BJ.%26aulast%3DPlott%26aufirst%3DS.%2BJ.%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DEstimates%2520of%2520serotonin%2520and%2520norepinephrine%2520transporter%2520inhibition%2520in%2520depressed%2520patients%2520treated%2520with%2520paroxetine%2520or%2520venlafaxine%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D3201%26epage%3D3212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozeki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iga, T.</span><span> </span><span class="NLM_article-title">Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT<sub>3</sub> receptor antagonists in cancer patients</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs00280-004-0798-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=15168080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Gks7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=185-190&author=Y.+Yamadaauthor=M.+Sugiuraauthor=K.+Higoauthor=T.+Ozekiauthor=R.+Takayanagiauthor=K.+Okuyamaauthor=K.+Yamamotoauthor=H.+Satohauthor=Y.+Sawadaauthor=T.+Iga&title=Receptor+occupancy+theory-based+analysis+of+antiemetic+effects+and+standard+doses+of+5-HT3+receptor+antagonists+in+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor occupancy theory-based analysis of antiemetic effects and standard doses of 5-HT3 receptor antagonists in cancer patients</span></div><div class="casAuthors">Yamada, Yasuhiko; Sugiura, Munetoshi; Higo, Kozue; Ozeki, Takeshi; Takayanagi, Risa; Okuyama, Kiyoshi; Yamamoto, Koujirou; Satoh, Hitoshi; Sawada, Yasufumi; Iga, Tatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-190</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Purpose: The aim of this study was to det. the usefulness of receptor occupancy theory-based anal. using pharmacokinetic and pharmacodynamic parameters for predicting the av. receptor occupancy (ΦB) in humans of each of five 5-HT3 antagonists administered at std. doses.  Methods: The relation between the ΦB value and the complete vomiting inhibition rate after a single i.v. administration of cisplatin (not less than 50 mg/m2) was analyzed.  Results: The predicted ΦB values after i.v. administration and oral administration of 5-HT3 antagonists were more than 65% and 50%, resp., suggesting that relatively high receptor occupancy is required to elicit sufficient antiemetic effects of 5-HT3 antagonists.  Moreover, significant (P<0.05) linear relationships were found between ΦB values and complete vomiting inhibition rates of 5-HT3 antagonists in preventive cisplatin therapy, with correlation coeffs. higher than 0.9, suggesting that the 5-HT3 receptor occupancy is an appropriate index of clin. efficacy of 5-HT3 antagonists, with higher receptor occupancy indicating more extensive antiemetic action.  Conclusion: The receptor occupancy theory-based anal. of the antiemetic effect of a 5-HT3 receptor antagonist used in this study should be very useful for not only estg. a rational dosage regimen but also detg. the std. dose of a new drug using exptl. data obtained in a preclin. study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQu7F1dLEx5LVg90H21EOLACvtfcHk0lhL3V8D07kqrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Gks7c%253D&md5=35aa120ab0b5a0af45f63b1bc113046a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0798-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0798-x%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DSugiura%26aufirst%3DM.%26aulast%3DHigo%26aufirst%3DK.%26aulast%3DOzeki%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DR.%26aulast%3DOkuyama%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DSatoh%26aufirst%3DH.%26aulast%3DSawada%26aufirst%3DY.%26aulast%3DIga%26aufirst%3DT.%26atitle%3DReceptor%2520occupancy%2520theory-based%2520analysis%2520of%2520antiemetic%2520effects%2520and%2520standard%2520doses%2520of%25205-HT3%2520receptor%2520antagonists%2520in%2520cancer%2520patients%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2004%26volume%3D54%26spage%3D185%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">PET-characterization of [carbonyl-<sup>11</sup>C]WAY-100635 binding to 5-HT<sub>1A</sub> receptors in the primate brain</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=1997&pages=196-202&author=L.+Fardeauthor=N.+Ginovartauthor=H.+Itoauthor=C.+Lundkvistauthor=V.+W.+Pikeauthor=J.+A.+McCarronauthor=C.+Halldin&title=PET-characterization+of+%5Bcarbonyl-11C%5DWAY-100635+binding+to+5-HT1A+receptors+in+the+primate+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DPET-characterization%2520of%2520%255Bcarbonyl-11C%255DWAY-100635%2520binding%2520to%25205-HT1A%2520receptors%2520in%2520the%2520primate%2520brain%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D133%26spage%3D196%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bantick, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Occupancy of agonist drugs at the 5-HT<sub>1A</sub> receptor</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">847</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=847-859&author=R.+A.+Bantickauthor=E.+A.+Rabinerauthor=E.+Hiraniauthor=M.+H.+de+Vriesauthor=S.+P.+Humeauthor=P.+M.+Grasby&title=Occupancy+of+agonist+drugs+at+the+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBantick%26aufirst%3DR.%2BA.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DHirani%26aufirst%3DE.%26aulast%3Dde%2BVries%26aufirst%3DM.%2BH.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DOccupancy%2520of%2520agonist%2520drugs%2520at%2520the%25205-HT1A%2520receptor%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D847%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dockens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajor, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yocca, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span> </span><span class="NLM_article-title">6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine<sub>1A</sub> receptor occupancy in rats</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1387</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=1387-1392&author=H.+Wongauthor=R.+C.+Dockensauthor=L.+Pajorauthor=S.+Yeolaauthor=J.+E.+Graceauthor=A.+D.+Starkauthor=R.+A.+Taubauthor=F.+D.+Yoccaauthor=R.+C.+Zaczekauthor=Y.-W.+Li&title=6-Hydroxybuspirone+is+a+major+active+metabolite+of+buspirone%3A+assessment+of+pharmacokinetics+and+5-hydroxytryptamine1A+receptor+occupancy+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DH.%26aulast%3DDockens%26aufirst%3DR.%2BC.%26aulast%3DPajor%26aufirst%3DL.%26aulast%3DYeola%26aufirst%3DS.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DStark%26aufirst%3DA.%2BD.%26aulast%3DTaub%26aufirst%3DR.%2BA.%26aulast%3DYocca%26aufirst%3DF.%2BD.%26aulast%3DZaczek%26aufirst%3DR.%2BC.%26aulast%3DLi%26aufirst%3DY.-W.%26atitle%3D6-Hydroxybuspirone%2520is%2520a%2520major%2520active%2520metabolite%2520of%2520buspirone%253A%2520assessment%2520of%2520pharmacokinetics%2520and%25205-hydroxytryptamine1A%2520receptor%2520occupancy%2520in%2520rats%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D1387%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40a"><span><span class="NLM_contrib-group">Moore, N. A.; Bang-Andersen, B.; Brennum, L. T.; Frederiksen, K.; Hogg, S.; Mørk, A.; Sanchez, C.; Smith, D. G.; Stensbøl, T. B.; Zhong, H.</span><span> </span><span class="NLM_article-title">Lu AA21004: A Novel Potential Treatment for Mood Disorders</span>. Presented at the 21st European College of Neuropsychopharmacology (ECNP), Barcelona, Spain, August 30−September 3,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Poster P.2.b.015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=N.+A.+Moore&author=B.+Bang-Andersen&author=L.+T.+Brennum&author=K.+Frederiksen&author=S.+Hogg&author=A.+M%C3%B8rk&author=C.+Sanchez&author=D.+G.+Smith&author=T.+B.+Stensb%C3%B8l&author=H.+Zhong&title=Lu+AA21004%3A+A+Novel+Potential+Treatment+for+Mood+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DN.%2BA.%26atitle%3DLu%2520AA21004%253A%2520A%2520Novel%2520Potential%2520Treatment%2520for%2520Mood%2520Disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit40b"><span><span class="NLM_contrib-group">Moore, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stensbøl, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Moore%2C+N.+A.%3B+Bang-Andersen%2C+B.%3B+Brennum%2C+L.+T.%3B+Frederiksen%2C+K.%3B+Hogg%2C+S.%3B+M%C3%B8rk%2C+A.%3B+Sanchez%2C+C.%3B+Smith%2C+D.+G.%3B+Stensb%C3%B8l%2C+T.+B.%3B+Zhong%2C+H.Neuropsychopharmacology+2008%2C+18+%28suppl.+4%29+S321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DN.%2BA.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DFrederiksen%26aufirst%3DK.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DStensb%25C3%25B8l%26aufirst%3DT.%2BB.%26aulast%3DZhong%26aufirst%3DH.%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D18%26issue%3Dsuppl.%25204%26spage%3DS321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Assié, M.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomenech, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravailhe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucillon, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span> </span><span class="NLM_article-title">Rapid desensitization of somatodendritic 5-HT<sub>1A</sub> receptors by chronic administration of the high-efficacy 5-HT<sub>1A</sub> agonist, F13714: a microdialysis study in the rat</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1038%2Fsj.bjp.0706859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=16921393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD28XptlSltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2006&pages=170-178&author=M.-B.+Assi%C3%A9author=H.+Lomenechauthor=V.+Ravailheauthor=V.+Faucillonauthor=A.+Newman-Tancredi&title=Rapid+desensitization+of+somatodendritic+5-HT1A+receptors+by+chronic+administration+of+the+high-efficacy+5-HT1A+agonist%2C+F13714%3A+a+microdialysis+study+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat</span></div><div class="casAuthors">Assie, M.-B.; Lomenech, H.; Ravailhe, V.; Faucillon, V.; Newman-Tancredi, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-178</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Desensitization of somatodendritic 5-HT1A receptors is involved in the mechanism of action of several antidepressants, but the rapidity of this effect and the amt. of agonist stimulation needed are unclear.  We evaluated the capacity of the high-efficacy 5-HT1A agonist, F13714 (3-chloro-4-fluorophenyl-4-fluoro-4-{(5-methyl-6-methylamino-pyridin-2-ylmethyl)-amino-methyl}-piperidin-1-yl-methanone) and of the partial agonist, flesinoxan, to desensitize somatodendritic 5-HT1A receptors involved in the control of 5-HT release.  Intracerebral microdialysis in the hippocampus of freely moving rats was used to examine the acute and chronic effects of the two compds. (administered by osmotic pumps for 3, 7 or 14 days) on extracellular 5-HT levels, measured by HPLC with electrochem. detection.  When given acutely, F13714, flesinoxan and the low-efficacy 5-HT1A agonist, buspirone, dose-dependently decreased extracellular 5-HT concns. (ED50 values: 0.04, 0.77 and 5.6 mg kg-1, resp.).  The selective 5-HT1A antagonist WAY100635 inhibited the effects of the three compds.  F13714 (2.5 mg kg-1 per day for 3, 7 or 14 days and 0.63 mg kg-1 for 7 days) significantly attenuated the inhibition of 5-HT release induced by buspirone (10 mg kg-1).  In contrast, flesinoxan (10 mg kg-1 per day) failed to alter the response to buspirone at any of the treatment durations.  Rat somatodendritic 5-HT1A receptors controlling hippocampal 5-HT release were rapidly desensitized by chronic activation with a high-efficacy 5-HT1A agonist, but not by chronic activation with a partial agonist.  Thus, rapid 5-HT1A autoreceptor desensitization by high-efficacy agonists may accelerate the onset of the therapeutic effects of antidepressants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfk47hYMSIRbVg90H21EOLACvtfcHk0liF45LTDUULQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptlSltr8%253D&md5=6342aa9d9937277a5d4e211f092a5198</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706859%26sid%3Dliteratum%253Aachs%26aulast%3DAssi%25C3%25A9%26aufirst%3DM.-B.%26aulast%3DLomenech%26aufirst%3DH.%26aulast%3DRavailhe%26aufirst%3DV.%26aulast%3DFaucillon%26aufirst%3DV.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26atitle%3DRapid%2520desensitization%2520of%2520somatodendritic%25205-HT1A%2520receptors%2520by%2520chronic%2520administration%2520of%2520the%2520high-efficacy%25205-HT1A%2520agonist%252C%2520F13714%253A%2520a%2520microdialysis%2520study%2520in%2520the%2520rat%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D149%26spage%3D170%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Haddjeri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Montigny, C.</span><span> </span><span class="NLM_article-title">Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT<sub>1A</sub> receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">10150</span><span class="NLM_x">–</span> <span class="NLM_lpage">10156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1523%2FJNEUROSCI.18-23-10150.1998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=9822768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=10150-10156&author=N.+Haddjeriauthor=P.+Blierauthor=C.+de+Montigny&title=Long-term+antidepressant+treatments+result+in+a+tonic+activation+of+forebrain+5-HT1A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors</span></div><div class="casAuthors">Haddjeri, Nasser; Blier, Pierre; De Montigny, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10150-10156</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We report here the first direct functional evidence of an increase in the tonic activation of postsynaptic 5-HT1A receptors by antidepressant treatments.  Because 5-HT1A receptor activation hyperpolarizes and inhibits CA3 pyramidal neurons in the dorsal hippocampus, we detd., using in vivo extracellular recording, whether the selective 5-HT1A receptor antagonist WAY 100635 could disinhibit these neurons.  Unexpectedly, no disinhibition could be detected in controls.  However, after long-term treatment with the tricyclic antidepressant imipramine, the selective 5-HT reuptake inhibitor paroxetine, the reversible monoamine oxidase-A inhibitor befloxatone, the α2-adrenergic antagonist mirtazapine, or the 5-HT1A receptor agonist gepirone or multiple electroconvulsive shock (ECS) administration, WAY 100635 markedly increased (60-200%) the firing activity of CA3 pyramidal neurons.  Such a disinhibition was absent in rats treated with the nonantidepressant drug chlorpromazine, in rats receiving only one ECS, or in rats receiving multiple ECSs in combination with an intrahippocampal pertussis toxin treatment to inactivate Gi/o-coupled 5-HT1A receptors.  These data indicate that such antidepressant treatments, acting on entirely different primary targets, might alleviate depression by enhancing the tonic activation of forebrain postsynaptic 5-HT1A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJ1AcmgEneU7Vg90H21EOLACvtfcHk0liF45LTDUULQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyqsLc%253D&md5=ff7aea089c6fba4caecebf4bcb61d762</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.18-23-10150.1998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.18-23-10150.1998%26sid%3Dliteratum%253Aachs%26aulast%3DHaddjeri%26aufirst%3DN.%26aulast%3DBlier%26aufirst%3DP.%26aulast%3Dde%2BMontigny%26aufirst%3DC.%26atitle%3DLong-term%2520antidepressant%2520treatments%2520result%2520in%2520a%2520tonic%2520activation%2520of%2520forebrain%25205-HT1A%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D1998%26volume%3D18%26spage%3D10150%26epage%3D10156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Brunello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendlewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zohar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racagni, G.</span><span> </span><span class="NLM_article-title">Noradrenaline in mood and anxiety disorders: basic and clinical studies</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1097%2F00004850-200307000-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12817153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ovFelug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=191-202&author=N.+Brunelloauthor=P.+Blierauthor=L.+L.+Juddauthor=J.+Mendlewiczauthor=C.+J.+Nelsonauthor=D.+Soueryauthor=J.+Zoharauthor=G.+Racagni&title=Noradrenaline+in+mood+and+anxiety+disorders%3A+basic+and+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Noradrenaline in mood and anxiety disorders: basic and clinical studies</span></div><div class="casAuthors">Brunello Nicoletta; Blier Pier; Judd Lewis L; Mendlewicz Julien; Nelson Craig J; Souery Daniel; Zohar Joseph; Racagni Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">191-202</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The neurotransmitter noradrenaline is known to be involved in a range of physiological and psychological processes, and dysfunctions of this neurotransmitter system have been implicated in a range of psychiatric disorders.  However, the clinical utility of targeting the noradrenergic system in the treatment of such disorders has been somewhat overshadowed by the availability of agents selective for the serotonin system.  A number of antidepressants with increased, but varying, selectivity for the noradrenergic system have become available in recent years, including mirtazapine, bupropion and, most recently, the first truly selective noradrenaline reuptake inhibitor, reboxetine.  This review brings together current thinking on the role of noradrenaline in the aetiology and therapy of mood disorders to encourage a rational, evidence-based approach to the treatment of such disorders, and to provide suggestions and guidelines for future research in the area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqxb9KPOdPDf3jf77P2BG3fW6udTcc2easS_YtvPwEPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ovFelug%253D%253D&md5=c375997492d9ca06f765613ad71328c0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1097%2F00004850-200307000-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004850-200307000-00001%26sid%3Dliteratum%253Aachs%26aulast%3DBrunello%26aufirst%3DN.%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DJudd%26aufirst%3DL.%2BL.%26aulast%3DMendlewicz%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DC.%2BJ.%26aulast%3DSouery%26aufirst%3DD.%26aulast%3DZohar%26aufirst%3DJ.%26aulast%3DRacagni%26aufirst%3DG.%26atitle%3DNoradrenaline%2520in%2520mood%2520and%2520anxiety%2520disorders%253A%2520basic%2520and%2520clinical%2520studies%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2003%26volume%3D18%26spage%3D191%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Laje, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassman, A. H.</span><span> </span><span class="NLM_article-title">Depression and nicotine: preclinical and clinical evidence for common mechanisms</span> <span class="citation_source-journal">Curr. Psychiatry Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">470</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs11920-001-0040-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=11707160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD3MnlsVGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=470-474&author=R.+P.+Lajeauthor=J.+A.+Bermanauthor=A.+H.+Glassman&title=Depression+and+nicotine%3A+preclinical+and+clinical+evidence+for+common+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Depression and nicotine: preclinical and clinical evidence for common mechanisms</span></div><div class="casAuthors">Laje R P; Berman J A; Glassman A H</div><div class="citationInfo"><span class="NLM_cas:title">Current psychiatry reports</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-4</span>
        ISSN:<span class="NLM_cas:issn">1523-3812</span>.
    </div><div class="casAbstract">Updated findings on the relationship between nicotine and depression are presented.  Clinical and preclinical research on nicotine use and depression suggests that nicotine may have some properties in common with antidepressants.  Updated findings involve the comorbidity of smoking and major depressive disorder (MDD), the influence of depression during withdrawal on failure to quit smoking, the course of MDD without nicotine and the neurobiology of smoking and depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSuM2gHDeirZBjv2lLSLOxFfW6udTcc2easS_YtvPwEPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnlsVGnug%253D%253D&md5=2731939dd25d21e0802e82d099e140b8</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1007%2Fs11920-001-0040-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11920-001-0040-z%26sid%3Dliteratum%253Aachs%26aulast%3DLaje%26aufirst%3DR.%2BP.%26aulast%3DBerman%26aufirst%3DJ.%2BA.%26aulast%3DGlassman%26aufirst%3DA.%2BH.%26atitle%3DDepression%2520and%2520nicotine%253A%2520preclinical%2520and%2520clinical%2520evidence%2520for%2520common%2520mechanisms%26jtitle%3DCurr.%2520Psychiatry%2520Rep.%26date%3D2001%26volume%3D3%26spage%3D470%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mørk, A.; Brennum, L. T.; Fallon, S.; Bisulco, S.; Frederiksen, K.; Bang-Andersen, B.; Lassen, A. B.; Zhong, H.; Patel, J. G.; Poon, P.; Smith, D. G.; Sanchez, C.; Stensbøl, T. B.; Hogg, S.</span><span> </span><span class="NLM_article-title">Pharmacological Profile of Lu AA21004, a Novel Multi-Target Drug for the Treatment of Mood Disorders</span>. Presented at the Society for Neuroscience Meeting, Chicago, IL, October 17−21,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Poster.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+M%C3%B8rk&author=L.+T.+Brennum&author=S.+Fallon&author=S.+Bisulco&author=K.+Frederiksen&author=B.+Bang-Andersen&author=A.+B.+Lassen&author=H.+Zhong&author=J.+G.+Patel&author=P.+Poon&author=D.+G.+Smith&author=C.+Sanchez&author=T.+B.+Stensb%C3%B8l&author=S.+Hogg&title=Pharmacological+Profile+of+Lu+AA21004%2C+a+Novel+Multi-Target+Drug+for+the+Treatment+of+Mood+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26atitle%3DPharmacological%2520Profile%2520of%2520Lu%2520AA21004%252C%2520a%2520Novel%2520Multi-Target%2520Drug%2520for%2520the%2520Treatment%2520of%2520Mood%2520Disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">de Groote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klompmakers, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westenberg, H. G. M.</span><span> </span><span class="NLM_article-title">Role of extracellular serotonin levels in the effect of 5-HT<sub>1B</sub> receptor blockade</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=153-158&author=L.+de+Grooteauthor=A.+A.+Klompmakersauthor=B.+Olivierauthor=H.+G.+M.+Westenberg&title=Role+of+extracellular+serotonin+levels+in+the+effect+of+5-HT1B+receptor+blockade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BGroote%26aufirst%3DL.%26aulast%3DKlompmakers%26aufirst%3DA.%2BA.%26aulast%3DOlivier%26aufirst%3DB.%26aulast%3DWestenberg%26aufirst%3DH.%2BG.%2BM.%26atitle%3DRole%2520of%2520extracellular%2520serotonin%2520levels%2520in%2520the%2520effect%2520of%25205-HT1B%2520receptor%2520blockade%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D167%26spage%3D153%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sarkisyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">The 5-HT<sub>7</sub> receptor as a mediator and modulator of antidepressant-like behavior</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2010&pages=99-108&author=G.+Sarkisyanauthor=A.+J.+Robertsauthor=P.+B.+Hedlund&title=The+5-HT7+receptor+as+a+mediator+and+modulator+of+antidepressant-like+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkisyan%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DA.%2BJ.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DThe%25205-HT7%2520receptor%2520as%2520a%2520mediator%2520and%2520modulator%2520of%2520antidepressant-like%2520behavior%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D209%26spage%3D99%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugovic, C.</span><span> </span><span class="NLM_article-title">Selective blockade of 5-hydroxytryptamine (5-HT)<sub>7</sub> receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1124%2Fjpet.107.119404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=17314195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltFehurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=690-698&author=P.+Bonaventureauthor=L.+Kellyauthor=L.+Aluisioauthor=J.+Sheltonauthor=B.+Lordauthor=R.+Galiciauthor=K.+Millerauthor=J.+Atackauthor=T.+W.+Lovenbergauthor=C.+Dugovic&title=Selective+blockade+of+5-hydroxytryptamine+%285-HT%297+receptors+enhances+5-HT+transmission%2C+antidepressant-like+behavior%2C+and+rapid+eye+movement+sleep+suppression+induced+by+citalopram+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents</span></div><div class="casAuthors">Bonaventure, Pascal; Kelly, Lisa; Aluisio, Leah; Shelton, Jonathan; Lord, Brian; Galici, Ruggero; Miller, Kirsten; Atack, John; Lovenberg, Timothy W.; Dugovic, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">690-698</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Evidence has accumulated supporting a role for 5-hydroxytryptamine (5-HT)7 receptors in circadian rhythms, sleep, and mood disorders, presumably as a consequence of the modulation of 5-HT-mediated neuronal activity.  We hypothesized that a selective 5-HT7 receptor antagonist, (2R)-1-[(3-hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine (SB-269970), should increase activity of 5-HT neurons and potentiate the effect of selective serotonin reuptake inhibitors (citalopram).  In rats, administration of 3 mg/kg s.c. citalopram alone increased the extracellular concn. of 5-HT.  This effect of citalopram on extracellular 5-HT concn. was significantly enhanced by an ineffective dose of SB-269970.  Combining this dose of SB-269970 with a low dose of citalopram also resulted in a significant increase in extracellular concn. of 5-HT, suggesting a potentiation of neurochem. effects.  In mice, citalopram and SB-269970 dose-dependently decreased immobility time in the tail suspension test.  The dose-effect curve of citalopram was shifted leftward by coadministration of an ED of SB-269970.  Furthermore, combining ineffective doses of citalopram and SB-269970 also resulted in a significant decrease of immobility time in the tail suspension test, suggesting potentiation of antidepressant-like effects.  In rats, SB-269970 potentiated the increase of rapid eye movement (REM) latency and the REM sleep decrease induced by citalopram.  SB-269970 also reversed the increase in sleep fragmentation induced by citalopram.  Rat plasma and brain concns. of citalopram were not affected by coadministration of SB-269970, arguing for a pharmacodynamic rather than a pharmacokinetic mechanism.  Overall, these results indicate that selective blockade of 5-HT7 receptors may enhance the antidepressant efficacy of citalopram and may provide a novel therapy to alleviate sleep disturbances assocd. with depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaP25kVYHm7bVg90H21EOLACvtfcHk0liJ-DxFZplyrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltFehurc%253D&md5=75134e9e2434b911c6414a529bb65cee</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.119404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.119404%26sid%3Dliteratum%253Aachs%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DL.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DAtack%26aufirst%3DJ.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDugovic%26aufirst%3DC.%26atitle%3DSelective%2520blockade%2520of%25205-hydroxytryptamine%2520%25285-HT%25297%2520receptors%2520enhances%25205-HT%2520transmission%252C%2520antidepressant-like%2520behavior%252C%2520and%2520rapid%2520eye%2520movement%2520sleep%2520suppression%2520induced%2520by%2520citalopram%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Drevets, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furey, M. L.</span><span> </span><span class="NLM_article-title">Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression</span> <span class="citation_source-journal">Brain Struct. Funct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">213</span><span class="NLM_x">, </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1007%2Fs00429-008-0189-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=18704495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A280%3ADC%252BD1crjsVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=213&publication_year=2008&pages=93-118&author=W.+C.+Drevetsauthor=J.+L.+Priceauthor=M.+L.+Furey&title=Brain+structural+and+functional+abnormalities+in+mood+disorders%3A+implications+for+neurocircuitry+models+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression</span></div><div class="casAuthors">Drevets Wayne C; Price Joseph L; Furey Maura L</div><div class="citationInfo"><span class="NLM_cas:title">Brain structure & function</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">213</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">93-118</span>
        ISSN:<span class="NLM_cas:issn">1863-2653</span>.
    </div><div class="casAbstract">The neural networks that putatively modulate aspects of normal emotional behavior have been implicated in the pathophysiology of mood disorders by converging evidence from neuroimaging, neuropathological and lesion analysis studies.  These networks involve the medial prefrontal cortex (MPFC) and closely related areas in the medial and caudolateral orbital cortex (medial prefrontal network), amygdala, hippocampus, and ventromedial parts of the basal ganglia, where alterations in grey matter volume and neurophysiological activity are found in cases with recurrent depressive episodes.  Such findings hold major implications for models of the neurocircuits that underlie depression.  In particular evidence from lesion analysis studies suggests that the MPFC and related limbic and striato-pallido-thalamic structures organize emotional expression.  The MPFC is part of a larger "default system" of cortical areas that include the dorsal PFC, mid- and posterior cingulate cortex, anterior temporal cortex, and entorhinal and parahippocampal cortex, which has been implicated in self-referential functions.  Dysfunction within and between structures in this circuit may induce disturbances in emotional behavior and other cognitive aspects of depressive syndromes in humans.  Further, because the MPFC and related limbic structures provide forebrain modulation over visceral control structures in the hypothalamus and brainstem, their dysfunction can account for the disturbances in autonomic regulation and neuroendocrine responses that are associated with mood disorders.  This paper discusses these systems together with the neurochemical systems that impinge on them and form the basis for most pharmacological therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlcOXRChdLC4xhnOQkIHOxfW6udTcc2eao6cHQVH4j27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crjsVSmtw%253D%253D&md5=ffa3c4efbcca262b28d66023e065cf3e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2Fs00429-008-0189-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00429-008-0189-x%26sid%3Dliteratum%253Aachs%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26aulast%3DPrice%26aufirst%3DJ.%2BL.%26aulast%3DFurey%26aufirst%3DM.%2BL.%26atitle%3DBrain%2520structural%2520and%2520functional%2520abnormalities%2520in%2520mood%2520disorders%253A%2520implications%2520for%2520neurocircuitry%2520models%2520of%2520depression%26jtitle%3DBrain%2520Struct.%2520Funct.%26date%3D2008%26volume%3D213%26spage%3D93%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Fanselow, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H. W.</span><span> </span><span class="NLM_article-title">Are the dorsal and ventral hippocampus functionally distinct structures?</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=7-19&author=M.+S.+Fanselowauthor=H.+W.+Dong&title=Are+the+dorsal+and+ventral+hippocampus+functionally+distinct+structures%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFanselow%26aufirst%3DM.%2BS.%26aulast%3DDong%26aufirst%3DH.%2BW.%26atitle%3DAre%2520the%2520dorsal%2520and%2520ventral%2520hippocampus%2520functionally%2520distinct%2520structures%253F%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Mørk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreilgaard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, C.</span><span> </span><span class="NLM_article-title">The <i>R</i>-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2003&pages=167-173&author=A.+M%C3%B8rkauthor=M.+Kreilgaardauthor=C.+Sanchez&title=The+R-enantiomer+of+citalopram+counteracts+escitalopram-induced+increase+in+extracellular+5-HT+in+the+frontal+cortex+of+freely+moving+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B8rk%26aufirst%3DA.%26aulast%3DKreilgaard%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DC.%26atitle%3DThe%2520R-enantiomer%2520of%2520citalopram%2520counteracts%2520escitalopram-induced%2520increase%2520in%2520extracellular%25205-HT%2520in%2520the%2520frontal%2520cortex%2520of%2520freely%2520moving%2520rats%26jtitle%3DNeuropharmacology%26date%3D2003%26volume%3D45%26spage%3D167%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boikess, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1177%2F026988110201600403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12503828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=297-304&author=C.+E.+Beyerauthor=S.+Boikessauthor=B.+Luoauthor=L.+A.+Dawson&title=Comparison+of+the+effects+of+antidepressants+on+norepinephrine+and+serotonin+concentrations+in+the+rat+frontal+cortex%3A+an+in-vivo+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span></div><div class="casAuthors">Beyer, Chad E.; Boikess, Steve; Luo, Bin; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">The present study employed in-vivo microdialysis techniques in the freely moving rat to systematically compare the neurochem. effects of various antidepressant agents on extracellular concns. of norepinephrine (NE) and serotonin (5-HT) in the frontal cortex.  We found that acute administration of the tricyclic antidepressant, desipramine (3-30 mg/kg, s.c.) and the dual serotonin/norepinephrine reuptake inhibitor, venlafaxine (3-30 mg/kg, s.c.), produced dose-dependent and robust increases in cortical NE concns. (498% and 403%, resp.).  Conversely, acute injection of the selective serotonin reuptake inhibitors, fluoxetine (30 mg/kg, s.c.) and paroxetine (1-10 mg/kg, s.c.), did not alter forebrain NE concns.  However, paroxetine did produce a significant increase in cortical NE concns. (164%) when administered at 30 mg/kg.  These changes in NE were not paralleled by 5-HT, which showed no increase following administration of desipramine, venlafaxine, paroxetine or fluoxetine.  Combination treatment with the 5-HT1A receptor antagonist, WAY-100635 (0.3 mg/kg, s.c.), significantly enhanced extracellular 5-HT concns. following venlafaxine (10 and 30 mg/kg), fluoxetine (30 mg/kg) and paroxetine (3-30 mg/kg).  Alternatively, WAY-100635 produced no augmentation of the antidepressant-induced changes in extracellular NE.  Collectively, these studies show that paroxetine, at low to intermediate doses, and fluoxetine are selective for 5-HT vs. NE systems, whereas venlafaxine produces similar effects on both 5-HT and NE levels at the EDs tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKBQ9tr1B2rVg90H21EOLACvtfcHk0lia2ASD8GdImg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D&md5=a1675211169ec4b13feb6ae7e5803f64</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F026988110201600403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600403%26sid%3Dliteratum%253Aachs%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DBoikess%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520antidepressants%2520on%2520norepinephrine%2520and%2520serotonin%2520concentrations%2520in%2520the%2520rat%2520frontal%2520cortex%253A%2520an%2520in-vivo%2520microdialysis%2520study%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2002%26volume%3D16%26spage%3D297%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sanchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storustovu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreilgard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mork, A.</span><span> </span><span class="NLM_article-title">Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2007&pages=468-476&author=C.+Sanchezauthor=L.+T.+Brennumauthor=S.+Storustovuauthor=M.+Kreilgardauthor=A.+Mork&title=Depression+and+poor+sleep%3A+the+effect+of+monoaminergic+antidepressants+in+a+pre-clinical+model+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DC.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DStorustovu%26aufirst%3DS.%26aulast%3DKreilgard%26aufirst%3DM.%26aulast%3DMork%26aufirst%3DA.%26atitle%3DDepression%2520and%2520poor%2520sleep%253A%2520the%2520effect%2520of%2520monoaminergic%2520antidepressants%2520in%2520a%2520pre-clinical%2520model%2520in%2520rats%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2007%26volume%3D86%26spage%3D468%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Blier, P.</span><span> </span><span class="NLM_article-title">The pharmacology of putative early-onset antidepressant strategies</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1016%2FS0924-977X%2802%2900173-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12650947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitV2gurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=57-66&author=P.+Blier&title=The+pharmacology+of+putative+early-onset+antidepressant+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of putative early-onset antidepressant strategies</span></div><div class="casAuthors">Blier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">57-66</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review. Although selective serotonin reuptake inhibitors (SSRIs) have improved the safety and tolerability of antidepressant treatment, the delays in their onset of action have not been improved.  There is evidence to suggest that the delay in onset of therapeutic activity is a function of the drugs, rather than the disease.  This suggests that research into the biol. characteristics of depression and its treatments may yield faster-acting antidepressants.  Emerging evidence from clin. studies with mirtazapine, venlafaxine and SSRI augmentation with pindolol suggests that these treatments may relieve antidepressant symptoms more rapidly than SSRIs.  The putative mechanism of action of faster-acting antidepressant strategies presented here is that conventional antidepressants acutely increase the availability of serotonin (5-HT) or noradrenaline (NA), preferentially at the cellular level, which triggers neg. feedback mechanisms.  After continued stimulation, these feedback mechanisms become desensitized and the enhanced 5-HT availability is able to enhance 5-HT and/or NA neurotransmission.  Putative fast-onset antidepressants, on the other hand, may uncouple such feedback control mechanisms and enhance 5-HT and/or NA neurotransmission more rapidly.  Further studies are required to characterize in detail the interactions between NA and 5-HT systems and to definitively establish the early onset of candidate antidepressants such as mirtazapine, venlafaxine and pindolol augmentation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxz7S-sssIDLVg90H21EOLACvtfcHk0lia2ASD8GdImg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitV2gurs%253D&md5=d69ba0b6542f355ed44a8c10cef7b541</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0924-977X%2802%2900173-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-977X%252802%252900173-6%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26atitle%3DThe%2520pharmacology%2520of%2520putative%2520early-onset%2520antidepressant%2520strategies%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2003%26volume%3D13%26spage%3D57%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Gardier, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malagie, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillat, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artigas, F.</span><span> </span><span class="NLM_article-title">Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1111%2Fj.1472-8206.1996.tb00145.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=8900496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADyaK28XjtFGrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=16-27&author=A.+M.+Gardierauthor=I.+Malagieauthor=A.+C.+Trillatauthor=C.+Jacquotauthor=F.+Artigas&title=Role+of+5-HT1A+autoreceptors+in+the+mechanism+of+action+of+serotoninergic+antidepressant+drugs%3A+recent+findings+from+in+vivo+microdialysis+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies</span></div><div class="casAuthors">Gardier, A. M.; Malagie, I.; Trillat, A. C.; Jacquot, C.; Artigas, F.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-27</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review, with 88 refs., of the central serotoninergic1A mechanism of serotoninergic antidepressants which discusses: the serotoninergic synapse; in vivo microdialysis techniques; and clin. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpifa0iQo6hCbVg90H21EOLACvtfcHk0li596hnaBMxKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtFGrurY%253D&md5=99138784a921bfa1aef361375eeb943c</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1996.tb00145.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1996.tb00145.x%26sid%3Dliteratum%253Aachs%26aulast%3DGardier%26aufirst%3DA.%2BM.%26aulast%3DMalagie%26aufirst%3DI.%26aulast%3DTrillat%26aufirst%3DA.%2BC.%26aulast%3DJacquot%26aufirst%3DC.%26aulast%3DArtigas%26aufirst%3DF.%26atitle%3DRole%2520of%25205-HT1A%2520autoreceptors%2520in%2520the%2520mechanism%2520of%2520action%2520of%2520serotoninergic%2520antidepressant%2520drugs%253A%2520recent%2520findings%2520from%2520in%2520vivo%2520microdialysis%2520studies%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1996%26volume%3D10%26spage%3D16%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wolfe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Scope and limitations of the Pd/BINAP-catalyzed amination of aryl bromides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1144</span><span class="NLM_x">–</span> <span class="NLM_lpage">1157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo9916986" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=1144-1157&author=J.+P.+Wolfeauthor=S.+L.+Buchwald&title=Scope+and+limitations+of+the+Pd%2FBINAP-catalyzed+amination+of+aryl+bromides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjo9916986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo9916986%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DJ.%2BP.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DScope%2520and%2520limitations%2520of%2520the%2520Pd%252FBINAP-catalyzed%2520amination%2520of%2520aryl%2520bromides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D1144%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Pettit, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberland, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blonda, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, M. A.</span><span> </span><span class="NLM_article-title">Antineoplastic agents: XI. <i>N</i>-Bis(2-bromoethyl)amines</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1964&pages=1699-1706&author=G.+R.+Pettitauthor=M.+R.+Chamberlandauthor=D.+S.+Blondaauthor=M.+A.+Vickers&title=Antineoplastic+agents%3A+XI.+N-Bis%282-bromoethyl%29amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DG.%2BR.%26aulast%3DChamberland%26aufirst%3DM.%2BR.%26aulast%3DBlonda%26aufirst%3DD.%2BS.%26aulast%3DVickers%26aufirst%3DM.%2BA.%26atitle%3DAntineoplastic%2520agents%253A%2520XI.%2520N-Bis%25282-bromoethyl%2529amines%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1964%26volume%3D42%26spage%3D1699%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm101459g&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm101459g&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm101459g&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lj74hvuGcBR9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Sánchez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergqvist, P. B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiborg, O.</span><span> </span><span class="NLM_article-title">Escitalopram, the <i>S</i>-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2003&pages=353-362&author=C.+S%C3%A1nchezauthor=P.+B.+F.+Bergqvistauthor=L.+T.+Brennumauthor=S.+Guptaauthor=S.+Hoggauthor=A.+Larsenauthor=O.+Wiborg&title=Escitalopram%2C+the+S-%28%2B%29-enantiomer+of+citalopram%2C+is+a+selective+serotonin+reuptake+inhibitor+with+potent+effects+in+animal+models+predictive+of+antidepressant+and+anxiolytic+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez%26aufirst%3DC.%26aulast%3DBergqvist%26aufirst%3DP.%2BB.%2BF.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DS.%26aulast%3DLarsen%26aufirst%3DA.%26aulast%3DWiborg%26aufirst%3DO.%26atitle%3DEscitalopram%252C%2520the%2520S-%2528%252B%2529-enantiomer%2520of%2520citalopram%252C%2520is%2520a%2520selective%2520serotonin%2520reuptake%2520inhibitor%2520with%2520potent%2520effects%2520in%2520animal%2520models%2520predictive%2520of%2520antidepressant%2520and%2520anxiolytic%2520activities%26jtitle%3DPsychopharmacology%26date%3D2003%26volume%3D167%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm101459g">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47017"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for synthesis of intermediates and target compounds; combustion analysis and HRMS data; descriptions for in vitro and in vivo assays; p<i>K</i><sub>i</sub> ± SEM values for h5-HT<sub>3A</sub> and h5-HT<sub>1A</sub> receptors; and pIC<sub>50</sub> ± SD/SEM values for rSERT, rNET, and rDAT. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101459g/suppl_file/jm101459g_si_001.pdf">jm101459g_si_001.pdf (443.2 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101459g&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm101459g%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101459g" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990d96af233d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
